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Abstract 
Synthesis of Tailored Ligands for Radiopharmaceutical Applications 
An important aspect of clinical imaging techniques involves the use of complexed 
gamma or positron-emitting radionuclides. e.g. 99mTc (y, t112 = 6.02 h, 141 keY) for 
Single Photon Emission Tomography (SPET), 62cu (~+,t112 = 9.74 min, 1.315 MeV) 
for Positron Emission Tomography (PET). With such radiopharmaceuticals in mind, 
two new classes of acyclic tetradentate ligands have been synthesised, featuring an 
N2S2 donor system. This array of donor atoms is particularly attractive for its 'soft' 
metal preference, favouring the complexation of radionuclides such as 64cu and 99mTc 
in diagnostic imaging of disease states, and 1861188Re (~-. t112 = 90h) in targeted 
radiotherapy. In both ligand systems the sulfur donor is adjacent to pentavalent 
phosphorus. Substitution at phosphorus allows easy modification of aryl or alkyl groups 
to vary the lipophilicity of the complex without affecting the binding properties. 
The first class of new ligands presented incorporate thiophosphinic acid groups which 
are more acidic than their corresponding phosphinates and carboxylates, increasing the 
stability of the complexes in acidic media. The synthetic routes to series of such ligands 
have been investigated and optimised. Initial attempts to access the aza-
thiophosphinates via treatment of the sulfur-containing P(III) species with the diamine 
and paraformaldehyde failed to show any significant reaction. The best method of P=S 
bond formation was found to be via sulfur transfer to the corresponding P(V) 
phosphinate. The other class of ligands synthesised incorporate the 
dialkylthiophosphoryl group in conjunction with hydrazide or aminopyridyl moieties. 
The solid state structures of the ligands were determined by X-ray crystallography. 
The solution complexation behaviour of the ligands with a variety of metals, 
particularly copper and rhenium was studied. The thiophosphinic acid ligands form 1:1 
complexes with copper(II) under dilute conditions and oligomeric complexes at high 
solution concentrations. The complexes formed with copper(II) and oxorhenium(V) 
appear to be charge neutral. Several of the dialkylthiophosphorylligands formed 
copper(!) complexes by spontaneous reduction of a copper(II) source, and redox 
behaviour was also shown towards oxorhenium(V). 
Some of the ligands radiolabel efficiently with technetium-99m and copper-64 and their 
preliminary evaluation shows promise for further development. 
Morag Ann M. Easson, 1997 
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Chapter One : Introduction 
1. Introduction 
A brief outline of the applications of radiopharmaceuticals is given ( 1.1) along with 
their importance within the range of imaging techniques available in diagnostic 
medicine ( 1.2 ). The processes involved for imaging with gamma-emitters and positron-
emitters are discusssed ( 1.3) with relevance to suitable radionuclides (1.4) and their 
potemial extension to therapeutic applications ( 1.5). The administration of metal 
radionuclides as coordination complexes is assessed ( 1.6) with particular attention to 
technetium, rhenium and copper prior to illustration of their corresponding 
radionuclides in nuclear medicine ( 1. 7). Finally, the subject matter presented in 
subsequent chapters is outlined ( 1.8). 
1.1 Radiopharmaceuticals 
Radiopharmaceuticals are drugs which contain a radioactive component for the 
diagnosis or therapy of disease. Quite simply, the radioactivity can act as a signal or 
tracking device in the former case, or it can be used to destroy diseased cells in the 
latter. They exploit both the nuclear properties of the radionuclide and the 
pharmacological properties of the radiopharmaceutical. Now in routine use in clinical 
nuclear medicine for disease diagnosis in a variety of imaging protocols, they are also 
under investigation for their use in treatment. 
1.2 Diagnostic Imaging in Medicine 
Imaging techniques are important for medical diagnosis: diagnosis can be crucial for 
health and life itself. Diagnostic techniques are essential in medicine for a range of 
investigations from the detection of cancer- where early diagnosis is vital - to the study 
of neurological diseases and cardiology. Metabolic pathways and drug metabolism can 
be studied to give a greater understanding of a variety of disorders and perhaps progress 
towards an effective treatment of these diseased states. A whole range of techniques are 
available - each with different advantages and abilities to gain different levels of 
information. All are complementary as they range from providing structural information 
to molecular detail. A particular technique is chosen according to the level of 
information required. For example, a ruler is a useful tool for measuring the breadth of 
this page but quite inadequate for measuring the length of a football pitch. Different 
techniques and instrumentation are required to answer different medical questions. 
Current imaging techniques available include X-ray computed tomography (X-ray CT), 
magnetic resonance imaging (MRI), ultrasound and the radiopharmaceutical modalities 
-single photon emission tomography (SPET) and positron emission tomography (PET). 
The level of information which can be gained by each of these techniques is illustrated 
-2-
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schematically (Figure 1.1). The range in sensitivity is from the detection of millimolar 
concentrations by MRI to picomolar concentrations in PEr- a billion-fold (1()9) 
difference. 1 With respect to specificity, the range is from tissue density/water content 
by MRI to a clearly identifiable molecule (radiolabelled) by PEr. The real advantage of 
radionuclide imaging is the ability to monitor biochemical and physiological processes 
as they occur in living systems. 
MAl 
Ultrasound 
~ 
\ 
' \ 
\ 
\ 
\ 
' \ 
\ 
\ 
Figure 1.1 The spectrum of diagnostic imaging in medicine (level of information 
from various imaging modalities) reproduced from reference 1 
1.3 Radionuclide Imaging 
The requirements of any imaging technique are: an energy source; the interaction of this 
energy with the studied matter in a useful and non-uniform manner; a means of 
detecting the contrast attained; and a method of displaying this information. This can be 
easily envisaged by considering a routine X-ray that most of the population will have 
experienced at some point. In this case, the X -rays from an external source pass through 
-~-
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the subject under investigation and are attenuated more or less strongly by different 
tissues. It is this contrast which produces a picture of the subject. The important 
difference in radionuclide imaging is that the energy source is internal, arising from 
radioactivity emitted by the radiopharmaceutical (Figure 1.2). Several imaging 
techniques utilise the characteristic emissions produced by unstable nuclei. A choice of 
emission pathways provide scope for highly sensitive imaging protocols as well as 
therapy. It is therefore appropriate to consider the processes involved for radiation to 
occur. 
[ (J<o ) Image display 
Gamma 
,, ---~;=>~~---1 
_cl,_ t:,_ ·-~ 
Figure 1.2 
· Radiopharmaceutical 
Schematic representation of radionuclide imaging 
reproduced from reference2 
The Rutherford-Bohr model provides the basic picture of a neutral atom with its 
nucleus consisting of protons and neutrons (providing the mass number, A) and 
electrons remaining in their discrete orbits. Nuclei are stable in their ground state but 
unstable if they possess too much energy in an excited state. Unstable nuclei lose 
energy in the form of electromagnetic radiation or particle emissions to decay to their 
stable ground state. The ratio of protons to neutrons determines the stability of the 
nuclei and the particular deficiency (proton or neutron) determines the mode of decay. 
Alpha, beta, positron and gamma-ray emissions are common, but only electromagnetic 
radiation, such as gamma-rays, has sufficient energy to allow external detection as 
required for imaging. Detection of this radiation as a function of time forms the 
fundamental basis of SPET and PET, providing data which allows extrapolation of the 
spatial and temporal distribution of the radionuclide. Construction of a 3D distribution 
of radiopharmaceuticals in vivo is effected from a set of two dimensional projectional 
images. The planar mode of SPET, widely available in clinical practice, provides only a 
2D projection of a 3D source of activity. 
-4-
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SPET (Single Photon Emission Tomography) 
The basis of SPET is the detection ofy-rays emitted (often mono-energetically) from 
radionuclides. If a nucleus remains in the excited state for a measurable time then it is 
met~table (denoted by 'm' after the mass number). Isomers are therefore possible due 
to two nuclides having the same number of protons and neutrons but different energies. 
The metastable nuclide decays by isomeric transition by emission of a gamma-ray or a 
'conversion electron'. Metastable nuclides are particularly favourable as they often have 
a single gamma emission and may not be complicated by other accompanying 
emissions, for example, alpha or beta particles (see 1.5). These particles have a short 
range and deposit most of their radiation close to the source, which would increase the 
dose of radiation to the patient unnecessarily. Other decay processes affecting SPET 
radionuclides are electron capture and internal conversion. 'Capture' of an orbital 
electron by a proton of a neutron deficient nucleus results in the formation of a new 
neutron (and a neutrino), followed by the emission of an X-ray (equation 1.1). The 
neutrino does not affect the imaging process and will not be considered here. 
n+v equation 1.1 
The atomic number therefore decreases by one unit: 
z~Y equation 1.2 
The X-ray emitted is characteristic of the daughter radionuclide (Y, equation 1.2) as it 
is produced when the vacancy left in the particular electron shell is filled by another 
electron from a higher energy level (Figure 1.3). The radionuclide, thallium-201, for 
example, decays by electron capture and is used in diagnostic nuclear medicine. 
X-ray 
Figure 1.3 Electron capture followed by X -ray emission 
-5-
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Internal conversion is the result of excess energy from the nucleus being transferred to 
an orbital electron rather than emission of this energy as a gamma-ray. The orbital 
electron is then ejected, followed by the emission of characteristic X-rays or a second 
(Auger) electron (Figure 1.4). As short range ionising radiation, Auger emission is 
potentially useful for therapeutic applications. 
Figure 1.4 
electron emitted 
X-ray 
Auger electron 
emitted 
Internal conversion is followed by X-ray emission or Auger emission 
Gamma-rays and X-rays are both forms of electromagnetic radiation, differing only in 
their origin. Gamma-rays are emitted from the nucleus: X-rays are emitted from 
electron orbitals. 
Efficient detection of this radiation is then required for imaging the position of their 
source. The most important interactions of photons with matter (within the energy 
range applicable to nuclear medicine) are the photoelectric effect and Compton 
scattering. In a photoelectric interaction, the atom absorbs all of the energy of the 
gamma-ray and uses it to eject an inner-shell electron called a photoelectron (Figure 
1.5a). This photoelectron has an energy equal to the y-ray energy minus the binding 
energy of the electron shell. Since the detection of radiation is dependent on its 
interaction with matter, the absorbing material must possess a suitable atomic number 
(Z) since the number of photoelectrons produced is related to Z and the energy (E) of 
the incident y-ray. Sodium iodide (Z=53) is commonly used in nuclear medicine as the 
-6-
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detector scintillate material for this reason and doping with thallium (Tl) improves the 
scintillation quality of the crystal. Another consequence of the photoelectric effect is 
that radionuclides emitting low energy y-rays are unsuitable for imaging protocols, 
since the emitted y-rays are absorbed by tissue and never reach an external detector -
merely giving the radiation dose to the patient. Medium energy rather than high energy 
y-rays are required as the photoelectric effect drops off with increased energy. Compton 
scattering dominates for high energies and is caused by the interaction of a photon with 
an outer-shell electron. The photon loses some of its energy which is transfered to the 
electron, resulting in the photon being scattered in a new direction (Figure 1.5b). 
Ey 
........ _ 
Figure 1.5 (a) Photoelectric effect (b) Compton scattering 
A balance in the energy of the radionuclide is required as it has to be high enough to 
penetrate the tissue and be detected externally, but low enough to avoid Compton 
scattering becoming the predominant interaction. Radionuclides with energies in the 
range 100-200 keV are suitable for imaging protocols as this energy window provides 
the highest detection efficiency for Nal detectors. Therefore, the photoelectric effect 
governs the design of instrumentation for SPET and the choice of radionuclide emitting 
radiation in the correct energy range. A source of error in the absolute quantification of 
the technique can arise from Compton Scattering by causing loss of intensity or 
degrading the image if a detected photon has been scattered in tissue and its path altered 
prior to external detection. 
Conventional SPET systems using gamma cameras can be used for both the planar and 
tomographic modes of imaging. Either the camera system rotates 360° around the 
patient or a 'dedicated' system (Figure 1.6) encompasses the patient completely with a 
ring of sodium iodide crystals. The latter system is more effective as information can be 
acquired more efficiently and cross-sectional pictures of the distribution of the radiation 
source within the body can be produced. The spatial resolution, field-of-view size and 
-7-
Chapter One : Introduction 
and detection efficiency can be optimised by the use of collimators which act in a 
similar manner to optical lenses focusing light rays. Improvement of these 
characteristics leads to an improvement in the sensitivity and specificity of SPET 
imaging of radiopharmaceutical localisation and disease detection. 
Nal crystal, 
optical coupling 
summation 
amplifiers 
_!=,~l.llllllll.l"l.ililii!lll"ill,llli·il.llllllll-1:111!11·: 
processing and display digital computer 
Figure 1.6 Representation of a dedicated SPET system 
reproduced from reference3 
PET (Positron Emission Tomography ) 
A positron can be considered as an anti-electron, having the same mass as an electron 
but the opposite charge. Positron-emitting nuclides are unstable due to their excess of 
protons and neutron deficiency. Thus, a proton in the nucleus is transformed into a 
neutron, a positron and a neutrino (equation 1.3). 
p ---....-n+~++v equation 1.3 
Thus, the nuclide, X, is transformed to its daughter nucleus, Y, with a decrease in the 
atomic number of one (equation 1.4). 
equation 1.4 
The initial kinetic energy possessed by the positron is lost by collision deactivation 
after it has travelled a short distance (1-4 mm). The positron then combines with an 
electron to form the short-lived positronium species which annihilates to emit two y-
. ~ 
rays of 511 keV at 180° to each other (Figure 1.7). This self-destruction emitting 
-8-
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collinear photons is fundamental to the high spatial resolution in PET. Simultaneous 
det~tion of these two y-rays by the use of coincidence circuitry allows a line to be 
constructed upon which the annihilation event took place. 
• I Unstable nucleus ... v 
( 
--------- ( ""' +• 
... decays, liberating a pos~ron 0 
and a neutrino. "' 
8 Positron collides with an electron to form a positronium 
Figure 1.7 
I 
Coincidence circuit 
Positronium annihilates to 
give two coli near 511 keV 
y-rays. 
'Y Radiation detector 
Positron annihilation and coincidence detection 
The electronic circuit only registers the event if both the opposing detectors register 
radiation at the same time. Several million coincidences are recorded in a PET scan, 
forming a large number of intersecting coincidence lines. A circumferential array of 
opposing crystal detectors linked in pairs and complex circuitry make up a PET camera 
(Figure 1.8) and allow the determination of the intersection of many lines of 
annihilation which define the spatial location and quantity of positron emitters within 
the subject scanned. The spatial resolution of PET is limited by the size of each 
individual detector, non-collinearity of the two photons (arising from some net 
directional component, <0.5°) and the range of the positron as it travels between 1-4 
mm before undergoing the annihilation event that is recorded. 
-9-
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Radiation 
Coincidence Coincidence 
Circuit Circuit 
Figure 1.8 Schematic illustration of a PET camera 
reproduced from reference4 
Detection of different positron-emitting radionuclides does not require adaption of the 
equipment as annihilation of the particles always gives rise to photons of the same 
energy (511 keY). However, this energy is significantly higher than the energies of 
commonly detected photons in SPET imaging and therefore, requires a different 
scintillation material.5·6 Bismuth germanate (BGO) is a suitable material exhibiting 
high absorbing power (high stopping power) for 511 keY radiation. The advent of new 
gamma-cameras for PET with 1000 times greater sensitivity than systems previously 
employed, has resulted from improvements in scintillation materials. Research is 
continuing to find materials which have the same high absorbing power as BGO 
currently employed, but emit more light per event and with faster rise and decay times. 
Bismuth gennanate remains the chosen material for the scintillation detection of 511 
keY photons although its light output and therefore energy resolution is lower than its 
Nai(Tl) counterpart. 
In clinical practice 
SPET is currently in widespread use for investigating regional cerebral blood flow and 
for bone and myocardial perfusion imaging. Although SPET does not offer as high 
resolution and sensitivity as PET, it is more widely available due to the supply and far 
lower cost of the appropriate radionuclides. 1231, 201Tl, 11 1 In and particularly 99mTc 
are extensively used in SPET scans. The preeminence of 99mTc in nuclear medicine is 
due to its favourable properties (see below), low cost and availability. PET facilities 
continue to expand despite the huge expense encountered. The cost-effectiveness of the 
-10-
Chapter One : Introduction 
technique in terms of radiation dose versus information gained has been questioned. 
However, it remains the most specific and sensitive means for quantitative imaging of 
molecular interactions and pathways in human tissue and is consequently a valuable 
tool for the clinician. Quantitative changes can be assessed by the magnitude of the 
change in blood flow measured in ml min-1. It has enormous potential considering its 
ability to study neurotransmitters, receptors and drug binding and gain vital information 
for neurology, cardiology and oncology in assessing disease staging. Psychiatric studies 
are also receiving increased interest and investigation. 
Research in many disciplines associated with radionuclide imaging and equipment is 
continuing. These include the design of cameras, new scintillation materials, 
collimators and improvements in radionuclide availability and production to reduce the 
tiny amount of carrier molecules (stable isotopes) present. Indeed, the approach appears 
to be multidisciplinary.? A further area for continuing innovation and improvement is in 
the design and development of new radiopharmaceuticals, which provides, in part, the 
motivation for the following chapters of this work. 
1.4 Choice of Radionuclide 
There is an abundance of radionuclides suitable for imaging applications with a variety 
of physical and chemical properties. The mode of radioactive decay determines the 
radiation dose to the patient as well as the imaging properties required by the detection 
system. Production of the chosen radionuclide dominates the feasibility of the logistics 
of the study. 
Availability 
· Many short-lived radionuclides are only available from very expensive cyclotrons, 
limiting their availability, although some cyclotron-produced nuclides with slightly 
longer half-lives are accessible by regional distribution. Half-lives of the order of 
minutes can only be considered if a cyclotron is available at the hospital where the 
study is to take place. By far the most convenient method for the production of 
radionuclides is the generator system which allows SPET and PET studies to be carried 
out at centres remote from a cyclotron. Generators rely upon a longer-lived nucleus -
the parent nucleus- decaying to the more stable yet radioactive 'daughter' nucleus 
which can be eluted from the generator as it is required in the hospital. The parent 
isotope can be produced at a remote site and transported to the required site for its use 
in a generator. The half-life of the parent isotope is important as it dictates the 'shelf-
life' of the generator between replenishments. More radionuclides are becoming 
accessible from generator systems: the most common example in clinical use is the 
99MofNmTc generator for the convienient production of 99mTc. 8 Molybdenum-99 is 
-11-
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bound to an alumina column and a supply of 99mTc daughter product is continually 
produced by decay of the parent.9 The metastable product is extracted from the 
generator by repeated elution so that a fresh supply is available for numerous 
radiopharmaceutical applications. 
99Mo0 2--~------.~._99mrco4- _Y _ _.. 4 
66h 6h 
The increasing accessibility of many ~+-emitters from generators (Table 1.1) provides 
another driving force for further increase in the amount of PET radiotracers and 
facilities. Nuclear medicine requires radionuclides to be produced in high chemical and 
radiochemical purity in a no-carrier added form, that is, free from contamination by any 
stable isotopes. 
Table 1.1 Generator produced~+- emitting radionuclides 
Parent tvz Daughter tvz Positron yield 
(d) (min) (%) 
52pe 0.34 52mMn 21.1 97 
62zn 0.39 62cu 9.74 97 
68oe 288 68oa 68.1 89 
72Se 8.40 72As 1560 88 
82sr 25.6 82Rb 1.27 95 
nosn 4.11 I lOin 69.0 62 
118Te 6.0 II8sb 3.60 74 
122Xe 0.83 1221 3.62 77 
I28sa 2.43 128cs 3.80 69 
I34ce 3.0 134La 6.70 61 
140Nd 3.3 140pr 3.39 54 
Radionuclear Properties 
Accurate spatial and temporal detection of a radiopharmaceutical requires large 
numbers of emitted photons. Diagnostic imaging procedures require a radionuclide 
possessing a suitable emission (or a range of emissions) which penetrate the body to 
give a detectable signal externally. The energy of emitted photons should be greater 
than about 80 keY for practical use in obtaining high detection efficiency, 10 but not so 
great that the patient is exposed to unnecessary radiation. Current instrumentation in 
nuclear medicine requires the energy ofy-emitters to be in the range of 80-300 keY, 
while PET requires special instrumentation for the uniform 511 ke V resulting from 
positron annihilation. The half-life of a suitable candidate nuclide is probably the most 
obvious criterion for its selection as it must possess a half-life appropriate to the time 
-12-
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frame of study. Sufficient time is required to synthesise and purify the radiotracer, 
inject the compound into the patient and image its distribution. The time required varies 
according to the nature of the study: a short time is required for perfusion (blood-flow) 
studies while a longer time is required for more prolonged studies such as the 
localisation of a radiopharmaceutical incorporating a targeting vehicle like a 
monoclonal antibody (MAb). The nuclide should possess the shortest practical half-life 
compatible with the particular physiological investigation. 
y.Emitters for SPET 
The gamma-emitter 99mTc is the mainstay of nuclear medicine, 11 occuring in > 90% of 
all scans, for several reasons. It is readily available from a generator system at low cost 
and its 6 hour half-life and single gamma ray emission (accompanied only by low 
energy Auger electrons) offer ample time for imaging and deny any harmful effects of 
accompanying emissions. Radiopharmaceuticals containing 99mTc have been 
developed into 'cold' kit packages for convenience. Only rejuvenation of a single vial 
containing the other essential components with radiotechnetium eluant is required to 
form the radiopharmaceutical (see below). Formation of such tracers is rapid at room 
temperature and occurs in high yields (> 90%) of radiochemical purity. The challenge 
of technetium radiopharmaceuticals is in the development of complexes suitable for in 
vivo use as technetium, unlike copper, is not a natural physiological metal. 
Table 1.2 y-Emitting radionuclides for SPET 
Radionuclide tl/2 Principle Ey Source 
(h) (keV) 
99mTc 6.02 141 Generator 
111In 68 171,247 Cyclotron 
67aa 78 93, 184 Cyclotron 
1311 193 364,367 Reactor 
1231 13.2 159 cyclotron 
Other useful nuclides for SPET are gallium-67 and indium-Ill. Their half-lives are 
somewhat longer than required, leading to excessive exposure of the patient to 
radiation. However, nuclides with longer half-lives are suitable for targeted applications 
(radioimmunoscintigraphy) where time for the localisation of the conjugate is required. 
Iodi~e-123 has a suitable half-life and energy (159 keV) for imaging, and indeed one of 
the common radiopharmaceuticals commmercially available as a blood-flow agent is 
[1231]-iodoamphetamine (IMP). Although it is commonly and efficiently used in many 
applications, it may suffer from problems of deiodination and subsequent localisation of 
the iodine-123 in the thyroid. 
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JJ+-emittersfor PET 
Much of the driving force for the evolution of PET was provided by the short-lived 
'organic' nuclides, ttc, t3N, ISo and t8p (Table 1.3). These nuclides can be 
incorporated into natural metabolites such as amino-acids, sugars and steroids by 
replacement of their analogous stable atom without affecting the in vivo metabolism of 
the molecules. This provides a useful method of gaining information about the 
physiological fate of such naturally occuring compounds and can be similarly applied to 
therapeutic drugs to find out more about their modes of action. Studies with tic and 
tSp are the most common although relatively simple molecules such as ammonia 
labelled with 13N and water labelled with t5o have found application in perfusion 
studies.12 Myocardial uptake proportional to blood flow is exhibited by t3NH3 and a 
high sensitivity and accuracy has been obtained in detecting coronary artery diseases 
(CADs). Radiolabelled water, H2t5o, has been used to assess both cerebral and 
myocardial perfusion. 
Table 1.3 Non-metallic positron-emitting radionuclides 
Radionuclide t I/2 
(min) 
tic 20.4 
t3N 9.96 
ts0 2.04 
18p 110.0 
Positron yield 
(%) 
>99 
>99 
>99 
96.9 
Fluorine is useful for the radio labelling of such molecules despite not being a natural 
constituent of bio-organic molecules~ It is a good isostere for hydrogen and its inclusion 
offers a slightly longer time-frame (110 mins) than the other non-metallic nuclides for 
studies to take place. l8F-Fluorodeoxyglucose (FDG) ((1), Figure 1.9) has been 
extensively used in metabolic studies of the heart and brain. 13 It is enzymatically 
phosphorylated after injection to FDG-6-phosphate which is not a substrate for the 
normal glycolysis pathway of glucose metabolism. As a result, it is trapped in the cell. 
Despite the usefulness of these radionuclides they are, however, limited to research 
applications as their production is too expensive and their distribution is unfeasible for 
routine use. 
1}18Fiuoride 
OTt 2}deprotection 
OAc OH 1eF (1) 
Figure 1.9 
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The exploitation of metallic positron-emitting radionuclides is becoming more 
widespread for PET studies. In particular, the use of medium half-life nuclides is 
receiving more attention as the sensitivity and quantitative accuracy of PET can 
potentially be combined with a large number of specific tracers such as those developed 
for SPET imaging.14 An abundance of metallic ~-emitting nuclides offer huge scope for 
the development of PET due to their vast range of half-lives (Table 1.4) and a variety of 
chemical properties. Ranging from transition metals to alkali metals and lanthanides, 
there is a diversity of chemistry available to be explored and developed. Bromine and 
iodine, although non-metallic, are recognised for their suitable nuclear and chemical 
properties for imaging applications. 
Tabie 1.4 ExamEles of Eositron-emittin~ radionuclides 
Radionuclide tvz ~+Yield Radionuclide tvz ~+Yield 
~h or state<Q (%) ~h or stated2 (%) 
52 Fe 8.2 57 75sr 1.6 76 
ssco 18 77 76sr 16 57 
57Ni 36 40 83sr 33 24 
6Icu 3.4 62 89zr 78 22 
62cu 9.8 mins 98 94gTc 4.9 11 
64cu 12.7 19 94mTc 0.9 72 
66Ga 9.5 57 134La 6.7 62 
68oa 68 mins 89 1241 100 22 
82Rb+ was the first FDA (Food and Drug Administration)-approved 
radiopharmaceutical for PET imaging and is widely used in clinical practice for the 
imaging of myocardial blood flow in the detection of CADs, by administration simply 
as a chloride salt (82RbCl). It can be considered as an analogue of K+ and is taken up 
by mycocytes using the Na+ -K+ ATP pump mechanism. IS Although it is conveniently 
available from the 82Sr/82Rb generator, the scope of Rb+ for PET imaging is somewhat 
restricted by its short half-life (1.27 min) and limited coordination chemistry. 68Ga, 
produced by the 68Gef>8Ga generator has a more suitable half-life (68 mins) and useful 
coordination chemistry for complexation with some multidentate ligands. Another 
generator produced positron-emiiter is llOin from the 110Sn!110In system. Despite the 
half-life of the parent isotope being a mere 4.15 h, the use of 110rn has been suggested 
for the labelling of white blood cells with regard to organ transplant rejection. 16 
Copper-62 has received more attention than most generator-produced positron emitters, 
due to its favourable chemistry, potential applications and the existence of several other 
useful copper radioncuclides of different emissions and half-lives. Whilst there are only 
two stable isotopes of copper (with slight variation of abundances), there are a range of 
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copper radioisotopes possessing various emissions and various half-lives (Table 1.5).17 
This itself is advantageous, as a new copper radiotracer in the early stages of 
development can be studied using a longer-lived copper radioisotope before 
employment of the relatively short-lived 62cu species which allows less handling time. 
However, practical application of the generator system may be limited due to short 
half-life of the parent isotope 62zn (t112 9.36 h). Replenishment is often required and 
this particular isotope can be available from many medium-energy cyclotrons. iS 
Copper-64 and copper-67 also offer scope for therapy because of their beta-emission 
and suitable half-lives (see section 1.5). 
Another opportunity which may soon be exploited is 94mTc. As a positron-emitter with 
a suitable half-life for imaging, 94mTc could access all the radiopharrnaceuticals used in 
the clinic for SPET by swapping technetium nuclides. 
Table 1.5 Ph~sical EroEerties of Cu radionuclides for imasins and theraE~ 
Radionuclide t1/2 Emission Ep Enp Rnp Source 
(h) (%) (keV) (keV) (mm) 
60cu 0.38 ~+ (93) 511 873 4.4 cyclotron 
EC (7) 1332 
6Icu 3.3 ~+ (62) 511 527 2.6 cyclotron 
EC (38) 283 
62cu 0.16 ~+(98) 511 1315 6.6 generator/ 
EC (2) cyclotron 
64cu 13 ~+ (19) 511 278 1.4 reactor/ 
EC (41) 1346 cyclotron 
~- (40) 190 0.95 
66cu 0.09 ~- (100) 1109 5.6 reactor/ 
cyclotron 
?7cu 62 ~- (100) 93 121 0.61 reactor/ 
c clotron 
EP=energy of the most abundant penetrating (y) radiation following the coresponding decay 
Enp=average energy of the most abundant nonpenetrating <W /(~+,} radiation 
Rnp=average range of nonpenetrating radiation in tissue 
1.5 Complementary radiopharmaceuticals for therapy 
As radiopharrnaceuticals depend upon both their biological behaviour and physical 
decay, maintaining effectively the same chemical properties but altering the mode of 
decay (by substitution of a different isotope) allows potential for therapy. The 
replacement of different metal nuclides in the same radiopharmaceutical is not limited 
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to isotopes of the same element (e.g. technetium-99m or 94m) nor to imaging 
applications. Some radionuclides, such as l88Re and 186Re, have suitable emissions for 
therapeutic and simultaneous imaging applications. There is interest in developing 
radiopharmaceuticals for therapy based on rhenium for two main reasons: rhenium 
complexes are very closely related structurally to their analogous technetium-
containing compounds and I88Re is available from the I88wti88Re generator. It is their 
analagous chemical behaviour and potential for complementary imaging and therapy 
which merits the discussion of rhenium radionuclides here as there are many other 
nuclides with suitable properties for therapeutic applications.19 Sufficient radioactivity 
must be transported to the tissue being targeted to kill the diseased cells whilst keeping 
the uptake in non-target tissue to a minimum. The ionising emission processes with 
potential suitability for therapeutic use decay by alpha, beta and Auger emission. 
Very heavy elements (Z>83) emit alpha particles which consist of two protons and two 
neutrons (helium nuclei) (equation 1.5). Despite their relatively large size and 
consequently short range (40-90 ~m or several cell diameters), alpha particles are 
suitable for therapy due to their strong ionising ability. 
equation 1.5 
Beta emission results from an excess of neutrons (and proton deficiency) and is the 
transformation of a neutron to a proton, an electron c~-) and a neutrino (equation 1.6). 
n ---.... p+W+v equation 1.6 
Therefore, the daughter nuclide is a different element, with an atomic number increased 
by one (equation 1.7). 
Ay 0 
Z+1 +_,e+v equation 1.7 
Although beta particles are lighter than alpha particles with a single charge enabling 
them to penetrate further, they still have a short range in tissue (in the order of several 
mm), giving most of their energy to matter close to the parent atom. 
Auger electrons (see section 1.3) may also prove useful in this context, although their 
range is extremely short- about one cell nucleus in diameter. 
Copper-64 uniquely combines positron, beta, and Auger emission, giving it the ability 
to be used in therapy and imaging simultaneously (Table 1.5, section 1.4). Both 
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radioisotopes of rhenium emit energetic beta particles possessing a strong ability to 
penetrate tissue (90% of the radiation is deposited within 5.5 mm). 188Re emits a high 
energy beta-particle CE.nax=2.1 MeV) suitable for the treatment of diseases requiring 
longer ranges. l86Re has a longer half-life (3.78 days) but less energetic emission 
CE.nax=l.08 MeV) which gives it a slightly shorter range (around 2 mm) compared with 
the range of l88Re (around 5.5 mm). Both rhenium radionuclides are suitable for 
therapy, providing variability in the half-life and positron energy, depending upon the 
target size and volume. 
These particle emissions are sometimes accompanied by emission of gamma rays. If 
these photons are of a suitable energy then they can be used for simultaneous imaging 
to monitor the localisation properties, pharmacokinetics and dosimentry in patients. 
The gamma-ray abundance should be low to minimise the adverse radiation dose, yet 
produce enough photons for imaging. Pure gamma-emitters like 99mTc can be used for 
imaging to establish the targeting suitability and a therapeutic analogue then prepared. 
For example, 99mTc diphosphonates are used for skeletal-metastases imaging. The 
therapeutic congener of technetium, 186Re, was subsequently prepared in the form of a 
diphosphonate- l86Re-HEDP (hydroxyethyldiaminetetramethylene-phosphonate) (2) -
to act as an agent for the pain relief of patients suffering from bone-cancer. 
H3CXOH 
o~P P~o 
HO'I l'oH 
OH OH 
(2) HEDP 
1.6 Administration of Metal Radionuclides 
The term 'pharmaceutical' may evoke images of natural products and organic molecules 
as therapeutic drugs. This is quite natural, considering the composition of biological 
matter. But metals have been used in medicine since antiquity and examples of these 
range from bismuth anti-ulcer treatments to platinum anti-cancer compounds.2o Metal 
radionuclides offer significantly more appropriate nuclear properties for imaging and 
therapy in many cases. They may appear more challenging to administer than their 
'organic' counterparts but this challenge highlights the value of coordination chemistry 
in medicine and offers scope to exploit the properties of the complexes and use them to 
best advantage. Increasing numbers of radiopharmaceuticals are based on well-defined 
coordination complexes. 
Metals must be administered to the patient in the form of coordination complexes and 
desirable metals must form stable complexes with good kinetics of complexation. 
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Thermodynamic stability is not the real issue: in vivo stability is important in this 
biological context. Although physiological conditions are pH7.4 and 3TC, there are 
various enzymes, proteins and cells as well as local variations in pH which may 
challenge the integrity of the coordination complex. Thus, it is the kinetic stability 
which determines the fate of the complex. Kinetic stability is favoured when the 
coordination sphere of the metal is saturated and the metal is in an oxidation state 
which is stable in vivo. The complex should be charge neutral or cationic to disfavour 
protonation and acid-catalysed dissociation pathways on electrostatic grounds. Charge 
neutrality is also necessary for passive diffusion through cell membranes and 
penetration of the blood-brain barrier (BBB) in humans. The BBB is a special 
membrane which protects the brain from fluctuations in the composition of the blood 
and from circulatory neurotransmitters and neuroactive agents. 21 It is selective in the 
choice of molecules allowed through and acts to restrain ions and peptides. Crossing the 
BBB also requires complexes to be lipophilic and of relatively low molecular weight22 
in order to become useful agents for imaging brain and heart. Additional functionalities 
present as part of a neutral complex - such as amide, alcohol or carbonyl groups - may 
exhibit some hydrogen-bonding and thus lower the overalllipophilicity of the complex. 
This would reduce the ability of the complex to cross the blood-brain barrier. Many 
radiopharrnaceuticals are excluded from the BBB in a normal brain and can 
consequently diagnose brain abnormalities. For example, in brain tumours, the BBB 
breaks down (post radiotherapy or chemotherapy) and many non-diffusable compounds 
enter. A positive scan provides information about these abnormalities. 23 
Another practical consideration is that the radionuclide must be added in a synthetically 
easy step which occurs rapidly in order that the time available from the decay is 
usefully employed for imaging. 
Design of Radiopharmaceuticals 
Radiopharmaceuticals can be classed as 'metal-esssential' and 'metal tagged'. Metal-
essential radiotracers rely on their own intrinsic properties such as charge, shape, 
lipophilicity and redox properties to determine their biological distribution. Metal-
tagged radiopharrnaceuticals are regarded as bifunctional chelators where the ligand 
that binds the radionuclide is attached to a targeting vector or carrier molecule such as a 
monoclonal antibody or small peptide. which determines its biodistribution. The metal 
is simply transported by this vehicle to act as a marker. In both cases, the metal 
coordination chemistry determines the ultimate geometry and stability of the 
radiopharmaceutical. A high kinetic stability is sought in order that the 
radiopharmaceutical localises in the target organ, or is excreted intact. 
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Features of Ligand Design 
Observations of a great many coordination compounds have led to the definition of 
certain general trends which can form the foundations for the design of new ligand 
architecture. Selection of donor atoms within a ligand can provide a means of 
increasing or decreasing the binding interactions with certain cations and affects the 
rate of formation of the complex. Pearson's classification of hard/soft acids and bases24 
provides a useful preliminary guide for the selection of a particular donor atom to 
favour binding for a specific metal cation. Metals are classified as 'hard' (class a), 'soft' 
(class b) or 'borderline' (Figure 1.10). 
Class a 
fl:l2:l ~
Class b 
--- ---
order line 
Figure 1.10 Classification of acceptor atoms in their common oxidation states25 
By selecting suitable complementary donors (Lewis bases) for a particular metal, the 
complex stability and ligand selectivity can be maximised. For example, a hard cation 
like Li+ could be matched with oxygen donors but a soft more polarisable cation like 
Au+ would be better matched with sulfur, while borderline cations may tolerate both. 
The common donors are: 
hard nitrogen as amines, imines, amides 
oxygen as ethers, carbonyls, carboxylates, alcohols 
soft phosphorus as phosphines 
sulfur as thiols, thiolates, thioethers 
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The influence of donor atoms is manifest in the coordination number as their charge 
can satisfy the charge demands of the metal and consequently affects the number of 
them which can be present. Metal-ligand attractions must exceed destabilising 
repulsions. Coordination number generally increases with the size of the metal ion to 
increase the complex stability; for example, first transition row elements favour 4, 5, or 
6-coordinate complexes while larger cations such as lanthanides prefer an 8 or higher 
coordinate environment. The complex geometry is associated with the coordination 
number as 4-coordinate complexes tend to adopt tetrahedral or square planar geometry 
while 6-coordinate complexes of the same metal are octahedral in order to minimise 
charge and steric repulsions. 
The chelate effect is another important consideration. Generally, a complex containing 
one or more 5- or 6-membered chelate rings is thermodynamically more stable than a 
complex with the same donors as monodentate ligands. The chelate ring size favoured 
for controlling metal ion selectivity and complex stability is dependent on the size of 
the metal cation. 5-Membered chelate rings are favoured by larger metal ions while 6-
membered chelate rings are favoured by smaller ions by virtue of the relative bite 
angles, metal-ligand bond length and the ring-strain which results (Figure 1.11).26 
Lowest ring strain geometry for : 
5-ring chelate 6-ring chelate eclipsing 
interactions ~ 
H H 
favours binding to larger cations 
in higher coordination numbers 
("'~~oA u 
favours binding to smaller cations 
in lower coordination numbers 
Ar~l.54A 
N'~~N I ..........- I lowest energy chair 
~ conformation 
H 
dlsfavoured 
Figure 1.11 Favoured geometries for 5- and 6-ring chelates 
Although much of the complexation criteria outlined have a profound affect on the 
thermodynamic stability, it should be remembered that it is kinetic stability and a rapid 
rate of formation of a complex which are the factors most relevant to 
radiopharmaceuticals (see above). Acid stability is especially important when 
considering local areas of low pH which may be encountered in vivo such as the 
stomach and bile. 
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Complementary ligands for technetium, rhenium and copper 
Technetium and copper offer joint opportunities for the design and development of 
various radioparmaceuticals (with a choice of nuclear properties- see above) for SPET 
and PET imaging using a single class of ligand. This is due to some similarities in the 
coordination preferences of these metals, for example, borderline donor atom 
preferences and complex geometry (see below). Versatility of component parts would 
allow tailoring of characteristics, such as lipophilicity, required for specific 
applications. Complexation of the same system with rhenium also offers the potential 
for therapeutic radiopharmaceuticals. Therefore, these metals in particular provide the 
focus for the material presented in subsequent chapters. 
Coordination chemistry 
Copper has found useful applications for an estimated 7000 years. It is no stranger to 
biology as it is the third most abundant trace metal in the human body and is found in 
protein-bound forms. Its chemistry is dominated by two major oxidation states, Cu(l) 
and Cu(ll), allowing a colourful range of coordination chemistry, characteristic of the 
transition metals, whilst uncomplicated by several oxidation states. Cu(ID) is far less 
cominon, being easily reduced, although it is present transiently in the redox chemistry 
of the element. 
Cu(ll) has an electronic configuration of [Ar]3d9 imparting paramagnetism and making 
regular complex geometries a rarity. Common coordination numbers are four, five and 
six arranged in square planar, tetragonally distorted octahedral or intermediate 
geometries as a result of Jahn-Teller distortion.27 The unequal electron occupancy of 
the eg set of the d9 configuration leads to an elongation of the axial bonds in octahedral 
geometry, and in the extreme situation, complete loss of these two ligands to effectively 
produce square planar geometry. In practice, distorted octahedral, square planar or 
distorted tetrahedral geometries (Figure 1.12) are not sharply differentiated and many 
intermediate distorted geometries prevail. 
OH2~2+ 
H2o,,,, I ,,,, OH2 
··c .. 
H20,..,.... (' OH2 
OH2 
distorted octahedral distorted tetrahedral square planar 
"f~l' 
1-C _,,,,\\NH2 I~NH2 
H2N~ 
trigonal bipyramidal 
Figure 1.12 Examples of Cu(II) geometries 
By contrast, Cu(l) is predominantly colourless or yellow in solution owing to its d 10 
configuration. Although commonly 4-coordinate and tetrahedral in geometry, 
coordination numbers of 2 and 3 are also known, giving linear and pyramidal 
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geometries respectively (Figure 1.13), in addition to binuclear bridged, polynuclear or 
chained structures. 
L L ,, 
L./C~L 
CuL4+ 
X 
I 
Cu .• ,,11 L./ ~ L 
L 
CuXLs 
X C 
,,,,,,L 
-~ L 
Figure 1.13 Examples of Cu(I) structures 
In solution, Cu(I) is unstable with respect to disproportionation: 
2Cu(l) __ __,.. Cu(II) + Cu(s) 
The redox couple, Cu(II) to Cu(l) (E. 0.153 V [H20, I=<U, 298K]), also provides a 
useful means of initiating complex dissociation: a substitutionally inert Cu(ll) complex 
may be readily reduced to a Cu(I) intermdiate and then undergo ligand exchange or 
dissociation. Such redox-catalysed ligand exchange can provide a useful biological 
trapping mechanism and a means of selective tissue targeting if the complex is tailored 
for this purpose. 
As discussed above the choice of donor atom is critical to ligand design. Copper(ll) is 
regarded as a 'borderline' cation according to the Pearson classification: a fact also 
evident from the natural occurrence of its major ores in the form of sulfides, oxides and 
carbonates. Fifty percent of all copper deposits are copper pyrite (CuFeS2). Nitrogen 
and sulfur are well established in complexation of copper and there is a wealth of 
examples of complexes possessing these donor atoms. Copper(!), in particular, exhibits 
strong binding interactions with 'soft' polarisable ligands such as thioethers, nitriles, 
isonitriles, phosphines and thiolates. Hence the use of a 'softer' donor set should favour 
the reduction of a copper(II) complex to Cu(l). Conversely, reduction of Cu(II) could 
be blocked by using hard ligands, for example, in a targeted conjugate where complex 
stability is of greater importance. 
As expected, the second and third row transition elements, technetium and rhenium, 
exhibit substantially similar coordination chemistry to each other. Their chemistry bears 
little resemblance to their first row counterpart, manganese, which is dominated by the 
oxidation state II. However, they have considerable chemistry in the IV and 
particularly, V oxidation states. 28,29 Oxo-compounds predominate and pertechnetate 
(Tc04-) and perrhenate (Reo4-) are especially useful. These ions are tetrahedral in 
geometry and stable in alkaline solution in contrast to their permanganate relation. Oxo 
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compounds are prevelant for the higher oxidation states of rhenium, in particular, V and 
VII. An important class of such complexes contain oxorhenium(V) centres with 
phosphine ligands. For example, ReOX3(PPh3h is readily obtained30 and the halide or 
ligand trans to the Re=O bond is labilised due to the trans effect (Scheme 1.1 and 
section 6.2). 
Scheme 1.1 
Three isomers of ReOX3(PPh3h are possible although only two are observed (Figure 
1.14). 
0 
Cl,,,,,, II ,,,,,PR3 
Re' 
R3P~ I ""Cl 
Cl 
trans-isomer 
green 
0 
R3P,,,, II ~,,CI 
•· Re··' 
R3P~ I ""c1 
Cl 
tao-isomer 
blue 
Figure 1.14 Isomers of ReOX3(PPh3h 
Complexes of rhenium(V) can also have a trans-dioxo core like technetium, for 
example, with pyridine as [Re02PY4l (3) (see later Figure 1.16) and ethylenediamine 
[Re02en:iJ. Nitrido complexes of rhenium(V) provide another series of stable 
complexes important to the metal in this oxidation state, such as [Re(N)X2(PR3)J]. 
The study of technetium coordination chemistry has taken place over the last fifty years 
since the discovery of the element. 31 There are no stable isotopes of technetium but full 
characterisation including X-ray structural analysis of technetium complexes has been 
achieved with the isotope 99Tc (t112=2.1 x 105 years) giving access to a useful array of 
structural information. 32,33 Coordination numbers vary from four to eight with six 
appearing the most regularly. In nuclear medicine, Tc(V) with an oxotechnetium 
(Tco3+) core has proved the most amenable to the synthesis of well-defined small 
molecules that have sufficient stability in aqueous solution. Flexibility in their chemical 
make-up and properties is allowed by virtue of the choice of ligands. Five-coordinate 
complexes with an oxo-technetium core are typical, like rhenium, and attributed to the 
ability of the oxo species to quench the high formal charge of the metal in the + V 
oxidation state and labilise the trans-position of the complex to give an overall distorted 
square pyramidal geometry. Many Re(V) and Tc(V) complexes which contain an oxo-
metal core are square-based pyramidal. The oxygen is at the apex and bidentate or 
tetradentate ligands occupy the basal positions, while the sterically demanding metal 
sits slightly above the basal plane (Figure 1.15). 
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Figure 1.15 Typical geometry for complexes with a Tco3+ core 
The size of the chelate rings typically found in this class of complex are five-membered 
although some six-membered chelate rings are also successful. Other types of oxo core 
are also common such as [O=Tc=O]+ and [0=Tc-O-Tc=0]4+. The bisoxotechnetium 
core is. important in the coordination chemistry of technetium(¥), e.g. [M02L4]+, with 
its formation dependent upon the ability of the other coordinating ligands to donate 
negative charge to the metal. Such complexes bear strong relation to the oxo-rhenium 
complexes. 
Neutral nitrogen donors tend to result in the formation of a bisdioxo (M02 +) core, like 
rhenium, as they are unable to deprotonate due to their relatively high protonation 
constants. As such, they are unable to offer any neutralisation of the high positive 
charge as demanded by the mono-oxo (M03+) core, and the bis-oxo complex 
predominates to aid the charge deficit and effect a mono-cationic complex. This 
similarity with rhenium is exemplified by characterisation of the analogous technetium 
complex with ethylenediamine34 ( 4) and complexes with the macrocycle, 1 ,4,8, 11-
tetraazacyclotetradecane (cyclam)35,36 (5) (Figure 1.16). 
0 
Py ,,,,, II ,,,,, Py 
"·Re·' 
Py f!""' II 'Py 
0 
(3) [Tc02(Py)4]+ 
Figure 1.16 Examples of complexes with rhenium or technetium trans-dioxo cores 
A range of donor atoms besides nitrogen are tolerated by technetium and rhenium, 
including oxygen, nitrogen and sulfur donors as well as phosphines and halides. Carbon 
donor ligands such as isonitriles form complexes with low oxidation state technetium. 
Athough rhenium and technetium in oxidation state (V) are regarded as 'soft' rather than 
'hard',37 they are known to bind 'hard' oxygen donors. Alcoholic or carboxylate forms 
of oxygen provide metal complexes which are amenable to ligand exchange, such as 
catechoP8 and tetrachlorocatechol (6),39 and consequently provide good starting 
materials for nuclear medicine where relatively mild complexation conditions are 
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sought. Glycol, tartrate, citrate and glucoheptonate are similarly involved in the 
preparation of radiopharmaceuticals.40 
0 
II 
CI~;~Tc,+:;~o~ Cl 
Cl~ ~CI 
Cl Cl 
(6) 
Sulfur donors are now extremely common in technetium and rhenium chemistry, 
having a high affinity for both metals, and forming well-defined mono-oxo species by 
satisfying the metal's positive charge. Although the metals can exhibit oxidation states 
from +I to VI, 'soft' sulfur donors promote Tc(V) and Re(V). This is especially true of 
negatively charged dithiolate ligand complexes, [TcO(S2h:r. NeutralS-donors such as 
thioethers and thiocarbonyls complex effectively with the metals and show a preference 
for oxidation states of less than five presumably due to their inability to satisfy the 
Tc(V) positive charge.41 
The use of mixed donor groups in Tc and Re chemistry is widespread, with thio-amine 
systems proving particularly advantageous. Ligands possessing the N2S2 donor set 
were shown to form neutral lipophilic complexes of 99mTc as early as 1979.42 For 
example, diamino-dithiols (DADT) ligands, [also known as bis(aminoethanethiol) 
(BAT)] (7) (Figure 1.17), form neutral complexes ofTc(V)o3+ owing to the 
deprotonation of both thiols and one of the amines to neutralise the positive charge. The 
penicillamine complex of technetium (8) is an example of an N2S2 system prepared in 
strong acid solution to favour the amines remaining in their protonated form. One of the 
pendent carboxylate groups coordinates to fill the trans position, compensating for the 
charge of the core and rendering the complex 6-coordinate. The amine protons of 
DADT systems (7), are sufficiently basic for one of them to remain protonated upon 
complexation to give a charge neutral complex. In contrast, systems based upon ligands 
with a diamidedithiol (DADS) (9) backbone lose both amide-nitrogen protons in 
addition to the two thiols rendering the complex negatively charged as a result.43.44.45,46 
Neutral complexes of Tco3+ are formed by diamide-thiol-thioether ligands (10). The 
alkyl group forming the thioether side chain may be varied to allow the preparation of a 
versatile series of analogues or to tolerate conjugation to a targeting vector.47 
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(8) 
Figure 1.17 Oxo-technetium complexes with N2S2 donor systems 
Mixed ligand sytems have recently increased in prominence because of the potential for 
easy modification of complex properties. Several possibilities are apparent in denticity 
and arrangement of ligands as illustrated (Figure 1.18). A tridentate amine ligand could 
form such a complex with, say, a thiolligand filling the last coordination site and 
allowing further elaboration of the rest of the thiol moiety. 
II 
~~~Tc~~L 
"---/ 
3+1 
II 
~~Tc~•~L) 
2+2 3+2 
0 
II 
~ 
4 
Figure 1.18 Possible arrangements of ligands around oxotechnetium 
Tetradentate ligands offer the possibility of a mixed set of donor atoms with functional 
groups predisposed to binding and increased stability owing to an increase in the 
chelate effect. 
1.6 Technetium, rhenium and copper complexes in nuclear medicine 
There is a wide variety of technetium complexes in clinical use or undergoing pre-
clinical and clinical research in nuclear medicine. Complexes which show promise for 
in vivo applications, but which are lacking in some quality necessary for imaging 
applications, can be derivatised and a series of analogues studied to find a more suitable 
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candidate. For example, more recent derivatives of DADT ligands (see above) were 
more lipophilic and the technetium complexes were able to penetrate the BBB as a 
result.48 Successful research efforts have produced many well-defined Tc complexes 
for particular target organs, in particular, the brain and heart.49,50,51,52 
This type of derivatisation was also employed to find a successful phosphine ligand. 
The ability of tertiary phosphine ligands to participate in synergic bonding enables them 
to form stable complexes with transition metals in a variety of oxidation states and 
geometries, for example, Tc (V), (ill) and (I) form cationic complexes with 1,2-
bis(dimethylphosphino)ethane (dmpe) (Figure 1.19). Subsequent studies and 
derivatisation of diphosphine ligands led to the synthesis of a promising myocardial 
imaging agent in the form of the trans-dioxotechnetium(V) complex of 1,2-bis(bis-
ethoxyethyl)phosphino)ethane (11). The ether functionalities improve the clearance of 
the lipophilic tracer from non-target tissue. 
Figure 1.19 Technetium complexes with dmpe 
Ether functionalities are similarly exploited to increase hydrophilicity and reduce the 
protein binding in vivo in the 99mTc-furifosmin complex, (12). It is a technetium(III) 
comi?lex with a mixed ligand system in which a tetradentate Schiff-base ligand, 
trans( 1 ,2-bis[ dehydro-2,2,5,5-tetramethyl-3-furanone-4-methylene-amino ]ethane) 
occupies the equatorial sites, and the phosphine ligands occupy the two axial positions. 
Available as a heart imaging agent, 99mTc-furifosmin is formed in high radiochemical 
purity from a 'cold' kit containing the lyophilised ligand and accompanying 
components. 
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There are a number of commercially available radiotracers for brain imaging. Du Pont's 
Neurolite® utilises L,L-ethyl cysteinate dimer (L,L-ECD) (13)- a diamine-dithiol 
system with two ester functionalities on the carbon skeleton. 53 The esters have little 
hydrogen-bonding properties enabling radionuclide complexes of the ligand to 
penetrate the BBB. Many neutral complexes are able to penetrate the brain but are 
simply washed out. L,L-ECD is washed out of several species including mice, cats, 
dogs and monkeys but shows uptake in humans. The mechanism for retention is 
extremely elegant as only one ester is hydrolysed by endogenous esterase enzymes. The 
singly charged complex is then retained in the brain. Retention is also enantioselective 
as D,D-ECD diffuses back across the BBB and is obviously not a substrate for the 
esterase enzyme. 54 
Propyleneoxime (PnAO) derivatives55 also form neutral complexes which show good 
cerebral extraction. Racemic hexamethyl propyleneoxime (d,l,-HMPAO) (14), available 
from Amersham International as Ceretec®, was the first approved 99mrc cerebral 
perfusion imaging agent for human applications. 56 The loss of two protons from two 
amines and one oxime renders the complex neutral. Once taken up into the brain, the 
racemic complex is retained and transformed (far more rapidly than the meso isomer) 
into a more hydrophilic species which is unable to diffuse back across the BBB. The 
selective retention mechanism is thought to involve intracellular glutathione, although 
the exact nature of the product species is not yet known. The conversion to the more 
hydrophilic species occurs within 30 minutes, hence imaging with d,l-HMPAO should 
be conducted as soon as the initial complex is formed. 
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(14)Tc-HMPAO 
Anionic complexes (TcO(MAG)3]2- (15)57 and the oxotechnetium complex of 
dime.rcaptosuccinic acid [Tc(DMSAhr (16) are useful for renal imaging as the 
carboxylic acid functions aid renal excretion of the complexes, with the former 
marketed as TechneScan. The [Tc(DMSAhr complex has three isomers due to the 
orientation of these acid groups in relation to the metal-oxygen core, similar to its 
rhenium counterpart (see below). 
HOOC . ?! COOH 
HOOC\b Tc d/COOH S'/~S 
s s 
syn-endo 
[TcO(DMSA)2r 
(16) 
The production of rhenium-188 from a tungsten generator system has opened up the 
potential of this radionuclide in radiotherapy. 58 Although it forms a suitable therapeutic 
partner for technetium, rhenium is a great deal more difficult to substitute than its 
imaging counterpart. For example, Re-DTPA requires higher temperatures and a larger 
amount of the stannous reducing agent for complexation to occur. In contrast, Tc-
DTPA forms instantly at room temperature. Radiopharmaceuticals of meso-1,2-
dimercaptosuccinic acid (99mTc-DMSA) have found application in renal diagnosis. The 
complex also localises in medullary thyroid carcinoma, thus if labelled with ~--emitting 
186Re or 188Re, a potential method of tumour therapy may be accessed. Again, the 
rhenium complexes require heating for formation (10<YC, 30 mins for l86Re)59 while 
the technetium analogues are formed immediately at room temperature. With both 
metals, three isomers are formed, resulting from the orientation of the carboxylate 
groups on the backbone upon complexation. The isomers of [Re(DMSAhr have been 
separated by HPLC60 and elute in the order anti, syn-exo, syn-endo (Figure 1.20). 
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Figure 1.20 [ReO(DMSAh:r isomers 
Another route to [ReO(DMSAh:r complex formation, which takes place at room 
temperature, has been reported by Lisic.61 It utilises the precursor ReOCl3(PPh3h 
complex in dichloromethane or chloroform. 
The specificity of radionuclide imaging techniques has led to the design and synthesis 
of some extremely innovative coordination complexes as potential radiolabelled probes 
for steroid receptors with the imaging of receptor-positive tumours as their goal. The 
obvious approach may be conjugation of a suitable metal-complex to a steroid: the 
ambitious approach is the integration of the metal-complex with the steroid so that the 
whole molecule imitates the overall size and shape of the steroid. Katzenellenbogen and 
co-workers have produced several mimics of hormonal steroids62,63 initially with the 
conjugated approach,64 such as (17), and now concentrating upon an integrated 
approach. The conjugate (17) consists of a of a DADT complex and a progestin. One of 
its stereoisomers binds the progestin-receptor with three times the affinity of the natural 
hormone, but is, however, too lipophilic which resulted in non-specific binding. Less 
lipophilic analogues65 still proved unsatisfactory for targeting due to their large mass 
and steric bulk. 
"h 
s 0 
'\.II/ 
M 
/". 
s 
0 
(17) 
The less lipophilic conjugates did show some promise in terms of the relatively low 
polarity of the metal-complex. This promise led to the design of integrated systems 
where the metal could be incorporated into a steroid-like structure. Obvious challenges 
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of integrating a unit of the size of a metal-ligand complex are associated with 
compromising the binding affinity due to the added bulk. Computer modelling 
suggested that the complex (19) closely mimics the androgen, 5a-dihydrotestosterone 
(18) by replacement of the trans-decalin BC ring system with a bis(aminothiol) 
complex of oxotechnetium or oxorhenium for potential application in imaging prostatic 
carcinoma. Subsequent synthesis of the complex overcame some challenging 
stereochemical issues which could only be determined upon binding of the ligand to the 
metal. The Re=O bond is anti to the methyl and hydroxyl groups which is essential to 
the mimicry of the biological substrate. Another interesting issue is the successful 
formation of a heterodimeric complex of two different aminothiolligands. Despite their 
successful synthesis, the complexes lacked stability arid are degraded in water. 66 
Recognition of the inferior stability of a bisbidentate complex compared to a 
tetradentate system has led to the synthesis of a tetradentate ligand for complexation 
and evaluation with oxotechnetium and oxorhenium cores. 67 
0 
OH 
N-- t'o 
- s 
0 ~ 
H 
(18) (19) 
Natural Steroid - Dihydrotestosterone Steroid-Mimic Design 
Figure 1.21 Steroid and complex mimic 
OH 
Several complexes have been synthesised as mimics of estradiol (Figure 1.22) including 
(20) - a bis-bidentate complex. Attempts to make the tetradentate system (21) led to a 
tridentate (3+ 1) complex (22). Complex stability was enhanced by the derivation of a 
tetradentate ligand (23) with amine-amide-thioether-thiol N2S2 donor system and the 
rhenium complex was synthesised. However, it only showed micromolar affinity for the 
estrogen receptor. 
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Figure 1.22 Estradiol and its steroid mimics 
The 3+ 1 system (25) (Figure 1.23) was also synthesised by the same research group to 
mimic the structure of the non-steroidal estrogen, hexestrol (24). Although stable, its 
affinity for the estrogen receptor was also found to be low. 68 
OH 
(24) 
hexestrol 
Figure 1.23 Hexestrol and its oxo-rhenium mimic 
The availability of 62cu from the 62znJ62cu generator69, 70,71 has increased the 
potential application of this radionuclide in imaging. Copper bis(thiosemicarbazone) 
complexes are a very important class of radiopharmaceuticals. In particular, CuPTSM 
[PTSM=pyruvaldehyde bis(4-methiosemicarbazone)] (26) (Figure 1.24) has been 
studied extensively for use as a perfusion tracer in PET imaging. Two other derivatives, 
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PTS (27) and PTSMz (28), differing only in their degree of methylation were also 
examined and the PTS complex was shown to be inadequate to penetrate the BBB. The 
more lipophilic complexes (PTSM and PTSM2) were able to diffuse into the brain, but 
PTSMz was rapidly cleared while PTSM was retained in the brain. The charge 
neutrality and lipophilicity of CuPTSM and its 'microsphere'-like distribution (rather 
than behaviour as a freely diffusible tracer) make it a good marker for perfusion 
measurement This is desirable as a radiopharmaceutical that distributes as a 
microsphere would allow the quantitative study of blood flow. The trapping mechanism 
of Cu-PTSM was investigated by Green et al ,12 by studying a variety of Cu(II) 
bis(semicarbazone) complexes and measuring their reduction potentials. Cu-PTSM 
diffuses into cells where Cu(II) is reduced to Cu(I) by intracellular glutathione, making 
the previously neutral complex anionic and subject to intracellular binding. Cu-PTSM 
is taken up and and retained in most tissues and has the potential for myocardial and 
cerebral perfusion imaging in addition to regional blood flow to tissues. 
NHMe 
,N=\ 
M):N S ~'\./ 
Cu 
H ~N/ ""-s 
'N=( 
NHMe 
(26) CuPTSM 
Figure 1.24 Copper bis(thiosemicarbazone) complexes 
Although Cu-PTSM is the best copper perfusion tracer to date, myocardial perfusion is 
underestimated at higher rates of flow. Uptake of the tracer is non-linearly proportional 
to blood-flow at higher flow rates and less tracer is extracted by the heart. This 
evidence in humans is contrary to the dog model and is an important example of 
interspecies variability which can often challenge radiopharmaceutical development. 
Consequently, more derivatives of Cu(II) bis(thiosemicarbazone) complexes have been 
prepared as the ligand system is known to be sensitive to substitution at the terminal 
carbon (C=S). 73 This time, two dissimilar thiosemicarbazone functions were 
incorporated (Figure 1.25). Thus the search for the perfect PET perfusion tracer 
continues. 
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a) R1= NHCH3, R2= NH2 
b) R1= NH2, R2= NHCH3 
c) R1 = NH(CH3)2, R2= NH2 
d) R1= NH(CH3)2, R2= NHCH3 
Further PTSM-type derivatives 
A number of Schiff-base ligands have been synthesised and give rise to an [N20v2-
core suitable for complexation with copper to form neutral, lipophilic molecules (Figure 
1.26). Although some of the 62cu-radiolabelled complexes showed penetration of the 
BBB in rats, none of them were as effective as 62cu-PTSM. 
HaC~CHa 
N o· 
A.iN o· 1 II I H3C~CH3 
Figure 1.26 Examples of Schiff-base ligands for copper complexation 
Copper radionuclides have also received much· attention for their potential to form 
macrocyclic complexes conjugated to antibodies for radioimmunoscintigraphy.74·75 The 
targeting of radiopharmaceuticals, in general, has been aided by the development of 
monoclonal antibodies which may be selectively functionalised by ligands for 
radionuclide complexation. 76 As the antibody has affinity for the antigens found on the 
surface of tumour cells, this protein can act as a carrier for the radionuclide and be used 
for both imaging and therapy77,78 depending upon the nature of the radiation emitted 
(see section 1.5). In both instances, it is crucial that the complexes formed are 
substitutionally inert in vivo and suitable conjugates are known. Copper-64, copper-67 
and technetium-99m have suitable half-lives for such applications. Both metals form 
thermodynamically stable and kinetically inert complexes with macrocycles like cyclam 
(Figure 1.16, section 1.6). Further application of stable complexes of nuclides like 
copper, with isotopes possessing suitable emissions, such as 64cu, may be found in 
targeted therapy and bifunctional complexing agents are under investigation for this 
purpose. 79 Several derivatives of cyclam bearing an appropriate pendent group allow 
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such protein conjugation. For example, the vinylpyridine group of (29) was conjugated 
to an antibody by conversion of the antibody lysine residue into a thiol and subsequent 
reaction of this functionality with the vinyl group. The study of other vehicles for the 
efficient and selective delivery of radiocopper is also in progress. Porphyrins are 
potentially suitable due to the high stability of copper-porphyrin complexes and the 
ease of porphyrin derivatisation for coupling. 
fs H H 
(29) 
1.8 Scope of this work 
IThis thesis is concerned with the synthesis of new ligand systems for radionuclide 
complexation, in particular, technetium, copper and rhenium. 
Chapter 2 introduces a new tetradentate ligand system incorporating thiophosphinic 
acid and amine functional groups to offer an N2S2 donor atom array. The 
thiophosphinate functionality has several advantages including high acidity and a 
pentavalent site to tolerate further elaboration of the system. The overall system allows 
scope for variation of component parts and modification of complex lipophilicity, in 
addition to the possibility of conjugation to suitable targeting vectors. Difficulties in the 
synthesis of this ligand system and several alternative synthetic routes are discussed in 
addition to the complexation behaviour of the ligands with metal ions such as copper 
and rhenium. 
Chapter 3 describes another new N2S2 tetradentate ligand system based on dihydrazide 
and dialkylthiophosphoryl functionalities. The ligand synthesis is described followed by 
the development of further ligands incorporating the dialkylthiophosphoryl functional 
group. The complexation behaviour of these systems is then addressed with particular 
attention to copper(!) and copper(II). 
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Chapter 4 considers ligand systems based upon the thiophosphinic acid group attached 
to more rigid skeletons. Difficulties in their synthesis are discussed together with 
several potential synthetic routes. 
Chapter 5 describes the radiolabelling and preliminary evaluation of the ligands 
synthesised in chapters 2 and 3 with copper-64 and technetium-99m. 
Chapter 6 details experimental procedures and general methods. 
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2. Aza-Thiophosphinic Acid Ligands 
The design of a new class of ligands based upon aminothiophosphinic acids is 
presented. Key features of the architechture are examined with respect to the tailoring 
ofradiopharmaceuticals (2.1), and the unique feature of the thiophosphinate 
functionality is related to aminocarboxylic acid and aminophosphinic acid analogues. 
The synthesis and difficulties experienced with different synthetic routes are explored 
and the successful synthesis of this ligand class is discussed (2.2). Complexation studies 
with rhenium and copper by techniques such as ESMS, HPLC and spectrophotometry 
are reported (2.3) and general conclusions are summarised (2.4 ). 
2.1 Design of a New Ligand System 
The range of radionuclear properties offered by the isotopes of copper, technetium and 
rhenium for their application in nuclear medicine provides the driving force for the 
design and synthesis of a new class of ligands to complex these metals and allow 
variation of the ligand component moieties to optimise the properties of the complex. 
Such versatility would allow the tailoring of the radiopharmaceuticallipophilicity by 
elaboration of the ligand, or alteration of radionuclear properties by substitution of a 
different radionuclide with similar coordination preferences. This may allow 
development of radiopharmaceuticals for different applications within nuclear 
medicine. Consideration of the desirable properties of a radiopharmaceutical reveals 
that a finite stability may in fact be advantageous (Ch.l). Rapid kinetics of 
complexation are essential and the complex should be sufficiently stable in vivo to 
reach the desired organs of the body and may encounter some areas of low pH in the 
process. However, degradation of the complex in some way, for example by 
dissociation or reduction of the metal, may provide a means of intracellular trapping 
and hence localisation of the radionuclide. These criteria together with analysis of the 
requirements of a ligand system for complexation of copper, technetium and rhenium 
radionuclides and consideration of observed trends in the coordination chemistry of 
these metals ( Ch.l) led to the design of a new class of ligands with the general structure 
represented below (Figure 2.1). 
~--------------------------. 
Figure 2.1 
l R = alkyl or aryl J n = 1 or 2 
(30) 
A new ligand system 
-42-
Chapter Two: Aza-Thiophosphinic Acid Ligands 
Overall architecture 
The overall structure of the ligand system is tetradentate with donor atoms arranged to 
form three 5-membered ring chelates or one 6-ring (n=2, Figure 2.1) with two 5-ring 
chelates. This offers the greater stability associated with ligands of higher denticity and 
optimum chelate ring size (see 1.6). Variation of the chelate ring-size may allow the 
opti~um architecture for the particular metal to be assessed. Use of the N2S2 donor 
system should prove advantageous for copper, technetium and rhenium with their 
'borderline' donor preferences. Neutral copper(II) complexes may be formed due to the 
combination of neutral amine donors with two negative sulfur donor atoms. Such donor 
atoms should favour the stabilisation of 'soft' Cu(l), which is potentially useful, as 
intracellular reduction of the Cu(II) complex (for example by glutathione) may lead to 
retention of the radionuclide. This could be due to the anionic nature of the reduced 
complex rendering it less able to diffuse back out of the cell, or because the Cu(O 
complex is expected to be less stable to dissociation and hence may be retained 
following loss of copper from the complex. Neutral complexes may also be formed 
with technetium and rhenium in oxidation state (V) with an oxometal core (see 
examples in 1.6 and 1.7) by charge donation from the two negative sulfur donors and 
one deprotonated amine. The secondary amines may be easily deprotonated, hence a 
charge neutral complex may be formed by such ligands with a Tco3+ core, for 
example, 99mTc-ECD (13) (section 1.7). 
Tuning of Lipophilicity 
Lipophilicity of radiopharmaceuticals is crucial to their activity in vivo, hence the 
ability to alter this characteristic without compromising other important properties is 
extremely advantageous. In the ligand design described above (Figure 2.1), it is 
possible to vary the lipophilicity of the complex without compromising the metal 
binding properties. The pentavalency at phosphorus allows control over complex 
lipophilicity and may also afford a means of conjugation to a suitable targeting vector 
through variation of the phosphorus alkyl or aryl substituents.4 The ethanediamine or 
propanediamine backbone allows another option for further elaboration of the ligand. 
Substitution of this two-carbon or three-carbon backbone would also provide a means 
of alteration of complex lipophilicity or allow a tether to a targeting vector to be 
attached. For example, (31) shows a propylene backbone which can be derived from a 
malonate fragment. 
R, S 
Htf\ 
'R>C''····· N OH 
"R ~ OH 
\._p~ 
'~s 
R 
(31) 
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Acidity of thiophosphinic acids 
The use of the thiophosphinate funtionality is a unique feature of this system. 
Thiophosphinic acids are more acidic than their corresponding phosphinic and 
carboxylic acid analogues, as demonstrated by the protonation constants for a series of 
acids (Table 2.1). Sequential replacement of the oxygen atoms by sulfur atoms 
decreases the protonation constants obtained. I This may enhance the stability of the 
metal complexes with respect to dissociation in acidic media. 
Table 2.1 Decreasing trend in protonation constants 
for phosphorus acids 
Ligand pKa 
EtC(O)OH 4.87 
Et2P(O)OH 3.29 
Et2P(O)SH 2.54 
Et2P(S)SH 1.71 
There is a tautomeric equilibrium between the two possible forms (Figure 2.2). With 
two different alkyl or aryl substituents at phosphorus, a stereo genic centre at 
phosphorus is formed which is not present in solution with the corresponding 
substituted phosphinic acids due to a similar tautomerism. With such phosphinates, 
however, a stereogenic centre is created at phosphorus when one of these phosphinate 
oxygens is bound to a metai.2·3 
R /.s "~ /p~ 
'R OH 
phosphinothionic acid 
Figure 2.2 
R SH 
"-/ p~ 'R/~0 
phosphinothiolic acid 
Corresponding amino-carboxylic and amino-phosphinic acids 
Amino-carboxylic acids are ubiquitous in nature and have been greatly studied. 
However, they are generally unsubstituted at nitrogen and a higher denticity or array of 
linked donor atoms is preferable for use in coordination chemistry. Arguably, the most 
important ligand of this type is Schwarzenbach's EDTA (ethylenediamine-N,N,N,'N'-
tetra-acetic acid)4 (32), which gives an N204 donor set arranged to give 5-membered 
chelate rings upon metal complexation. Its relation, EDDA (ethylenediamine-N,N'-
diacetic acid) (33),5 has fewer donor atoms with an N202 donor set. Variations with a 
propylenediamine backbone, giving a 6-membered chelate ring have been exploited, as 
have·macrocyclic arrays such as NOTA and DOTA.6 
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Figure 2.3 EDTA and EDDA 
Amino-phosphinic acids are generally similar in their properties to their carboxylic 
counterparts although the phosphinate oxygen is more difficult to protonate, as 
mentioned above, and a wealth of examples supporting this observation are 
documented. 7 ,8,9,10 Indeed, several azaphosphinate macrocyclic complexes are 
remarkably resistant to acid-catalysed dissociation.ll Phosphinate analogues of EDT A 
and EDDA were reported by Martefll2- EDTPi (ethylenediamine-N,N,N,'N'-tetra-
phosphinic acid) (34) and EDDPi (ethylenediamine-N,N'-di-phosphinic acid) (35) 
(Figure 2.4). They show an increase in acidity (lower pKa's) for P(O)OH deprotonation, 
as expected, and the basicity of the amine is lowered by the presence of the electron 
withdrawing groups. The ligands form 1:1 complexes with transition metals, although 
these are less thermodynamically stable than analogous carboxylate complexes. 
(35) 
Figure 2.4 EDTPi and EDDPi 
The next stage in the development of such systems was substitution at phosphorus to 
yield ethylenediamine-tetrakis-[ methylene(phenylphosphinic)] acid (H4EDTMPPh), 
(36). Studies of the protonation behaviour of this ligand by Lukesl3,14 indicate that it 
shows greater similarity to EDTA than analogous phosphonic acids. 
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(36) 
Although the most profound difference between the use of phosphinic acid groups in 
preference to carboxylic acids is an increase in acidity, there are other consequences of 
this change. The use of a phosphinic acid offers a larger chelate bite angle upon 
complexation than a carboxylic acid (Figure 2.5). The angle at the metal ( <NMO) 
formed by the phosphinate is less acute than the angle produced by the carboxylate. 
Both the C-P and P-0 bonds of the phosphinate (185 pm and 150 pm respectively) are 
longer than the corresponding C-C and C-0 bonds of the carboxylate (154 pm and 125 
pm respectively). iS 
Figure 2.5 Chelate bite angles formed by aza-carboxylates and aza-phosphinates 
Several acyclic tetradentate ligands incorporating substituted phosphinic acid 
functionalities were synthesised and their complexation behaviour was investigated by 
Parker et al. 16 The protonation constants for the methyl and phenyl P-substituted 
ligan_ds was found to be very similar, while ligands with a diaminopropane skeleton 
gave higher protonation constants at nitrogen than the corresponding diaminoethane-
based systems. The ligands were synthesised by the reaction of diaminoethane or 
diaminopropane with paraformaldehyde and the appropriate phosphorus (III) precursor 
to form the cyclic aminal diester (37) which was purified by column chromatography 
on alumina (Scheme 2.1). Subsequent hydrolysis by heating in 6M hydrochloric acid 
yielded the amino-phosphinic acid ligand (38). 
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31PNMR 
(CHO)n, RP(OR')2, 
THF.~ 
R=Me,Ph 
R'=Me,Et 
R ,~Q 
. r'oR· 
C> 
N OR' \_~ 
I Q 
R 
(37) 
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6MHCI 
R 
'.....&:0 ~~~ t 'cJH 
Jl\._ ,PH 
p~ 
I 0 
R 
(38) 
Scheme 2.1 Synthesis of substituted aza-phosphinic acids 
Another useful feature of both the phosphinic acid ligands and the proposed new 
thiophosphinic acid ligands is their amenability to 3lp NMR. This is an invaluable tool 
for monitoring the synthesis and complexation behaviour of new ligands. For example, 
a phosphinic acid with 8p in the range of 20-30 ppm is in stark contrast to its 
thiophosphinic acid analogue with 8p in the 60-80 ppm range - a difference in the 
regiqn of 40-50 ppm. This is extremely diagnostic, since differentiation between sulfur 
and oxygen attached to phosphorus is much less apparent by a study of the 
neighbouring protons in the 1H NMR spectra. Furthermore, the progress of a reaction 
can be studied simply by the temporary removal of a small sample and direct analysis 
by 3lp NMR since a deuterated solvent is not essential. 
ligand Series 
Many variations upon this type of system (Figure 2.1) can be envisaged since a large 
number of alkyl or aryl substituents at phosphorus are possible. In order to allow 
evaluation of the coordination preferences of such aza-thiophosphinate ligands, a 
simple series of four ligands was proposed (Figure 2.6). For example, the use of a 
diaminoethane or diaminopropane moiety allows the effect of a five-membered chelate 
ring versus a six-membered chelate ring to be assessed with either a P-phenyl or a P-
methyl substituent for each. The P-phenyl derivative with a diaminoethane backbone 
unit was addressed first, in order to establish a viable synthetic route. 
-47-
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Ph, :rs 
HtF( 
eN OH N OH 
H \_p' 
1 ~s 
Pn 
Me, 8 
HlP( 
eN OH N OH 
H\._' p~ 
· I S 
Me 
Figure 2.6 Amino-thiophosphinic acid ligand series 
2.2 Synthesis 
Initial P(lll) route 
A flexible, general synthetic route allowing a variety of different substituents at 
phosphorus was envisaged (Scheme 2.2) in an analogous manner to the synthesis of 
corresponding aza-phosphinic acids.16 Therefore, the phosphorus(III) precursor 
required for this pathway was a monothioester of the type RP(OR')(SR") and had first 
to be prepared from a dichlorophosphine via a monosubstituted chloroethoxy 
intermediate. 
+ 
OR' / 
R-P""-
SR' 
(CHO)n, THF, 
~ 
R \ ~0 
lp\ 
SR' 
CN> 
N SR' 
'-' p~ 
I 0 
R 
R ~0 17 ~ 'sH 6MHCI 
~ SH \_I p~ 
I 0 
R 
Scheme 2.2 Proposed synthesis of amino-thiophosphinic acid ligands 
Preparation of chloroethoxyphenylphosphine, PhP(OEt)Cl, was initially attempted by 
addition of one equivalent of sodium ethoxide to dichlorophenylphosphine, PhPCh. in 
dry ether (Scheme 2.3). The reaction was followed easily by 31p NMR, and more 
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sodium ethoxide was added until there was no dichlorophenylphosphine starting 
material remaining. The product mixture was filtered to remove the sodium chloride 
salt (removal of all traces of halide prior to Arbuzov reaction is crucial) to give a 
mixture of chloroethoxyphenylphosphine and diethoxyphenylphosphine. 
+ NaOEt 
Scheme 2.3 
Cl 
I 
PhP\ 
OEt 
+ 
OEt 
I 
PhP\ 
OEt 
However, purification by vacuum distillation proved exceedingly difficult as both of the 
phosphorus (III) species are extremely sensitive to hydrolysis and very volatile. Use of 
higher temperatures induced the decomposition of both P(III) species. Therefore, a 
method was sought to prepare the phosphine more cleanly as this attempted purification 
proved too problematic. This was achieved by a metathetical reaction where equimolar 
amounts of dichloroethylphosphonite and dichlorophenyl phosphine were mixed at o·c 
in an inert atmosphere to form chloroethoxyphenylphosphine cleanly (Scheme 2.4).17 
ooc 
+ PhP(OEt)2 
No solvent 
Scheme 2.4 Disproportionation reaction to give the pure product 
The best result was obtained by carrying out the reaction in the absence of solvent, and 
31p NMR revealed that the monochloroethoxyphenylphosphine (8p +174 ppm) was the 
sole product. The mechanism by which this reaction occurs can be addressed by 
considering the relative nucleophilicities of the two different phosphorus species 
present. The more nucleophilic diethoxyphosphine may attack the dichlorophosphine 
and an intramolecular rearrangement may then occur to give only one product (Figure 
2.7). 
Ph 
/' ~OEt 
~CI ·.' PhP\~ OEt 
Cl 
Figure 2.7 
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This procedure was also applied to an alkyl-substituted dichlorophosphine, in the form 
of an ethyl rather than methyl derivative due to the availability of the dichloroethyl 
starting material. The disproportionation reaction also worked well, producing the 
chloroethylethoxyphosphine after preparation of the other necessary starting material, 
diethylethylphosphonite, by addition of sodium ethoxide to dichloroethylphosphine in 
dry diethyl ether (Scheme 2.5). 
+ 2 NaOEt EtP(OEt)2 
dry ether 
Scheme 2.5 
0°C 
No solvent 
Cl 
I 
EtP\ 
OEt 
Preparation of ethoxyphenyl-S-ethylphosphine, PhP(OEt)(SEt), was initially attempted 
by the addition of sodium ethanethiolate to the neat monochloro phosphine in order to 
displace the remaining chloride (Scheme 2.6). However, the reaction was observed to 
be too exothermic to allow effective heat dissipation from such a small reaction 
volume, and hence some solvents were considered for this step. Distilled toluene was 
found to be the best solvent for this reaction performed at -50°C. These conditions 
allowed the precipitation of the sodium chloride salt, enabling it to be removed 
effectively by filtration. 31p NMR analysis indicated that the product, PhP(OEt)SEt, (Op 
+ 145.8 ppm) represented about 50% of the phosphorus species present. The chemical 
shifts of the other products were all much lower ( -0-50 ppm), indicating that they were 
all P(V) species and that the only P(lll) species present was PhP(OEt)SEt, although the 
overall purity of the sample was only 50%. However, the other products present were 
P(V) which have no effect upon the following Arbuzov reaction. 
PhP(OEt)CI + NaSEt 
Scheme 2.6 
-50 oc 
toluene 
/OEt 
PhP"-
SEt 
The analogous dithiophosphine, PhP(SEt)2 (Op +74.4 ppm) was prepared by the 
addition of two equivalents of sodium ethanethiolate to dichlorophosphine in 
dichloromethane at -30°C (Scheme 2_7). In an effort to prepare PhP(OEt)SEt more 
efficiently, a disproportionation reaction was attempted with PhP(SEth and PhP(OEth 
but perhaps unsurprisingly, no reaction was observed. 
PhPCI2 + 2 NaSEt 
-30 oc 
DCM 
Scheme 2.7 
-50-
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Reaction of substituted thiophosphines 
With the required PhP(SEt)OEt freshly prepared, the Arbuzov reaction was attempted 
by refluxing ethylenediamine and paraformaldehyde with the phosphine in dry THF 
using a Soxhlet apparatus with molecular sieves for 2 days, until only a little starting 
material remained visible by 31 P NMR. However, a mixture of several products had 
formed and a mass spectrum showed that none of the species present had a large 
enough mass to be consistent with the formation of the desired product The largest 
mass observed, 230, was presumably the oxidised starting material - PhP(O)(OEt)(SEt) 
- which seemed to have formed competitively despite the inert gas atmosphere used. An 
analogous reaction was attempted with the less air-sensitive, 18,19 PhP(SEt)2, but this 
failed to show any significant reaction. 
Since the initial attempts to form the cyclic aminal diphosphinates from thiophosphines 
failed, consideration was then given to reactions with the oxygen analogue PhP(OEth 
to investigate if this reaction occurred readily, since it is known that the 
dimethoxyphosphines react effectively under identical conditions. 20 These results are 
summarised (Table 2.2) and indicate that a phenylphosphine with diethoxy substituents 
surprisingly does not exhibit the expected reactivity. 
Table 2.2 Reactions with diethylphenylphosphonite 
Amine Aldehyde Result of reaction 
or Ketone 
0 0 
Ph II II Ph CNH, -R P.-(CH20)n 1 '--N~N_/ \OEt 
molecular 
EtO ~ 
NH2 
sieves + hydroxymethylene 
0 
CNH, ~-Ph (CH20)n HO_./ bEt 
without orily hydroxymethylene NH2 
sieves (H, 0 11 -Ph 
(CH20)n HOJbEt N~ 
hydroxymethylene CNH, 0 A No reaction N~ (H, 0 ) No reaction 
N~ 
-51-
Chapter Two: Aza-Thiophosphinic Acid Ugands 
Specifzcity problems of reactions with substituted phosphines 
The problem with the failed reaction of the original scheme remained extremely curious 
as PhP(SEt)OEt and even PhP(OEth failed to react under these conditions when the 
analogous reaction is known with PhP(OMeh. A similar reaction was undertaken with 
PhP(OMeh, paraformaldehyde, and ethylenediamine under identical conditions. 
Purification of the products by chromatography and characterisation confirmed that the 
cyclic aminal bisphosphinate had formed readily, and the excess phosphine and 
paraformaldehyde had formed the hydroxymethylene species (Scheme 2.8). 
/OEt 
Ph-~ 
OEt 
+ 
+ 
CNH, 
NH2 
eN~ 
N~ 
(CHO),., THF, 
li 
(CHO)Il' THF, 
li 
no cyclic aminal 
formed 
Ph, O 
R~ 
/'oMe 
CN> 
N \._ ,OMe 
p~ 
I 0 
Ph 
(39) 
Scheme 2.8 Reactivity difference between methoxy- and ethoxyphosphines 
It can be concluded that although reactions occur with diethoxyalkylphosphines, they 
do not proceed when the substituent is phenyl rather than alkyl. Greater reactivity is 
exhibited by dimethoxy-substituted phosphines as the reaction occurs even when the 
electron-withdrawing phenyl group is present. 
With this knowledge, the original scheme was re-employed adopting dimethoxy 
phosphines in place of the diethoxy analogues. The original interchange reaction was 
attempted to prepare PhP(OMe)Cl. However, thereaction was much more vigorous 
and formed additional species presumably due to the release of a large amount of heat. 
The reaction was attempted in toluene at low temperature to give a greater volume to 
dissipate the heat of reaction. However, the reaction could not be carried out cleanly, as 
shown by 31P NMR analysis. Formation ofPhP(SMe)2 was then attempted by addition 
of two equivalents of sodium methane thiolate to dichlorophenylphosphine, however, a 
mixture of products was obtained. The reaction itself was not visibly as instantaneous 
as its ethanethiolate counterpart 
In order to overcome the problem of decreased nucleophilicity of the phenyl substituted 
phosphines, an alkyl phosphine was utilised as the starting material in place of the 
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phenyl compound. Since the alkyl group is electron donating rather than delocalising, it 
should be more nucleophilic. Ethyldithioethylphosphine, EtP(SMeh, was prepared 
from dichloroethylphosphine by addition of sodium methanthiolate. The monothio-
substituted product appeared to form reasonably rapidly (()p 166.6 ppm), and further 
portions of methanethiolate were added until conversion to the dithiomethyl species (()p 
88.6) was complete. The product dithiophosphine was treated with diethylamine and 
paraformaldehyde under the usual conditions, as a test reaction, but it was found to 
merely oxidise to S,S-dimethylethylphosphodithiodic ester, EtP(O)(SMe)2. Purification 
of EtP(SMeh from slight P(V) impurities was attempted by distillation, but gave the 
same result- formation of EtP(O)(SMe)2. 
It is clear that the phosphine precursors are formed more readily with ethoxy and 
ethylthio substituted phosphines, but methoxy and methylthio substituted phosphines 
are required for the Arbuzov step. Furthermore, each phosphine with its particular 
substituents appears to have its own specific reactivity depending upon the choice of 
alkyl/aryl and alkoxy substituents rather than forming a series exhibiting general trends. 
Consequently, the planned route to these thiophosphinates is not at all versatile as had 
been initially hoped. 
Another, though less immediate, problem with these thiophosphinate esters may be 
difficulties concerning their subsequent hydrolysis. The only literature examples to date 
detail the hydrolysis of activated thiophosphinate esters, (Figure 2.8) often requiring 
catalytic procedures with enzymes21,22 or high pH. 23 This process is extremely slow 
and may not be achieved easily with the particular esters studied in this work. 
u -o-Ph-Fj-0 \_ ~ X 
OEt 
X=CN 
Figure 2.8 Activated phosphinate esters 
With these difficulties in mind, alternative routes for the synthesis of aza-
thiophosphinic acids were sought. 
Conversion of P=O to P=S following cyclic aminal formation 
Due to the failure of this initial route, attention was then directed towards a direct 
sulpliur transfer to the oxygen analogues (P=O to P=S). This had been attempted in 
previous work by Eleanor Cole,20 when it was found that a thiourea (41) formed on the 
bridge of the cyclic aminal ( 40) (Scheme 2.9). 
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Sa. pyridine 
(40) (41) 
Scheme2.9 
Since sulphur transfers to this position initially, the resulting thiourea was treated with 
phosphorus pentasulphide in a further attempt to transfer sulphur to the phosphonate 
esters (Scheme 2.10). 31p NMR showed two major products had formed, Op 85.1 and 
8p 80.7, with the major mass intensity at 391 corresponding to the thiophosphinate 
adduct with ammonia (374 + 17). However, the proton NMR spectrum indicated the 
presence of the phosphorus methyl and ethoxy groups, but a great shift or 
disappearance of the N-CH2-P methylene protons. This pilot reaction was undertaken 
on a very small scale using an old sample from previous work and, clearly, further 
investigations are required here. However, the documented difficulty in the hydrolysis 
of such thiophosphinate esters provided sufficient motivation to investigate other routes 
which circumvented this anticipated problem. 
Me, 0 R~ 
f 'oEt N [~s 
N OEt \_t 
p~ 
M~ 0 
(41) 
Alternative synthetic approaches 
Scheme 2.10 
Sulphur transfer then amine addition 
Me '~s ~p\ 
I OEt N [~s 
N OEt 
'-' p~ I S 
Me 
(42) 
Consideration was therefore given to a number of alternative approaches. It is possible 
that the phosphinothiolic moiety can be created prior to the reaction with a tosylated 
amine. Hydrolysis of the esters and removal of tosyl groups may then be affected by 
HBr in glacial acetic acid (Scheme 2.11). One concern of this reaction may be the 
possibility of competing S-alkylation.24 Nevertheless, if the mesylated 
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phosphinothiolate could be prepared without this interference, then the success of a 
subsequent reaction is a serious possibility. 
s 
II MeO-~OMs 
I 
R 
(1) DMF I K2C03 
(2) HBr/ AcOH 
Scheme 2.11 
R 
\ .& s ~P.~ 
H' \ eN OH 
N OH H\._ I f::::::s 
R 
The precursor could be prepared from a hydroxymethylene compound with a silicon 
group protecting the alcohol during the sulphur transfer (Scheme 2.12). Indeed, the 
silylation step was accomplished and the sulphur transfer was attempted, using 
ethyl[(hydroxymethylene) phenylphosphinate] which was isolated as a by-product from 
earlier reactions. The P=S compound sought was not initially isolable from the reaction 
mixture, and a parallel approach which showed more promise was pursued in 
preference. 
MeO"-
P-R 
/ 
MeO 
0 
II 
MeO-P~ 
I OH 
R 
TBDMS-CI J 
THF, 
imidazole 
MeO-~~cr-J- Bu1 ~~luene Meo-~o-li- Bu1 ! I ---- J I 
TBAF 
s 
11/"-.. 
MeO-P OH 
I 
R 
MsCI 
Et3N /THF 
················-~ 
s 
MeO-rOMs 
I 
R 
Scheme 2.12 Proposed synthesis of mesylated-thiophosphinate 
-55-
Chapter Two: Aza-Thiophosphinic Acid Ligands 
Direct addition of sulfur 
Attempts to transfer sulfur to a phosphinate ester have already been considered with 
regard to the aminal (see above). However, assuming this could be achieved, the 
question of hydrolysis of thiophosphinate esters remains unanswered. Hydrolysis of the 
phosphinate esters prior to sulfur transfer was thought to be a good solution as it may, 
in addition, be beneficial to the sulfur transfer step itself. This can be explained in terms 
of the relative ease of enolate formation (Figure 2.9). The NCH2P methylene protons 
would not be so acidic and hence prone to sulfur insertion with an oxygen anion rather 
than a neutral ester. 
R Mea,' P=a ( 
~N~ (a) (N)=s 
N ___ .,.. 
~P.='O' s~P.-'cfo M a ....... \ e R 
M a ....... \ 
e R 
......._/ 
N 
(b) ~ P."'O' unfavourable. 
w'Qe 
Figure 2.9 a) Possible problem with sulfur transfer 
b) Methylene protons are less acidic with anion instead of ester 
One possible route would require the cyclic aminal phosphinate esters as precursors 
which could then be treated with elemental sulfur to block the methylene bridge prior to 
removal of the esters with lithium hydroxide (Scheme 2.13). Sulfur transformation 
could then be achieved using P 4S10 for example, and finally, hydrolytic removal of the 
thiourea bridge would give the desired molecule. The replacement of P=O by P=S in 
such phosphinic acid derivatives has recently been reported by Harger. 25,26 
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Alternatively, the cyclic aminal phosphinate ester may be treated with DIBAL or 
sodium triethylborohydride to reduce the esters, allowing sulfur insertion into the P-H 
bond (Scheme 2.14). 
R \ ~0 
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I 0 
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R \ ~0 
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I 0 
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Variations upon the route of phosphinic acid preparation!P=S conversion were 
envisaged. For instance, the methylene bridge of the aminal may be removed, and the 
amines protected prior to sulfur transfer by treatment with PSCl325 or P4S10 26(Scheme 
2.15). 
i) Hydrolysis 
ii) N-protection 
F\ 0 
rlrf' (fj OH 
N OH 
Ts\..._ 1 p~ 
I 0 
R 
Scheme2.15 
F\ .&s 
/P\ 
i)Sulfur transfer IJ..J OH 
ii)deprotection c 
-N OH 
H \._pi 
1 ~s 
R 
This last proposed route was concentrated upon because, on paper at least, it looked the 
most accessible although all of these last three suggested routes avoid the possible 
problem of thiophosphinate ester hydrolysis at the final stage of synthesis. 
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The successful route- from P(O)OH to P(O)SH 
The phosphinate ester (39) was prepared by reaction of ethane-1 ,2-diamine with freshly 
sublimed paraformaldehyde and PhP(OMeh in dry tetrahydrofuran as described by 
Parker et al. 16 Purification by chromatography on alumina gave the ester as a colourless 
oil in 72% yield; in addition, methyl [(hydroxymethylene)phenylphosphinate] was 
isolated as a by-product. Hydrolysis in 6M hydrochloric acid with heating at reflux for 
16 hours yielded the precursor amino-acid ( 43). Protection of the amine functionalities 
was effected by tosylation in aqueous sodium hydroxide solution, maintaining the pH 
around 10 by further additions of sodium hydroxide, to give (44) (Scheme 2.16). The 
pH was critical to the success of the reaction as basic conditions were required for the 
solubility of the amino-acid while very high pH conditions (>pH 11) merely served to 
convert tosyl chloride to the acid, leaving less tosyl chloride to react with the amino 
acid. Therefore, the optimum conditions required pH 8-10 with heating to 40°C as the 
reaction proceeds only very slowly. Isolation of the product ditosylamide in 65% yield 
with high purity was facilitated by precipitation with 4M hydrochoric acid to pH 2. 
R 
'-:::::-0 fp\ 
[N) OR' _6_M_~_c_,_ 
N OR' \_, 
p~ 
I Q 
R 
(39) (43) 
Scheme 2.16 
R \ .;::;.0 
Ts/P\ 
N OH TsCI, NaOH (aq) c 
~ N OH 
Ts\_' r~o 
R 
(44) 
Before the sulfur transfer could be attempted, the phosphinic chloride of the 
ditosylamide ( 44) had to be formed. The phosphinic chloride ( 45) was prepared in 
quantitative yield (31p NMR analysis) as a 1:1 mixture ofRR/SS and RS 
diastereoisomers by treatment with oxalyl chloride of a suspension of the ditosylamide 
in dichloromethane (Scheme 2.17), giving a clear solution. This was observed by 31 P 
NMR (8p 46.8 and 47.0) (Figure 2.10). The solvents and excess oxalyl chloride were 
removed under reduced pressure and the product was kept under high vacuum for 3-4 
hours to ensure complete removal of all traces of the reagent prior to the P=O to P=S 
transformation. 
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sa 55 sa 45 4a 
Figure 2.10 31P NMR shows diastereoisomers of (45) 
Subsequent exchange of oxygen for sulphur gave the thiophosphinic chloride ( 46) in 
94% yield, by heating in PSCl3 with a catalytic amount of dimethylformamide as 
originally described by Coogan and Harger.26 The 1H NMR spectrum of the 
thiophosphinic chloride ( 46) showed an interesting, if somewhat complicated, splitting 
pattern (Figure 2.11/over). Although the unusual pattern shown between 3 and 5 ppm 
could be assigned to the methylene protons between nitrogen and phosphorus (NCH2P), 
there was initial difficulty in the absolute interpretation as the pattern was expected to 
account for the diastereoisomerism, phosphorus splitting and vicinal coupling (Figure 
2.12a). 3lp NMR analysis showed a 1:1 mixture of diastereoisomers was present 
(Figure 2.12b). Complete assignment of the couplings shown in the 1H NMR spectrum 
required acquisition of the spectrum at a higher frequency to spread out the shifts of the 
diastereoisomers (Figure 2.12c), and a 31p decoupled lH spectrum in order to identify 
the phosphorus splitting (Figure 2.12d) by comparison. The result was surprising as the 
coupling to phosphorus was absent or too small to be observed for the proton resonating 
at higher frequency. 
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Cl \ .# 
Figure 2.12a The chiral centre at phosphorus generates 
an ABX spin system for the diastereotopic methylene protons 
' 95 35 7B 
Figure 2.12b 
3l P NMR spectrum showing two diastereoisomers 
I I 
Figure 2.12c 1H NMR (400 MHz, CDC13) spectrum of (46) showing NCH2P protons 
Figure 2.12d 1H {31 P} NMR (400 MHz, CDCl3) spectrum of (46) showing NCH2P 
protons 
Having successfully synthesised the aminothiophosphinic chloride in high yield and 
purity, the conversion of the chloride to the acid and subsequent detosylation were 
expected to be trivial manipulations. However, the P-Cl bond of ( 46) showed 
remarkable stability with respect to hydrolysis and several unsuccessful attempts were 
made using a variety of conditions (Table 2.3) before complete hydrolysis to the 
thiophosphinic acid ( 47) was achieved in near quantitative yield by heating the 
thiophosphinic chloride ( 46) with 5M potassiu'm hydroxide for 16h. 
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Table 2.3 Attempted hydrolysis of thiophosphinic chloride to thiophosphinic acid 
Reaction conditions 
( 46) dissolved in CH2C12, stirred vigorously with NaOH 
(pH 11), heated for 2 days_ 
( 46) dissolved in CH2Cl2, stirred vigorously with NaOH + 
phase transfer catalyst (cetyltrimethylammonium bromide), 
heated for 2 days. 
(46) added to HBr/acetic acid/phenol, heated lOOT 
( 46) added to CH3COONa/CH3COOH at 25°C 
Solid (46) stirred in KOH (SM), lOOoC, 16 h 
Result 
no reaction 
no reaction 
mixture of many 
species 
P=S reverted to P=O 
Quantitative yield 
of acid 
Detosylation of the protected thiophosphinic acid ligand was attempted under standard 
method of heating to reflux in hydrobromic acid/acetic acid with phenol. However, 
these conditions proved far too harsh and merely facilitated C-P and N-C(P) cleavage. 
Neither treatment with dissolved sodium metal in liquid ammonia under Birch 
conditions nor the use of samarium (II) iodide10 with DMPU led to satisfactory 
detosylation. The ditosylated aza-phosphinic acid ( 44) was used to as a model for the 
sulfur-containing ligand in order to find a successful method of deprotection. 
Successful detosylation of the phosphinic model and the thiophosphinic ligand ( 47) to 
give ( 48), required gentle heating at 40T in HBr/acetic acid in the presence of a ten-
fold excess of phenol over a period of two days. The desired ligand precipitated from 
the reaction mixture as a pale yellow solid (77% yield) which was characterised as the 
dihydrobromide salt. 
The overall synthetic route is summarised in Scheme 2.18 
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Scheme 1 (i) (CHOk,, RP(OR'h, THF (ii) 6M HCI, 100°C (iii) TsCI, NaOH(aq) pH10, 40°C, 
(iv).(COCI)2, CH2 Ci:2 (v) PSCI3, cat. DMF 110°C (vi) KOH(aq) 100°C (vii) HBr/CH:P02H, phenol, 40°C 
Scheme 2.18 Synthesis of aza-thiophosphinic acid ligands 
With a feasible synthetic route proven for the phenyl-substituted thiophosphinic acid 
( 48), the synthesis of the other proposed members of the series (from Figure 2.6 above) 
was then attempted. Preparation of the precursor phosphinates ( 49), (50) and (51) was 
achieved via analogous syntheses employing 1,3-diaminopropane or the 
dialkylphosphine, RP(OR'h [R=Ph, R'=Me; R=Me, R'=Et] starting materials. 
Hydrolysis in hydrochloric acid (6M) gave the desired phosphinic acids in near 
quantitative yield (Scheme 2.19). Tosylation of these acids proceeded under basic 
conditions (pH 8-10) as before, although the isolation of the P-methyl-substituted 
ditosylamides proved more difficult than their P-phenyl analogues due to their greater 
solubility in water. As a result, they did not precipitate from the reaction mixture with 
the addition of hydrochloric acid but remained in solution. After removal of the 
solvents, sparing amounts of cold water were required to wash the P-methyl 
ditosylamides and isolate them from the salts of p-toluenesulfonic acid. This procedure 
resulted in a lowering of the isolated yield for the P-methyl compounds. 
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Preparation of the corresponding phosphinic chlorides was effected as described for 
(45) and sulfur transfer to phosphorus was achieved analogously with thiophosphoryl 
chloride and DMF catalyst. Although each analogue was successfully converted to its 
thiophosphinic derivative, none of the thiophosphinic chlorides could be produced in as 
high a yield or purity as the original phenylthiophosphinic chloride, (46). The P-methyl-
substituted analogues were the most difficult to convert, although the diaminoethane 
derivative, (59) (Scheme 2.20), precipitated from the PSCl3 solution and was isolated in 
high purity by filtration. 
1 H NMR of these subsequent thiophosphinic chloride derivatives showed similar 
splitting patterns to ( 46). 
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4.6 4.6 4.4 42 4.0 3.6 3.6 3.4 32 ppm 
Figure 2.13a 1H NMR (400 MHz) spectrum of (58) showing NCH2P protons 
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4.6 4.6 4.4 42 4.0 3.6 3.6 3.4 3.2 ppm 
Figure 2.13b 1H {31P} NMR (400 MHz) spectrum of (58) showing NCH2P protons* 
*Minor signals due to impurities are present in the 1H {31 P} NMR spectrum only, as this decoupling 
experiment was performed at a later date with a less pure sample than the original (a). 
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Figure 2.14a 1H {31P} NMR (400 MHz) spectrum of (59) showing NCH2P protons 
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Figure 2.14b 1H {31P} NMR (400 MHz) spectrum of (59) showing NCH2P protons 
Similar stability of the P-Cl bond with respect to hydrolysis was observed for all 
subsequent derivatives (58) to (60), as the use of lower concentrations of potassium 
hydroxide or lower temperatures resulted in incomplete hydrolysis. Deprotection of the 
ditosylamides (61)-(63) was achieved by the same 'mild' reaction conditions with HBr/ 
acetic acid and phenol at 40-50°C for 2-3 days. The aminothiophosphinic acids (64) and 
(66) were isolated by dropping the reaction mixture into diethyl ether prior to isolation 
following centrifugation while a small amount of (65) precipitated from the HBr/acetic 
acid reaction mixture as the ligand-dihydrobromide salt in an analogous manner to that 
of ( 48). The ligands and intermediates gave 1 H NMR, Be NMR, 31 P NMR spectra, 
mass spectra and elemental analyses which were consistent with the structures shown. 
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All four ligands were synthesised as a 1: 1 mixture of RR/SS and RS diastereoisomers, 
which was evident both by 3lp NMR and 1H NMR as exemplified by the P-methyl 
ligand (65) (Figure 2_15)_ 
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Figure 2.15a 1H NMR (400 MHz) spectrum of (65) 
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Figure 2.15b 1H {31P} NMR (400 MHz) spectrum of (65) 
N-substituted aza-thiophosphinic acid ligands 
A potentially useful extension to this ligand series could be ligands substituted at 
nitrogen_ For example, methylation at nitrogen could affect the overall stability of the 
metals complexes formed with this type of ligands_ Alkylation may render the nitrogen 
donors more electron-donating and offer more rapid formation or greater stability of the 
metal complexes formed_ However, this type of substituent could also cause some 
destabilising interactions by the associated diaxial steric strain, in a similar manner to 
tetramethyl 12N4, where the diaxial interactions between methyl groups decrease 
complex stability.27 Synthesis of such a ligand, (67), was investigated in order to gain 
more of an insight into the behaviour of this new class of ligand. 
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Reductive methylation of the thiophosphinic acid, ( 48), was attempted with 
formaldehyde and formic acid (Scheme 2.21) as described by Pine and Sanchez.28 The 
volatility of the other reagents makes isolation of the product simple. Although N-
methylation was successful, the thiophosphinic acid functionality was lost by 
replacement of sulfur by oxygen, yielding (68), which is, itself, a new aza-phosphinic 
acid ligand. 
fonnic acid/ 
fonnaldehyde 
80'C 
Scheme 2.21 Reductive methylation of aza-thiophosphinic acid ligand 
Sulfur transfer to reform the thiophosphinic acid of this new N-methylated ligand, (68), 
was attempted under the previous conditions using thiophosphoryl chloride and a 
catalytic amount of DMF. However, 1H NMR analyis revealed that some other 
undesirable process had taken place as the spectrum showed a mixture of products and 
lacked any remnants of recognisable features such as the NCH2P protons. The only 
difference between this reaction and previous sulfur transfer reactions performed under 
identical conditions is the substituent on nitrogen. Therefore, it is reasonable to 
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conclude that successful employment of the N-protecting toluenesulfonyl groups in the 
original reaction scheme prevented the nitrogen lone pair from interfering in the 
subsequent reactions at phosphorus. In contrast, the N-methyl substituents have a 
detrimental effect by allowing attack of the nitrogen nucleophile at the electrophilic 
phosphorus centre_ 
It was apparent that sulfur transfer would not prove easy following methylation and 
another method of N-methylation of the thiophosphinic acid was sought. A milder route 
was then attempted utilising a procedure described by Hemo and Charles, 29 involving 
treatment of the thiophosphinic acid ( 48) with aqueous formaldehyde at 60°C for 30 
minutes and subsequent reduction with sodium borohydride. However, the result was 
identical: N-methylation of the ligand was accompanied by the replacement of sulfur by 
oxygen. 
Corresponding dithiophosphinic acids 
It is possible that similar ligand systems may be synthesised incorporating the 
dithiophosphinic acid moiety, that is, RR'P(S)(SH). This would have the effect of 
lowering the pKa further than the mono-thio systems and removing the chiral centres 
from the ligands which give rise to diastereoisomers prior to complexation. However, 
the absolute stability of such systems is uncertain as the analogous thiophosphinic acids 
have a tendency to revert to phosphinic acids under certain conditions, and dithio 
systems may be even less stable. 30 
An attempt was made to synthesise the dithiophosphinic analogue of ( 48) by treating 
the appropriate thiophosphinic chloride ( 46) with excess sodium thiolate in aqueous 
solution with heating over several hours. However, the reaction mixture contained none 
of the desired ligand. 
2.3 Solution Complexation Behaviour 
Electrospray Mass spectrometry 
Complexation was first investigated by electrospray mass spectrometry (ESMS) 
because it is a soft ionisation technique which allows detection of intact metal 
complexes without the fragmentation observed with many other mass spectroscopy 
techniques. The major isotope patterns are presented and the software allows the 
modelling of the isotope pattern expected for a particular molecular formula which is a 
particularly useful diagnostic tool when studying metal complexes. Many metals, such 
as copper and rhenium, have more than one major stable isotope each with a different 
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relative abundance, and modelling allows a clearer indication of the validity of the 
'envelope' of the major peak(s) observed experimentally. 
Complexation of all four ligands with copper was initially investigated by ESMS. The 
negative ion mode of operation produced the best results, showing the copper 
complexes as bromide adducts and isotope patterns which correlate with these 
structures (Figure 2.16). The ESMS spectra were consistent with the formation of 
neutral copper(ID complexes picking up bromide in the negative ionisation process. 
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Figure 2.16 ESMS- spectrum of [Cu(64)Br-] (bottom) with isotope model (top) 
Complexation with rhenium 
Before ligand complexation with rhenium could be attempted, a precursor rhenium 
complex in the correct oxidation state (V) with an oxo-rhenium core had to be prepared 
due to the inherent difficulties associated with rhenium substitution. The favoured 
complex for this task is normally [ReOC13(PPh3)i] (Ch.l, 1.6 & 1.7) which was duly 
prepared according to the method ofWilkinson.31 The documented difficulty with the 
labile axial position trans to Re=O (section 1.6) was also experienced as the reaction 
solvent, ethanol, was found to occupy this position upon characterisation of the 
complex as Re(O)Cl2(EtOH)(PPh3h- Due to this lability, the substitution was ea5ily 
reversed by dissolving the greeny-brown dichloro complex in dichloromethane and 
stirring vigorously with 6M hydrochloric acid. The desired trichloro derivative 
precipitated from the mixture as a yellow-green solid. Due to the low solubility of the 
oxorhenium precursor, it was suspended in benzene prior to complexation, and the 
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ligand (48) was added as a solution in methanol. Mter heating the mixture under reflux 
for 16 hours, the complex was isolated as a deep pink solid (Scheme 2.22). 
benzene I methanol 
[ 0p 65.8 (MeOH) ) op 1 00.7 (br) (MeOH) 
v Reo 927cm·1 
A. max 526 (E=240 dm3 mor1 cm-1) 
Scheme 2.22 Complexation of ligand ( 48) with oxorhenium 
Further evidence for this complex was given by the electrospray mass spectrum and the 
excellent correlation with the isotope model (Figure 2.17). The two stable isotopes of 
rhenium (185 and 187) are observed in their expected relative abundances as 
oxorhenium complexes of the ligand (48). The peaks correspond to the formation of a 
neutral complex (that is, deprotonation of one amine N-H) with the loss of a further 
proton occurring in the electrospray ionisation process with the negative ion mode. 
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Figure 2.17 ESMS- spectrum of [Re(0)(48)] shows excellent correlation with model 
Preparation of the analogous oxorhenium complex with the propylene ligand, (64), was 
attempted under identical conditions. However, the resulting black oil proved difficult 
to purify and characterise. 
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Isolation of the copper complexes 
Addition of equimolar amounts of ligand ( 48) and Cu2+ in the form of a triflate, 
perchlorate or tetrafluoroborate salt in methanol led to the precipitation of a dark green 
solid. Attempts to redissolve the solid after its isolation were unsuccessful, even in 
DMF or DMSO. Heating in DMF did, however, result in solvation but the compound 
reprecipitated upon cooling only slightly. The deep green colour showed that some type 
of complex was present, but its lack of solubility in any solvent suggests that it is 
oligomeric in nature rather than a discrete molecule. 
A similar result was obtained when the ligand was treated in the same manner with 
zinc(ll) triflate, nickel(II)chloride and cadmium(II) triflate which yielded colourless, 
pale green and colourless solids respectively. The infrared spectra of these oligomeric 
complexes showed some similar features to one another. Combustion analysis 
confirmed the n:n (n=integer) stoichiometry of the compounds formed with (48) and 
each of these metals. 
The isolation of the discrete complexes proved difficult due to this oligomerisation in 
methanol but was possible in dilute methanol solution(< 5 mmol dm-3). Analysis by 
ESMS confirmed the 1:1 stoichiometry and the formation of discrete rather than 
oligomeric species. Complexation occurred readily in aqueous solution and the 
products remained in solution. The ligand, however, exhibited a low solubility in water 
which led to only dilute solutions being employed for complexation. 
HPLC analysis 
Further investigation of the solution complexation behaviour of the ligands with copper 
was undertaken by HPLC analysis since this method of quality control is often used in 
radiopharmaceutical development. A study of the 'cold' complexation using HPLC as a 
quality control may be directly analogous to preparation of radiotracers of these ligands 
and radiocopper. Both P-phenyl substituted ligands were studied as their phenyl 
chromophore allows UV detection O'·abs=254 nm). HPLC analysis of a methanol 
solution of the free ligand (5 mmol dm-3), a 1:1 ligand-copper solution, and a 2:1 
ligand-copper solution was undertaken for both ligands, (48) and (64). 
The HPLC trace for the free ligand ( 48) showed a single peak with a retention time of 
around 4-5 minutes, confirming the high purity of the complex. For the 1:1 complex, a 
retention time of 11 minutes was observed while another, albeit minor, peak was 
present in the chromatogram of both the 1:1 and 2: 1ligand/metal preparations with a 
retention time of 8 minutes (Figure 2.18). Neither variation of the ligand/metal ratio nor 
the concentration of the solution appeared to affect the formation of this unknown 
spectes. 
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Figure 2.18 HPLC traces of Cu(II)( 48) 
Chapter Two: Aza-Thiophosphinic Acid Ligands 
2:1 L:M "' = 1 ·e 
~ 
-
-
I I I 
An analogous result was observed for copper complexation by ligand (64): 
complexation was immediate, little or no unbound ligand was observed with a 1: 1 LIM 
solution, and a further, unknown species was observed at a shorter retention time (7.7 
minutes) than the copper complex of the ligand (at 12.5 minutes). 
Table 2.4 Summary ofHPLC analysis ofCu(II) complexation with (48) and (64) 
Retention Time I minutes (% species) 
Preparation free ligand unknown impurity Cucomplex 
free ligand ( 48) 4.7 
1:1 L/Cu (48) little oberved 8.4 (14%) 11.3 (82%) 
2:1 L/Cu (48) 4.3 (39%) 8.4 (5%) 11.2(48%) 
free ligand (64) 4.2 
2:1 L/Cu (64) little observed 7.7 (11%) 12.5 (21%) 
Attempts were made to identify the unknown species produced by copper(II) and ligand 
( 48) with a retention time at around 8 minutes. Less than one milligram of the 
compound was isolated by preparative HPLC, and ESMS analysis of this sample 
showed none of the Cu( 48) complex but some species with a mass corresponding to the 
ligand with two sulfur atoms replaced by oxygens. 
The absolute stability of ligand ( 48) in methanol solution was also shown by the 
absence of change in its HPLC profile over a period of 6 hours, and the observation of 
an unchanged 3lp NMR spectrum over five days at room temperature. 
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Ultraviolet and Visible Photospectroscopy of Ligands with Copper 
The UV -visible spectra gave data that was consistent with the formation of 1:1 
complexes with copper (from [Cu(BF4)z]) in water. The wavelengths and extinction 
coefficients of absorption maxima in the visible region were compared with the values 
obtained for the analogous substituted aza-phosphinic acid ligands with copper in 
previous work by Eleanor Cole.20 The aza-thiophosphinic acid ligands formed green 
complexes as reflected in the values given (Table 2.5). 
Table 2.5 Comparison of Au.ax (nm) and extinction coefficients for copper(IO 
complexes with P(O)OH and P(O)SH ligands in H20 
Ligand Amax I nm Eldm3 mol-1 Amax I nm Eldm3 moi-1 
(H20) cm·1 (H20) cm·1 
Hr-\ H 
x=oa 710 40 p~N ) Ph 
X=Sb 598 300 332 8300 X • 'OH HO""f\" 
X (48) 
HflH x=oa 774 20 
Ph[N ).,...Ph X=Sb 628 350 
'oH H<J""'"~~ 
X X (64) 
H r""\ H 
x=oa 725 40 
Mef'N l Me X=Sb 598 150 334 10000 •'oH H~ 
X · X 
(65) 
a From reference 20 
b This work 
Comparison of the general trends shows that the thiophosphinate complexes absorb 
around 600 nm while the analogous phosphinate complexes absorb at over 700 nm. 
Within each ligand series, the trends appear similar: the phosphorus substituent has 
little effect, while the change from a five- to six-membered chelate ring shows a 
pronounced difference. The ligands incorporating a propanediamine unit have slightly 
higher Au.ax values compared to the ethylenediamine ligands, suggesting that they 
engender a weaker ligand field. Further evidence for this is given by the disappearance 
of this absorption band from the spectrum of Cu(64) with time (several days). The 
solution turned colourless with time, indicating that Cu(II) had been reduced to Cu(l). 
The corresponding ethylenediamine-based complex, Cu(48), showed only a slight loss 
of co.lour intensity over the same period. The similarity of the A-max values for Cu(48) 
and Cu(65)- differing only in phenyl and methyl phosphorus substituents respectively-
is consistent with the metal binding remaining unaffected by the substituent at 
phosphorus. 
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NMR titrations 
In an attempt study the metal binding of the ligands, NMR titrations were performed by 
adding small increments of a solution of the metal (O.lM) to a sample of the ligand 
(O.OlM) and monitoring any shift in the NMR spectrum. Since the Cu(ll) ion is 
paramagnetic, an attempt was made to determine the stability constant of the Cu(l) 
complex using [Cu(CH3CN)4BF 4] in a solution of acetonitrile/water (1: 1) followed by 
31PNMR. 
Mter only 4 values had been measured with Cu(I) corresponding to M/L=0.4, a small 
but sharp peak was observed in the 3lp spectrum at 8p 18.6 ppm. After two further 
additions of metal (MIL=0.6), the phosphinate peak was even more pronounced and 
some precipitate had formed. The solution in the NMR tube was green, indicating that 
some Cu(ll) species had been created in addition to the desulfurisation of the ligand to 
give its phosphinate analogue. 
Attention then turned to zinc as a tetrahedral model without the redox chemistry of 
copper. The same procedure was carried out using zinc triflate in the same solvent 
system at the same concentration. The difference in the change of shift was noted and 
the results plotted as MIL with change in the chemical shift. However, a large scatter in 
the points was observed as well as a continuing increase rather than reaching a plateau. 
This behaviour is consistent with only very weak binding of the metal, under these 
conditions. 
Protonation constants 
The protonation constant for the thiophosphinic acid ligand was determined using 
potentiometric titrations (by Hayati Sari at the University of Newcastle) followed by an 
iterative least-squares analysis carried out by Dr Ritu Kataky at the University of 
Durham. Titrations were carried out in a thermostatted cell at 25°C at an ionic strength 
ofO.l mol dm-3 tetramethylammonium nitrate, using tetramethylammonium hydroxide 
(0.05 mol dm-3) as the base. The latter solution was calibrated by titration against a 
standard solution of hydrochloric acid (0.02 mol dm-3). Incremental additions to the 
cell containing the ligand in the background electrolyte were controlled by a computer 
which allowed the volume added and time between the additions to be adjusted. The 
results are tabulated and presented together with pKa values for similar ligand systems 
(Table 2.6). 
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Table 2.6 Nitrogen protonation constants for disubstituted ligands 
Ligand pKI pK2 
ena 9.89 7.08 
EDDAa 9.57 6.48 
EDDPib 8.08 4.98 
(SJ)C 8.35 5.33 
(54)C 8.91 7.00 
(4J)C 8.63 4.34 
(48)d 8.19 5.09 
a Data from reference 9 c Data from reference 16 
b Data from reference 12 d This work 
The values shown are the constants for protonation of the nitrogen atoms (Figure 2.19), 
as the thiophosphinic acid oxygens have lower protonation constants which could not 
be evaluated by this method. 
Ph lls 
.,pii' 
H,( 'o-
CN+H N-H 
/I+ 
H , o· 
F( 
pt( 's 
P~~s 
H (" 'o-c:: :::;;:::=H=+~ 
~ o· ( ptf's 
L~ LK L~ 
Figure 2.19 Protonation constants for ( 48) 
The speciation diagram (Figure 2.20) shows the percentage of these ligand species 
present in solution at a given pH. For example, at pH 3 only the LH2 species is present, 
whereas, at just above pH 8, there is a 50% mixture of the free ligand and LH species, 
showing the pKa· 100 ~~~~~~~~~~-~11-1-----:-:-::::-:T-I-T~~~~ 
x Free 
Ligand 
6 AH 
A AH2 
% 
Figure 2.20 Speciation diagram for the variation of protonation behaviour of ligand 
(48) with pH. 
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Inspection of Table 2.6 shows that the effects of a different phosphorus substituent 
upon the protonation behaviour for the phosphinic acid ligands are negligible. The 
second pKa for (43) is slightly lower than that of the corresponding methylphosphinate 
(53) due to the electron withdrawing effect of the phenylphosphinate group rendering 
the amine less basic. 
Stability constants for copper complex formation 
The stability constant for the formation of Cu(II)( 48) was determined and analysed, 
again by Ritu Kataky, using a similar pH-potentiometric procedure to the method used 
for the determination of the protonation constants for the pure ligand ( 48) above. A 1: 1 
ratio of the ligand and copper(II) solutions in an electrolyte background of 
tetramethylammonium nitrate (0.1M) was stirred in a thermostatted cell at 25"C and 
tetramethylammonium hydroxide was used as the titrant. 
The metal-ligand and protonated metal-ligand species were observed (Scheme 2.22) 
and their formation constants were determined using a non-linear least squares analysis. 
Formation of some MLOH- was also observed although the formation constant was 
small. The values are tabulated with those of the corresponding aza-phosphinic acid 
ligands for comparison (Table 2. 7). 
[ML] [MLHt 
1l
oH· 
KMLOH 
[MLOHr 
Scheme 2.22 Solution complexation equilibria 
Previous work 16•20 showed that the 1:1 complexes formed with substituted aza-
phosphinic acid ligands were relatively weak and bound only through the nitrogen 
donors while the oxygens did not appear to contribute to the overall binding of the 
complex. The log~ML value obtained for the thiophosphinic acid ligand (48) is higher, 
as expected, and is consistent with the visible spectrophotometric data which indicated 
that binding to copper takes place through both sulfur and nitrogen. 
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Table 2.7 Formation constants for copper complex formation 
of (43), (53), (54), and (48) (298K, 1=0.1 mol dm-3 NMe4N03) 
Compound CuL 
(53)a 8.03 
(54)a 7.43 
(43)a 6.56 
(48)b 10.13 
a Data from reference 16 
log~ 
CuLH 
13.85 
b This work 
CuLOH 
0.1 
Attempts were made to obtain a crystal of the Cu(48) complex for X-ray analysis. 
Solutions of different concentrations containing equimolar amounts of ligand and Cu2+ 
were left to stand. However, only colourless crystals formed and were found to be the 
amino-phosphinic acid ligand ( 43), providing further evidence for the desulfurisation of 
the ligands with time after complexation with copper. The disappearance of the green 
colour was consistent with the reduction of Cu(II) to Cu(I) with, possibly, concomitant 
ligand oxidation to form the phosphinic acid from the thiophosphinic acid. 
The X-ray structure was solved by Janet Moloney (Figure 2.21a and Appendix A). The 
ligand is present as its zwitterionic form, with two protons positioned on each nitrogen 
and the phosphinate oxygens entirely deprotonated. The amine protons were actually 
located rather than modelled. The hydrogen bonding interactions between the 
phosphinate oxygen and the amine protons of another ligand molecule are extremely 
strong (Figure 2.21b). For example, the distance 01-H(3)N is only 1.84(5) A or H(2)N-
03 is 1.83(5) A for these linear interactions (see Figure 2.21 and Appendix A) while a 
similar hydrogen bond interaction which is non-linear, 01-H(4)N, is longer (2.52(4) 
A). The incredible packing diagram along the a-axis shows how these strong 
interactions (distance- 1.8A) govern the stacking of the molecules in their dimers 
(Figure 2.22). Each ligand has three water molecules of crystallisation associated. 
Figure 2.21a X-ray crystal structure and numbering system of ( 43) 
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Figure 2.22 Packing diagram in the X -ray crystal structure of ( 43) viewed along the 
a axis. Hydrogen atoms are omitted for clarity 
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Square Wave Voltammetry 
In an effort to gain more of an insight into the redox behaviour of the ligand (48) upon 
copper(ll) complexation, square wave voltarnmetry was carried out by Dr Ritu Kataky 
at the University of Durham. The current passing through the electrolyte was monitored 
as a function of the applied stepped voltage by this technique. An aqueous solution of 
the thiophosphinic acid ligand (48) (0.001 mol dm-3) was prepared with the addition of 
one molar equivalent of a standard sodium hydroxide solution (to neutralise one of the 
ligand protons) and a background electrolyte of tetramethylammonium nitrate (0.1 mol 
dm-3). A solution of copper(II) nitrate (0.01 mol dm-3) was similarly prepared in the 
aqueous electrolyte. The peaks observed correspond to the electroactive species present 
and the peak height relates directly to the concentration of the species. 
The samples of the background (containing an equimolar amount of sodium bromide 
with the ligand above), a second background containing copper, and unbound ligand in 
the electrolyte, showed no evidence of any electroactive species present in the voltage 
range (0-1 V) (Figure 2.23). With the ligand and copper(II) salt present, the oxidation of 
a single species was observed at 0.9 V with concomitant precipitation of a small 
amount of a pale green solid from the electrolysed solution. This species is likely to be 
a dirner or oligomer as described above. The electroactive species observed at 0.9 Vis 
also consistent with the formation of a dimer or an oligomeric species as the redox 
behaviour characteristic of copper(II) normally occurs at a lower potential than that of 
the species observed (in the region of +300 to -200 mV).32 
18 
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Figure 2.23 Square wave voltammogram of ( 48), Cu2+, and Cu( 48) in 
tetramethylammonium nitrate/NaBr background 
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Molecular Modelling 
Modelling of the copper complexes of the ligand series was performed by Christopher 
Edlin using the Sybyl6_3 programme (Tripos UK Ltd) at Zeneca Specialties, Blackely_ 
The charge distribution of the complexes was calculated using MNDO (minimum 
neglect at differential overlap) force field routine, and the structures were then 
minimised using an AM 1 force field (Figure 2.24 and 2.25). The models are consistent 
with the above results and discussion as they show that the phosphorus substituent has 
little effect upon the metal binding, while the size of the chelate rings does affect the 
overall geometry. The complexes of the ethanediamine-based systems with three 5-
membered chelate rings show a distorted square planar geometry, while the 
propanediamine systems incorporating a 6-membered chelate ring tend more to a 
distorted tetrahedral arrangement. These models are in agreement with observations that 
the copper complex of ligand ( 64) tends to Cu(l) more easily than the copper complex 
of ligand ( 48). 
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2.4 Conclusions 
A viable synthesis of this new class of ligand - amino-thiophosphinic acids - has been 
established, which allows variation of substituents and component parts. This proven 
synthetic route may allow many other such derivatives to be prepared. The failure of the 
sulfur transfer step following N-methylation was, however, disappointing for its wider 
implications, for example, the facile synthesis of future systems such as a 
tetrathiophosphinic acid analogue of EDT A. 
Characterisation of the oxorhenium and copper complexes of the new ligands 
synthesised shows promise for successful radiolabelling with radionuclides of these 
metals and technetium. The solution stability of the copper complexes, in particular, 
appears to be finite and may thereby offer potential for a cellular trapping mechanism. 
Clearly, the ligands are suitable candidates for radiolabelling studies (see Chapter 5). 
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3. Dialkylthiophosphoryl Ligand Systems 
The design of a new class of ligands which incorporate the dialkylthiophosphoryl 
func~ional group is presented. The scope for variation of component parts is considered 
in tandem with the ligand architechture with respect to the tailoring of 
radio pharmaceuticals ( 3.1 ). Synthetic routes to these ligands are discussed and the 
design and synthesis of further ligands of this class are explored (3.2). Complexation 
studies with rhenium and copper by techniques such as ESMS, HPLC and UV-visible 
spectrophotometry are reported ( 3.3) and general conclusions are summarised ( 3.4 ). 
3.1 Design of New Dialkylthiophosphoryl Ligands 
The importance of the copper complex, Cu-PTSM (26) has been highlighted previously 
(Ch. 1, section 1.7) as an imaging agent for use in Positron Emission Tomography as it 
is one of the best perfusion tracers to date. Despite this promising performance, Cu-
PTSM is by no means a perfect PET perfusion tracer (see section 1. 7) and the search for 
improved derivatives continues. 1 With this in mind, new ligands analogous to PTSM 
may be formed by replacement of C=S by P=S (Figure 3.1) and allow further scope still 
for substitution at phosphorus and consequent variation of lipophilicity. As with the 
design of the thiophosphinate series (Ch.2), the pentavalency at phosphorus may also 
provide a tolerant site for the attachment of a tether. Similarly, substitution of the 
backbone allows further means of elaboration of the ligand and, hence, of the metal 
complexes. 
R 
H \ R' 
,N-( 
H3YN s 
H~N S 
' II N-P 
H I 'R' 
R 
(26) PTSM (69) thiophosphoryl 
analogue 
Figure 3.1 Possible PTSM-analogues containing disubstituted thiophosphoryl groups 
This design of a new thiophosphorylligand may be generalised to allow various 
substituents on the carbon skeleton and at phosphorus (70), (Figure 3.2). This new 
ligand system was designed and pursued concurrently with the thiophosphinic acid 
ligand series (Ch. 2). It incorporates much of the same overall architecture in terms of 
the choice of donor atoms and size of chelate rings which has already been discussed 
(sections 1.6 and 2.1). The ligand system should form three 5-membered chelate rings 
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upon complexation and also has two nitrogen and two sulfur donor atoms although the 
latter are present as neutral rather than anionic donors. 
'R 
H \ R' :x~N-\ R= H. Me, Ph N, 11s l R'= alkyl, aryl J 
Figure 3.2 
N-P. 
H J'R' 
'R 
(70) 
A new ligand system 
However, neutral copper complexes may form by deprotonation of the nitro gens 
adjacent to phosphorus which make up the chelate ring (71) in an analogous process to 
the formation of Cu-PTSM (section 1.7). This type of amide N-H deprotonation also 
occurs in peptide complexes of copper above pH 5. 2 A similar complexation process 
occurring with oxorhenium(V) or oxotechnetium(V) may lead to the formation of 
cationic species or complexes with a dioxo core to satisfy the high positive charge of 
the metal. 
'R 
\ R' f=P\ RXN s 
-?"-/ Cu 
~/"-
R N S \ I N=P 
I'R' 
'R 
(71) 
The incorporation of hydrazine and hydrazide moieties within phosphorus-containing 
ligands has proved useful for the development of new.systems for coordination in 
transition metal and organometallic chemistry.3 Although diverse, many of these 
systems possess similar structural motifs, (72) or (73). 
(72) 
Figure 3.3 Typical structures of P(III) and P(V) hydrazides 
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Some phosphorus hydrazide ligands have been shown to form complexes with 99mTc 
for the development of new potential radiopharmaceutials, for example, 99mTc(V) 
phenylbis(hydrazide)phosphine (74).4 Indeed, hydrazine moieties continue to find 
application as nitrogen-based ligands in the complexation of both early and late 
transition metals. 5 Furthermore, they can be elaborated into a flexible ligand framework 
due to the versatile reactivity of the terminal hydrazido groups in many reactions. This 
allows the incorporation of other donor atom sites or another hydrazide fragment to 
impart greater stability to metal centres. Ligands with the structure (75) have also been 
reported for complexation of palladium (II), copper(!) and cobalt(l).6 
(74) (75) 
Dialkylthiophophoryl groups 
Many disubstituted phosphonothioic halides are known and some examples of these are 
given in Figure 3.4. Although derivatives with alkyl (Ct-2o). cycloalkyl (Cs-6), aryl, 
bromide and chloride substituents are known, some syntheses require very harsh 
conditions of extremely high temperatures and give a mixture of the R2P(S)X and 
RP(S)X2. 7 There are, however, systems which are more accessible, such as Me2P(S)Br 
and Ph2P(S)Br or their chlorides& via their respective bi(phosphine sulfide) derivatives 
(see section 3.2 below). 
s s 
II II 
/P~''Br 
Me Me 
/p~''CI 
Ph Ph 
Figure 3.4 Examples of disubstituted phosphonothioic halides 
3.2 Ligand Synthesis 
The general synthetic route envisaged for these bisdialkylthiophosphorylligands was 
by reaction of an appropriate dihydrazide with a suitable thiophosphorus compound 
(Scheme 3.1). 
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Scheme 3.1 Synthetic route to new bis(dialkylthiophosphoryl) ligands 
Preparation of the thiophosphoryl moiety 
There are many potential sources of dialkyl or diaryl thiophosphoryl functionalities, as 
mentioned above. Dimethylthiophosphoryl bromide [(76) R'=Me, X=Br] was chosen 
for this purpose due to its relative ease of preparation and an initial preference for 
methyl substituents of the ligand as they are not bulky or too lipophilic. This 
thiophosphoryl bromide was prepared very simply by addition of a molar equivalent of 
bromine to the co~sponding substituted diphosphine disulfide (77) (Scheme 3.2).9 The 
preparation of the latter precursor (77), although facile, was not as simple due to the 
extreme vigorousness of the reaction. A solution of thiophosphoryl chloride in diethyl 
ether was added very slowly and carefully to a stirred solution of methylmagnesium 
bromide in diethyl ether at around -15"C. Mter a short induction time, the reaction 
proceded quite vigorously and the temperature was maintained at -20 to -10·c. 
Maintaining the temperature within this range was extremely important: if the reaction 
is not cooled, then it proceeds almost explosively; and if it is cooled too much, then it 
hardly reacts at all, until the mixture has warmed up and the whole amount of both 
reagents react violently at once rather than being added together in a controlled manner. 
With this addition successfully accomplished, the reaction mixture containing the white 
precipitate formed was poured carefully onto crushed ice prior to washing with sulfuric 
acid and water. Recrystallisation from ethanol gave long colourless needle-like crystals 
which could be stored until the subsequent thiophosphoryl bromide was required. 
Usually the thiophosphoryl bromide was freshly prepared and used in situ as a solution 
in carbon tetrachloride by addition of a molar equivalent of bromine in carbon 
tetrachloride to a stirred suspension of the bisphosphine (77) at o·c. 10 Although a 
portion of dimethylthiophosphoryl bromide was isolated by distillation of the solvent at 
atmospheric pressure and subsequent purification by vacuum ditillation to give a 
colourless solid, the best results were obtained by the in situ reaction of this material. 
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.S s CH3 s II CH3MgBr \\ I Br2 II p H3C-P-P-CH3 s-P 
c1/l'c1 Et20 H3C/ ~ CCI4 r /'CH3 H3C 
Cl (77) 
Scheme 3.2 Preparation of dimethylthiophosphoryl bromide 
Dihydrazone synthesis 
For the synthesis of the dihydrazone moiety, an appropriate a-diketone was required. 
There are many such ketones commercially available, such as phenylgyloxal, benzil, 
pyruvic aldehyde, butanedione and isomers of hexanedione, constituting suitable 
starting materials. Initially, phenylglyoxal was treated with hydrazine hydrate in ethanol 
in an attempt to synthesise the precursor (78) required for the ligand (79) (Scheme 3.3) 
which is unsymmetrical in its substitution like PTSM. 
+ 
(78) 
Scheme 3.3 
ethanol 
Me 
H \P."'"Me 
,N-~ PhxN S 
H ~N S 
'\ II 
N-P 
H I 'Me 
Me 
(79) 
Proposed synthesis of a 'PTSM-type' ligand 
A white solid precipitated from the reaction mixture but a mass spectrum (DCO of the 
solid showed a mass of 293. The reaction which had taken place was not the formation 
of the dihydrazone (79), but formation of a dimeric species of the constitution (80). The 
synthesis was repeated by dropping the phenyl glyoxal into an excess of hydrazine 
hydrate in an attempt to form the dihydrazone. However, the solid product (80) was 
again formed and its structure was confirmed by full characterisation. The synthesis of 
the disubstituted analogues was then addressed since the preparation of di-substituted 
di-hydrazones was expected to be less problematic. II 
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Pht:N, ~ NH2 
~WNH2 
H N-N H 
NxPh pxN 
I I 
H2N NH2 
Ph~ ethanol 
+ 
(78) 
(80) 
Scheme 3.4 Attempted preparation of phenylglyoxal dihydrazone 
The diphenyl substituted dihydrazone (81) was conveniently prepared from benzil and 
hydrazine hydrate in n-butanol solution (Scheme 3.5), following the standard procedure 
of Cope.12 Mter heating under reflux for 48 h, the dihydrazone crystallised from the 
solution upon cooling. The methyl substituted analogue (82) was similarly prepared 
from butane-2,3-dione. 
nBuOH 
+ 
(81) R =Ph 
(82)R=Me 
Scheme 3.5 Preparation of substituted dihydrazones 
Initially, the synthesis of corresponding diphenylligand (70)[R=R'=Ph] was undertaken 
by the addition of benzildihydrazone (81) to a stirred solution containing two molar 
equivalents of freshly prepared dimethylthiophosphoryl bromide. However, no trace of 
the ligand or starting material was present in the mixture of products. Mass 
spectroscopy (DCI) confirmed that the predominant species had a mass 412 (MH+, 413) 
corresponding to the cyclic dimer (83) (Scheme 3.6) and no evidence for the formation 
of even a mono-substituted dihydrazone was found. This observation is consistent with 
the synthesis of (83) (3,4,7 ,8-tetraphenyl-1,2,5,6-tetrazocine) and several analogues 
which were reported by Schlesinger via condensation of benzildihydrazone with an 
aromatic substituted dike tone such as benzil. 13 
Ph ::::--N-~ Ph 
p;(_):Ph + 
(83) 
Scheme 3.6 Unexpected formation of the tetraphenyltetrazocine 
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The same reaction was then carried out in the presence of an organic base. The 
dihydrazone (81) was added to a freshly prepared solution of thiophosphoryl bromide in 
carbon tetrachloride with two equivalents of triethylamine (Scheme 3. 7). The reaction 
was followed by 3lp NMR analysis and after several hours, the triethylamine salts 
precipitated allowing their removal. Evaporation of the solution left a residue which 
was taken up into diethyl ether. Large yellow-orange coloured crystals of the ligand 
(84) formed in 70% yield upon standing. On occasions when crystallisation did not 
occur spontaneously, an aqueous work-up was performed on the ether solution to 
remove any impurites and the organic phase was evaporated to give (84) as a pale 
orange powder. 
The methyl analogue (82) reacted analogously under identical conditions with 
dimethylthiophosphoryl bromide, only a different work-up was required. The product 
(85) co-precipitated from the reaction solution with the triethylamine salts and was 
isolated by filtration and washed with water to remove the salts. The ligand (85) was 
obtained in 89% yield as a pale yellow powder. 
CCI41' NEt3 
(84) R =Ph 
(85) R =Me 
Scheme 3. 7 Synthesis of disubstituted bis[(dimethylthiophosphoryldihydrazides)] 
Amino-pyridine type ligands 
A bidentate ligand (86) (Scheme 3.8) based upon this dialkylthiophosphoryl 
functionality and amino-picoline was also considered. The incorporation of the pyridine 
nitrogen donor with the neutral sulfur donor gives an NS donor set. Two of these 
ligands may coordinate to metals, such as copper, giving an N2S2 array of donor atoms 
in an ML2 complex. The methyl substituent on pyridine (position 6) was incorporated 
in the ligand to restrict the number of possible coordination geometries. Its presence 
disfavours an octahedral or trigonal bipyramidal coordination geometry because of the 
steric effect of the methyl group. Indeed, it may tend to favour Cu(l) by stabilising a 
tetrahedral geometry in preference to the square planar or square pyramidal geometry 
characteristic of copper(ll). 
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Synthesis was achieved by the reaction of three molar equivalents of 2-amino-6-
picoline (available commercially) in a stirred solution of freshly prepared 
dimethylthiophosphoryl bromide in carbon tetrachloride where the excess amino-
picoline acted as the base. The product (86) co-precipitated with the amine picolinic 
hydrobromide salts and was extracted into diethyl ether and allowed to crystallise. 
Large colourless crystals were formed in 82% yield. When only two equivalents of the 
aminopicoline were used, the product yield was lowered due to the formation of a 
species with disubstitution at nitrogen (87). This species is similar to another 
disubstituted amine (88) reported in 1968 which was arguably the first ligand of this 
class to be synthesised.14 
~+ ~NANrt? 
cc~ 
Scheme 3.8 Synthesis of the bidentate ligand 
(87) (88) 
A similar reaction was undertaken with 2,6-diaminopyridine with excess 
thiophosphoryl bromide in the presence of triethylamine to give the disubstituted ligand 
(89). This new tridentate ligand was designed to incorporate an NS2 donor set in order 
to form two 6-membered chelate rings upon complexation to a metal. This ligand would 
therefore require another single monodentate ligand to make up the fourth coordination 
site15 (3 + 1 system, section 1.6) if its application were attempted in this context. It 
may, however, find application in the complexation of other metals preferring a lower 
coordination number such as Au+ or transition metals with a preference for an 
octahedral geometry, in an ML2 complex. 
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Variation of the dihydrazide system 
Many variations within this class of ligand were originally envisaged, with particular 
respect to the tetradentate system, in terms of the wealth of possible substituents at 
phosphorus and on the C-C backbone. Further extensions were proposed to alter the 
chelate ring size or enforce some rigidity. For example, instead of a 1,2-diketone 
arrangement of the precursor, a 1,3 spacing would allow the 5-ring chelate to become 6-
ring. However, pentane-2,4-dione could not simply replace butane-2,3-dione in the 
above synthesis (Scheme 3. 7) as the central methylene protons are extremely acidic 
(pKa -9) due to the two adjacent carbonyls. These positions had, firstly, to be blocked. 
The mono-methylated material, 3-methyl-2,4-pentanedione (90) was obtained 
commercially as a mixture of tautomers and formed a suitable starting compound for 
the proposed synthesis. Treatment of (90) with sodium hydride in tetrahydrofuran 
followed by methyl iodide (Scheme 3.9) as described in the literature,16 gave the 3,3-
dimethyl derivative (91) as a colourless oil. 
H 0 Hs 0 i) NaH/THF 
H3C 0 ii) CH3I 0 
H3C HsC (90) (91) 
Scheme 3.9 Methylation of 3-methyl-2,4-pentanedione 
Preparation of the pentanedihydrazone (92) was then attempted with the dimethylated 
diketone (91) using the conditions described previously (Scheme 3.5). However, the 1H 
NMR spectrum of the products indicated that although two different environments of 
methyl proton were present in equal proportions, no amine protons were observed. In 
the mass spectrum (ESMS+), the molecular ion at 147 (MH+) was in agreement with 
the formation of the isopyrazole (93) 17 (Scheme 3.1 0). Despite further efforts to effect 
the formation the desired product by slow dropwise addition of the diketone to an 
excess of hydrazine, the same white solid (93) was recovered as the major product. 
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HaC 
HaC 
* 
HaC 
Ha 0 (92) 
+ fi2N-NH2 
0 ~ 
HaC Ha 
HaC 
(93) 
Scheme 3.10 Treatment of the 1,3-diketone with hydrazine hydrate 
Another tetradentate ligand in this dialkylthiophosphoryl series was designed to include 
a rigid backbone (94). Use of a cyclopentane or a cyclohexane unit in this manner was 
proposed to allow less flexibility in the orientation of the thiophosphorylhydrazide units 
and perhaps render greater predisposition to metal binding. Although cyclopentane 
offers greater rigidity, the cyclohexyl system was investigated first, due to the 
commercial availability of cyclohexane-1,2-dione as a suitable starting material. 
Me 
H \_.,Me 
N-F?. 
CXN' \. N S \ II N-P 
H I 'Me 
Me 
(94) 
This -time, a different retrosynthesis was envisaged, given some of the above problems 
with formation of the appropriate dihydrazones. Synthesis of a thiophosphorylhydrazine 
unit was proposed first, followed by reaction of the hydrazine moiety with any diketone 
in an attempt to eliminate the complications which arose from two neighbouring 
dihydrazone functions (Scheme 3.11). 
-95-
s 
II 
Br-f'Me 
Me 
+ 
Chapter Three : Diall..ylthiophosphoryl Ligand Systems 
Me 
s U DIKETONE 
H2N-~- \'Me 
~ \ Me /-( 
N S 
Me N S 
' It ~-r'Me 
Me 
(95) 
Scheme 3.11 An alternative flexible synthesis 
Dimethylthiophosphorylhydrazine (95) was prepared by the dropwise addition of 
dimethylthiophosphoryl bromide (freshly prepared as before but concentrated by 
distillation of carbon tetrachloride at atmospheric pressure) to an excss of hydrazine 
hydrate. After stirring at room temperature for 4 hours, the product (95) was extracted 
into chloroform and isolated as a colourless oil. Treatment of the cyclohexane dione 
with dimethylthiophosphoryl hydrazine (95) failed to show any reaction and the starting 
material was recovered from the reaction mixture. 
In order to investigate whether this failure to react was specific to the cyclohexane 
dion~ or typical behaviour for these systems, a control experiment was undertaken. This 
alternative route of hydrazine-ketone condensation as the second step was applied to the 
benzilligand (84) previously synthesised by the initial method (Scheme 3.7). 
Dimethylthiophosphorylhydrazine (95) was added to a stirred solution of benzil in 
butanol and heated under reflux for 20 hours. Upon cooling the reaction mixture, a 
white precipitate formed which was identified by 1 H NMR analysis as 
benzildihydrazone (81). Clearly, the P-N bond had cleaved as no phosphorus signal was 
detected in the sample by 3lp NMR analysis and the dihydrazone had formed. Although 
the reaction was repeated using milder conditions of 25°C, the result was the same. 
Clearly, synthesis via condensation of the dike tone with a substituted 
thiophosphorylhydrazine was not as generally applicable as the original synthesis via 
formation of the corresponding dihydrazones. In view of this evidence, synthesis of the 
cyclohexylligand (94) was attempted using the original scheme. Cyclohexane dione 
was treated with hydrazine hydrate inn-butanol under reflux for 40 hours. Upon 
cooli_ng the reaction mixture, no precipitation occurred and the solvents were 
evaporated to give a brown oil. ESMS analysis of the residue indicated that the 
dihydrazone was indeed present, and its preparation and recrystallisation are described 
in the literature.l8,19 However, purification of the compound was not pursued at that 
time due to the limited time available for the pursuit of other systems described b~low 
and complexation study of the ligands synthesised above. 
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The synthesis of further systems based upon the pyridine ligand (86) was also 
envisaged in parallel with the work described above, since this system only has one 
thiophosphorus functionality and avoids the synthetic problems of reacting two sites 
simultaneously. The original pyridine ligand (86) and an analogous system containing a 
substituted thiophosphinic acid (96) (see also Ch.2), rather than the 
dialkylthiophosphoryl functionality, may provide an interesting comparison. This new 
system would also allow the formation of neutral complexes without deprotonation of 
the amide N-H due to the much lower PKa expected for the thiophosphinic acid proton. 
·~ 
Ha~NANH 
l-Me 
s?" 
OH (96) 
A synthetic route to this ligand (Scheme 3.12) was proposed and attempted. The 
required precursor, chloroethoxyphenylphosphine, was prepared as previously 
described (section 2.2) and added dropwise to a stirred solution of excess amino-
picoline in dichloromethane. 3lp NMR analysis showed the formation of a single P(III) 
species atOp 104, confirming that chloroethoxyphenylphosphine (Op 174) was no 
longer present The phosphine (97) was then treated with trimethylsilyl bromide under 
an inert atmosphere for 30 minutes prior to the addition of water. 1 H NMR analysis 
revealed the loss of the distinctive N-H coupling to phosphorus and suggested that P-N 
bond cleavage had occurred. This was not altogether surprising considering the acid 
lability of the phosphorus-amine bond. 
CH2CI2 
..-.1-:
8
-lu-e-ne-- H,CM NH ::::;:=====~~eM NH 
I I 
HO/ p"- Ph (99) H"" ~-Ph 
0 
~ 
HacAANH 
(96) \.,.....Me ~p'\. 
OH 
Scheme 3.12 Proposed synthesis of a thiophosphinate analogue of the pyridine ligand 
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An alternative route was proposed and attempted (Scheme 3.13) which involves the 
preparation of the amino-picoline-N-ethoxyphenylphosphine (97) from 
chloroethoxyphenyl phosphine and excess 2-amino-6-picoline in a similar procedure to 
the above, using acetonitrile as the solvent. The amino-picoline hydrochloride salt was 
removed by filtration and the solvent was evaporated from the filtrate. The residue (Op 
104) was then stirred in 6M hydrochloric acid for 16 hours at room temperature to 
hydrolyse the P(III) ester (97) to (99). Removal of the solvent yielded the colourless 
solid product (Op 22). Elemental sulfur was the chosen sulfonating reagent for the next 
step as the tautomeric eqilibrium of the phosphinous acid with its P(III) form (see 
Scheme 3.12) allows reaction by nucleophilic attack of phosphorus. Crushed, dry sulfur 
was added to a stirred solution of the phosphinous acid (99) in acetonitrile and heated at 
45"C for 16 hours. However, 31p NMR analysis revealed that the compound (99) was 
the only phosphorus-containing species present and that no reaction with sulfur had 
taken place. Aluminium trichloride was added to the reaction mixture, in an attempt to 
activate the s8, and the reaction was heated at reflux for 20 hours. The result was 
identical: no reaction being observed by 3l P NMR analysis. 
6MHCI 
(97) (99) (96) 
Scheme 3.13 Possible alternative synthesis of the thiophosphinate pyridine ligand 
Due to the failure of these attempts to synthesise the ligand (96) the design was 
modified slightly in order to render the ligand synthetically more accessible. The design 
of the dithiophosphinate ligand (100) was based upon the reaction envisaged between 
2-amino-6-picoline and the cyclic thiophosphinic anhydride (101) known as Lawesson's 
reagent (LR) (Scheme 3.14). 
+ dichloromethane 
(101) 
~ KJCA~NH 
l_sH 
-::;;:-PQ s ~ 
r 
.--:::; 
(100) 
Scheme 3.14 Synthesis of dithiophosphinate ligand 
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The latter compound (101) is the dimeric anhydride of methoxyphenyldithiophosphinic 
acid which is well known as an extremely effective thionating reagent.20 It has been 
used extensively in the synthesis of thioamides, thioketones, thioesters, thiopeptides 
and sulfur-containing heterocycles. Another use is its application to other 
transformations in organic synthesis where mild conditions are sought, such as the 
conversion of an ester to the corresponding ether via the intermediate thioester and 
subsequent removal of sulfur with Raney nickel. The preparation of 
alkyl(aryl)dithiophosphonic acids and their derivatives are known by the reaction of 
different nucleophiles such as primary and secondary amines21with LR.22 For example, 
carboxylic acids attack at phosphorus of LR to open up the dithiaphosphetane ring 
resulting in the formation of mixed anhydrides as useful intermediates for further 
synthesis (Scheme 3.15). 23,24 
Scheme 3.15 Nucleophilic attack at Lawesson's reagent 
It was this type of nucleophilic attack which was envisaged by the amino-picoline on 
LR to form the ligand (100). 2-Amino-6-picoline was added to a stirred suspension of 
Lawesson's reagent in dichloromethane, and a solution was formed immediately. After 
10 minutes, the suspension reappeared, but analysis by 1 H NMR confirmed that some 
starting material and another species were present and that the reaction was still in 
progress. After 18 hours, the product was extracted into water and lyophilised to give a 
white solid. Despite the evidence of lH, Be and 3lp NMR analysis (Op 72) in addition 
to combustion analysis which gave data consistent with the structure (100), the mass 
spectrum of the product was inconclusive as it did not show the expected mass of 310 
-only several lower masses. This led to concern that the structure was a 1:1 salt rather 
than a single molecule since ESMS is the softest mass spectroscopy technique, least 
likely to fragment the molecule. It was also noted in the laboratory handling of the 
product, that it reacted with trace amounts of ethanol stabilisers in chloroform, 
suggesting a that the nature species was labile. Hence, further studies of this system 
were not pursued as P-N bond was perhaps too labile with such an acidic function. At 
this point, the evaluation of the potential for metal complexation of the systems 
successfully synthesised and fully characterised above was deemed more important 
before further derivatives were proposed. 
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X-ray structural analysis of ligands 
Crystalline samples of the tetradentate ligand (84) and bidentate ligand (86) of suitable 
quality for X-ray analysis were easily obtained from diethyl ether solution and without 
further recrystallisation. A small sample of the tetradentate ligand (85) was 
recrystallised from diethyl ether, and small pale yellow crystals formed. X-ray crystal 
structures of the tetradentate ligands (84) and (85) were solved by Dr. Andrei Batsanov 
and Christian Lehmann respectively (Figures 3.5 and 3.6 and Appendix B). 
In both structures, (84) and (85) the amino nitrogen atoms have planar (sp2) bonding 
geometry within experimental error. However, their molecular conformations are quite 
different. The backbone of (84) adopts a 'curled' conformation, being twisted by 
approximately 72° around the central C(l)-C(2) bond and by a smaller degree around 
the other single bonds (see Table 3.1). The structure of (85) possesses a crystallographic 
inversion centre (Figure 3.6). All non-H atoms (save the P-methyl carbons) are coplanar 
(with a maximum deviation of 0.07 A and the mean one of 0.03 A). The absence of 
signifigant hydrogen bonding in both structures is noteworthy. In (84) the 
intramolecular contacts N(2)-H. .. N(3) and N(4)-H ... N(l) exhibit H ... N distances of 
2.55(2) and 2.53(2) A with N-H-N angles of 116(2) and 119(2)". They may be regarded 
as electrostatic interactions rather than hydrogen bonds, since the direction of the 
contacts do not correspond to the lone pair sites on N(l) and N(3). 
Ph Me 
---N \/Me 
s I -:;:;;- ' P 
\\ N N/ \\ / ,~ I s Me/~ N ---\----H 
Me Ph 
Figure 3.5 X -ray crystal structure of ligand (84) 
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Me Me 
__ N \,....Me 
s I ~' P 
\\ N N/ ~ 
P.,.... , ~ I s 
Me/\ N ---,----H 
Me Me 
Figure 3.6 X-ray crystal structure of (85) 
The structure of ligand (86) was also solved by Dr Batsanov (Figure 3. 7) and shows 
inversion-related molecules linked by intermolecular hydrogen bonding of the amines 
to sulfur (N(2)-H ... S'), lying practically in the same plane. 
Figure 3.7 X-ray crystal structure of ligand (86), showing intermolecular hydrogen 
bonds. Inversion-related atoms are primed. 
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Table 3.1 Selected bond distances (A), bond and torsion angles (") 
Structure (84) 
P(1)-S(l) 1.935(1) P(2)-S(2) 1.947(1) 
P(l)-N(2) 1.680(2) P(2)-N(4) 1.689(2) 
N(1)-N(2) 1.376(2) N(3)-N(4) 1.380(2) 
C(1)-N(1) 1.292(2) C(2)-N(3) 1.291(2) 
C(l)-C(2) 1.506(2) P-C mean 1.786(5) 
N(4) ... N(l) 3.156(2) N(2) ... N(3) 3.139(2) 
N(l)C(l)C(2)N(3) 71.9 
S(l)P(l)N(2)N(l) 167.4(1) N(3)N(4)P(2)S(2) -177.1(1) 
P(l)N(2)N(l)C(l) -168.7(1) C(2)N(3)N( 4)P(2) -165.6(1) 
Structure (85) 
P-S 1.955(1) P-N(l) 1.676(1) 
N(l)-N(2) 1.383(1) C(l)~N(2) 1.296(2) 
C(l)-C(2) 1.478(2) P-C mean 1.801(2) 
Structure (86) 
P-S 1.966(1) P-N(2) 1.677(1) 
N(l)-N(2) 1.400(2) P-C mean 1.798(2) 
N(2) .. .s' 3.544(2) N(2)H(2) ... S' 166(1) 
SPN(2)C(2) 176.2(1) PN(2)C(2)N(l) 7.2(2) 
3.3 Complexation Studies 
The ligands (84), (85), (86) and (89) prepared above displayed extremely poor aqueous 
solubility. However, the ligands were found to be soluble to varying degrees in 
common solvents such as acetonitrile and methanol. This did not deter studies with a 
view to future radiolabelling of these ligands, since the complexation of Cu-PTSM 
itself takes place with the aid of ethanol to dissolve the ligand rather than under purely 
aqueous conditions. 25 Initial studies were performed by electrospray mass 
spectrometry, as for the previous ligand series (Ch. 2). 
Electrospray Studies 
Complexation and electrospray analysis was carried out with (84), (85), (86) and (89) 
using the divalent metal ions of copper, nickel and zinc as their perchlorate salts 
(warning- perchlorate salts are explosive). Analysis of complexation with Cu(l) was 
also undertaken with [Cu(I)(CH3CN)4]BF4 which was prepared from copper(!) oxide in 
acetonitrile in a similar manner to [Cu(I)(CH3CN)4]PF6 prepared by Kubas.26 Stock 
solutions of the ligands and metals with concentrations of the order of 104 M were 
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prepared. Although not quantitative, the ESMS+ studies gave a preliminary insight into 
the coordination preferences of the ligand. 27 
Butane-2,3-bis[( dimethylthiophosphoryl)hydrazide (85) 
Equimolar amounts of ligand (85) and copper(II) perchlorate in acetonitrile gave a 
clean spectrum of the ML complex only with the major mass (100%) at 359.94 
corresponding to the loss of two protons from the ligand on positive ion mode. The 
isotope model with the major intensity at 359.98, showed close correlation with the 
observed mass (CgH1sN4P2S2Cu requires 359.98, ES+). When a similar analysis was 
performed using Cu(I) as the initial source of copper, the major mass (100%) was 
observed at 360.78, corresponding to the loss of one proton (Figure 3.8), and 
correlating with an isotope model intensity at 360.99 (CgH 19N4P2S2Cu). This suggests 
that neutral complexes of the ligand are formed with both Cu(ll) and Cu(l). The nickel 
complex also gave a strong signal corresponding to the 1:1 complex, Ni(85). 
Complexation also occurred with zinc, but other species including a very small amount 
of Zn(85h were also observed. 
100 
% 
100 
360.99 
362.99 
/ 
360.78 
362.73 
/ 
Scan ES+ 
9.74e5 
0 1~~'TTT"rrrT~,.,..,...,..,c;+'n-.,.,....,_...-rr1I-~..,.,..,~~,...,.~.....,.,.,....,...~,.....,..,~~rrrr<...,-rr~n-rr m/z 
200 250 300 350 400 450 500 550 600 650 700 
Figure 3.8 ESMs+ spectrum of Cu(l)(85) showing loss of one ligand proton 
1,2-Diphenylethane-1,2-bis[(dimethylthiophosphoryl)hydrazide (84) 
Equimolar amounts of the ligand (84) and copper(II) perchlorate produced ML and 
ML2 species, at 484.74 and 906.27 respectively. The major mass (100%) at 484.74 
corresponds to the loss of one proton from the ligand (using positive ion mode), 
suggesting that a neutral copper(!) complex had formed. The isotope model with the 
major intensity at 485.02, showed close correlation (within the calibration of the 
instrument) with the observed mass (C1sH23N4P2S2Cu requires 485.02, ES+). The 
ML2complex at 906.27 corresponds to copper complexation of two ligands with the 
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loss of two protons overall, suggesting that this species is a copper (II) complex. 
Complexation with zinc produced a similar result, as both Zn(84) and Zn(84h species 
were observed in the spectrum, in addition to a peak at the ML half-mass 
(corresponding to the doubly-charged complex) and a perchlorate adduct of ML. Again, 
nickel produced a similar spectrum, with ML, M~ and the half-mass peak of ML 
predominating. 
100-
100 
485.02 
484.74 
I 
I 
Scan ES+ 
7.06e5 
%· 14~6.43 
1~~~ .. ,t" ... , .... , ........ , .... , ... , .... , ........ , ... , ......... , ... , .... , .. :.r,.m,, 
400 450 500 550 600 650 700 750 800 850 900 
Figure 3.9 ESMS+ spectrum of Cu(84), showing a Cu(I)L complex predominantly 
and a Cu(II)L2 complex. 
2 -Dimethylthiophosphory lamino-6-picoline ( 86) 
Since the expected coordination preference of copper(II), nickel(II) and zinc(II) with 
the ligand (86) involved the formation of bis-bidentate complexes, separate electrospray 
studies were carried out using both 2: 1 and 1: 1 equivalents of ligand to metal. The 2:1 
CulL solution gave a spectrum containing Cu(86h at 100% intensity in addition to 
smaller peaks due to some ML complex and unbound ligand. The 1: 1 solution again 
showed the ML2 species was dominant although Land ML were observed. Spectra for 
both nickel and zinc complexes (1: 1 MIL) gave intense peaks consistent with the 
formation of ML2 species and the remaining uncomplexed ligand, while the respective 
ML species were visible as only small peaks. The CuL and Cu~ species at 262.98 and 
462.95 respectively, showed the loss of one ligand proton in both species, suggesting 
that copper(l) complexes had formed. 
ESMS analysis of 2:1 solutions of the ligand with zinc and nickel showed the unbound 
ligand as the major mass intensity and an ML2 species as the only complex present, as 
expected. All of these observations suggest that M~ complexes are preferred and that 
copper is bound more avidly than either nickel or zinc. 
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Figure 3.10 ESMS+ spectrum of (86) + Cu2+ prepared as 1:1 ratio and a 2:1 ratio 
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Figure 3.11(a)ESMS+ spectra (86) + zn2+ 
prepared as a 2: 1 ratio 
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(b)ESMS+ spectra (86) + zn2+ 
prepared as a 2: 1 ratio 
The spectrum of the 1:1 complex of copper showed an extremely clean spectrum of 
Cu(89) only and no unbound ligand (Figure 3.12) with the major mass intensity at 
355.81 corresponding to the single deprotonation of the ligand, consistent with the 
formation of a copper(!) species. By contrast, electrospray analysis of the nickel and 
zinc species formed upon complexation with ligand (89) showed that several species 
were present in each sample. With nickel, the most intense peak was due to the free 
ligand, then ML (349.9) and ML2 (642.7), as well as peaks at 449.8 and 742.5 which 
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indicated the presence of perchlorate adducts of ML and ML2 respectively. The 
formation of all of these species was mirrored by the spectrum of the ligand with zinc: 
peaks due to L, ML, ~ and their perchlorate adducts were present. 
100 355.96 -- l 
% 
0'~~~~.~~~~~~~,.~ ..~~·~ .. ~·1~· .. ~·1~"~"~1·~·"~1'~"~'i~· ..~·t~"~"~l"~"~l'~"~'l~· ..~·t~"~"l~"~"~'·~ ... ~,.~ .. ~·i~"'~'l~" 
100 355.81 
357.73 
!( 
%· 
il 
II 
I !I· 
• • ,, •• 1• • • ,. •· , ,,, r· ,, 1 , ,,,,, 1 ,, ,,,, , • 1 ,, ,,,, , 1, ,,, 1,, .,. ,, 1,,,,·1,,,, 1 .• , •••• , ••• , .• r. 1 ,,,,, m/z 250 300 350 400 450 500 550 600 650 700 750 800 
0·. 
Figure 3.12 ESMS+ spectrum showing Cu(89) and isotope model (above) 
Another interesting observation was that nickel and zinc ML peaks corresponded to the 
mass of the metal plus ligand, minus two protons. The same calculation with copper 
corresponded to the loss of only one amine proton, which suggests that copper is 
present as copper(n. 
At this stage it was unclear if the reduction to Cu(l) occurred upon ligand complexation 
or during the electrospray ionisation process. 
Ultraviolet and visible photospectroscopy of ligands with copper(/) and (II) 
The UV -visible spectra provided further evidence which was consistent with the 
formation of complexes with copper. The "-max values for the free ligands (Table 3.2) 
and their copper complexes were measured in acetonitrile using copper(II) triflate and 
tetrakis (acetonitrile)copper(l) tetrafluoroborate as sources of Cu2+ and cu+ ions 
respectively (Table 3.3). 
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Table 3.2 Amax values of dimethylthiophosphorylligands 
Ligand Amax.l nm € I dm3 mol-l cm-1 
HM'( Me 
.~r( 274 31000 
H
3:XN s (C=N: 1t-1t*) (85) 
H, "{ 
.s N-P, 
H I Me 
Me 
H-1'\ Me 
,N-1( 276 31000 
PXN s (84) Ph f't 
.s 
N-, ..... 
fl.1e Me 
M 232 11000 (86) 286 4000 NH I_..Me 
~' Me 
H~NH 244 8 000 (89) 300 6000 
Ma) I.,..Me 
"->s ff"", Me Me 
Table 3.3 Amax values of 1: 1 complexes formed from Cu(CF3S03h and 
[Cu(I)(CH3CN)4BF4] in acetonitrile at 293K 
Ligand COPPER(II) ADDED COPPER(!) ADDED 
A-maxi nm 
(85) 206 
302 
392 
636 
(84) 208 
280 
(86) 232 
286 
(89) 240 
302 
326 
€ I dm3 mol-1 cm-1 
19 600 
12 500 
4700 
210 
shoulder 
50000 
49300 
15 200 
shoulder 
8 800 
5 700 
Amax I nm € I dm3 mol-1 cm-1 
204 
274 
430 
40000 
35 000 
2000 
280 78 000 
232 
286 
240 
18 500 
62 500 
18 400 
302 12 000 
Comparison of the results in the presence of added Cu(ID and Cu(l) clearly shows that 
only ligand (85) forms a Cu(II) complex while ligands (84), (86) and (89) reduce 
copper(II) to copper(!). The values given for the complexation of these three ligands 
with ·the two sources of metal are very similar. In contrast, the A-max values for ligand 
(85) with copper<n and copper(II) are quite different, indicating an entirely different 
geometry. The obvious difference amongst the ligands is that (85) does not contain any 
-107-
Chapter Three: Dialkylthioplwsplwryl Ligand Systems 
aryl group whereas the other ligands form conjugated systems which include a pyridyl 
or phenyl aromatic rings. 
Measurements were also carried out upon the complexes formed with copper (II) and 
the same ligands in methanol to check for any evidence of a solvent dependence (Table 
3.4). Again, the methyl dihydrazide ligand (85) formed a dark green solution showing a 
weak d-d band CA.max 638 nm, £ 150 dm3 mol-1) consistent with the formation of a 
copper(ll) complex. The complex formed with the phenyl dihydrazide ligand in 
methanol showed more colour than the corresponding species in acetonitrile. The 
former species showed an extra band, a metal to ligand charge transfer band (Amax 404 
nm, £ 180 dm3 mol-1), giving rise to the yellow colour. 
Table 3.4 Amax. values of dimethylthiophosphorylligands in methanol 
Ligand COPPER(II) ADDED complex 
Ama!/nm £ I dm3 mol-l cm-1 colour 
(85) 208 16 500 dark green 
310 15 400 
388 7 600 
638 150 
(84) 206 40100 greeny-yellow 
280 26000 
404 180 
(86) 232 28 200 colourless 
286 10100 
(89) 240 13800 pale yellow 
310 6100 
Upon standing for five days, the methyl ligand copper(II) complex Cu(II)(85) showed 
different behaviour in the two solvents. In acetonitrile, the dark green Cu(II) complex 
remained whereas, in methanol, the formerly dark green solution had turned very pale 
yellow in colour, indicating that the Cu(II)(85) complex had been reduced to the 
corresponding Cu(I)(85) complex. 
NMR titrations 
A similar procedure to the method used for the metal binding study of the 
thiophosphinic acid ligands (Ch. 2, section 2.3) was adopted. NMR titrations were 
attempted with both zinc and copper(!). Ligand (84) showed only minor changes .in the 
shift of the phosphorus signal followed by 31 P NMR analysis during the incremental 
addition of the metal. However, for the formation of a 1:1 complex, the shift expected 
upon· addition of excess metal (MIL >1) would be much less than any initial shift due to 
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binding of the ligand. These continuous minor shifts provided evidence of only weak 
bindingwith Cu(l). However, several 1H NMR spectra were obtained (in CD3CN) 
during the incremental addition process, and a change in the chemical shift and 
coupling constant of the P-methyl substituents were observed, although only 
qualitatively, due to the proximity of the protonated solvent peak. The coupling 
constant increased from 4Hz to 19Hz over the metal addition process. With the 
addition of zinc ions the phosphorus chemical shift hardly changed at all, as expected 
from the ESMS analytical evidence above, of only very weak formation of a zinc 
complex. 
The ligands (84) and (85) themselves, were studied for N-HIN-D exchange in CD30D. 
The proton NMR spectrum of a sample of each ligand in CDC13 showed the distinctive 
phosphorus-coupled broad doublet at -6 ppm (J-21 Hz) characteristic of these ligands. 
Two drops of CD30D were added to each sample, and proton NMR spectra were re-
aquired. The spectrum of the methyl ligand (85) showed that the N-H signal had 
disappeared completely, while the analogous spectrum of the phenyl ligand (84) 
showed an N-H signal, but its integral was reduced by greater than 50%. These 
observations indicate that N-HIN-D exchange occurs with both ligands and that the rate 
of N-H/N-D exchange is more rapid for the methyl ligand (85). At an infinite time 
point, the 1 H NMR specrum of CDC13/CD30D sample of the phenyl ligand (84) 
showed that the integral of the N-H proton was very small ( « 0.5H). Obviously there is 
an equilibration process taking place between the acidic H and D of the ligand and the 
excess CD30D, indicating a similarity in the pKa values of the species. Hence the 
acidity of the ligand N-H may be estimated to be somewhat less than that of CD30D 
(the dissociation constant of methanol is 15.92). 
HPLC analysis 
HPLC analysis was performed with tetradentate phenyl-substituted ligand (84) and 
copper(II) acetate in methanol as a prelude to possible radiolabelling studies. The 
chromatogram of the ligand (84) confirmed the purity of the compound and gave a 
single peak with a retention time of 13 minutes. Analysis of a solution containing a 1:1 
mixture of (84) and Cu2+ (as copper(ll) acetate) revealed that very little complex was 
present, and only the ligand along with another very minor small peak corresponding to 
a minor impurity were observed in the chromatogram. Preparation of the complex with 
the addition of 2: 1 equivalents sodium methoxide to ligand followed by the addition of 
copper showed an improvement in the amount of complex formed. The chromatogram 
still showed some ligand (Rt 13 minutes, 28%) but a higher proportion of the copper 
complex was observed with a retention time around 15 minutes (44%) in addition to a 
minor species with a retention time of 16 minutes (8%). This sample was also analysed 
by ESMS which confirmed that the major species formed were CuL and CuL2. 
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Isolation of solid complexes 
Crystallisation of the copper complexes was attempted in order to obtain suitable 
crystals for structural elucidation in the solid state by X-ray analysis. Initial attempts 
focussed upon ligand (85) since it formed complexes with both Cu(l) and Cu(II) and 
solid state structures of both complexes would have allowed comparison of the copper 
geometries. However, upon cooling ( -YC) and standing, the deep green solution of 
Cu(II)(85) in acetonitrile yielded only small amounts of colourless suspensions and the 
complex appeared to degrade rather than form crystals with time. The Cu(l) complex of 
ligand (85) was prepared by the addition of a solution of [Cu(CH3CN)4]BF4 to a 
solution of the ligand. An orange solid precipitated immediately and was isolated and 
characterised by elemental analysis and ESMS as the neutral Cu(l)(85) complex. 
Crystals were formed by allowing a solution of the complex in acetonitrile to stand and 
undergo slow evaporation of the solvent, but characterisation of the colourless crystals 
which formed, showed that these were [Cu(CH3CN)4]BF 4· This suggests that the 
complex has a limited stability and dissociates with time. 
Similarly, solutions of a 1: 1 complex of (85) and Cu(II) and a 2:1 complex of Cu(86h 
which instantly reduced Cu(II) to Cu(l) (deduced from the yellow and colourless 
solutions respectively) failed to yield any crystals but produced very small amounts of a 
colourless solid powder. Attempts to induce crystallisation by the addition of diethyl 
ether or tetrahydrofuran and by changing the counter ion to perchlorate or 
hexafluorophosphate failed to give any suitable crystals. 
Attempted complexation with oxorhenium (V) 
Preparation of the oxorhenium derivatives of ligands (84) and (85) was attempted using 
[Re(O)Cl3(PPh3)J] in an analogous manner to that described previously (Ch. 2, section 
2.3). The phenyl ligand (84) gave a dark brown solid which was only sparingly soluble 
in solvents such as methanol and acetonitrile. The ESMS- spectrum obtained in 
methanol gave a rhenium isotope pattern at 249 and 251 in relative abundances 
corresponding to perrhenate and the other major intensity at 389 correspondng to the 
ligand with two sulfurs replaced by oxygen. 3lp NMR analysis showed a single 
phosphorus species atOp 47.32 (MeOH)- a chemical shift more characteristic of P=O 
species- in agreement with the above observations. Combustion analysis of various 
samples of the solid product failed to give consistent results, indicative of a mixture 
rather than a well-defined single species. A dark brown solid also formed with the 
methyl ligand (85) and combustion analysis similarly failed to give consistent results. 
Attempted complexation of the ligands with oxorhenium(V) was also performed in 
dichloromethane but similar dark brown solutions were obtained. From the above 
observations, it appears that some redox processes occur at the P-S bond in the 
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thiophosphorylligand allowing transformation to its phosphoryl analogue with 
concomitant electron transfer to and from the rhenium centre. 
Molecular Modelling 
Models of the copper complexes of the bis[(dimethylthiophosphoryl)hydrazide] ligands 
(84) and (85) were created by Christopher Edlin at Zeneca Specialties using the method 
as described previously (Ch.2, section 2.3). The models (Figure 3.13) show copper with 
a distorted tetrahedral geometry suggesting that the ligands may stabilise Cu(l) and 
destabilise Cu(ll). This correlates with the observations that the ligands have a tendency 
to stabilise Cu(I) although the phenyl-substituted ligand (84) performs the Cu(II)/(1) 
reduction instantaneously whereas the corresponding methyl ligand (85) does not 
behave in this manner as discussed above. These simple models do not account for the 
behaviour of the metal with the specific ligand system but give a good insight into the 
possible preferred geometry of the metal. 
3.4 Conclusions 
The synthesis of new dimethylthiophosphorylligands is relatively simple provided that 
the appropriate dihydrazone can be prepared. The synthesis of the dihydrazide ligands 
via disconnection of the P-N bond proved to be more general in scope than 
condensation of the corresponding dike tone with a substituted 
thiophosphorylhydrazine. Although all of the thiophosphoryl derivatives considered 
above were dimethyl substituted, a range of substituents may be accessible via the 
bi(phosphine sulfide) compounds, including those containing two different alkyl groups 
at phosphorus. 28 
Analysis of the copper, nickel and zinc complexes by electrospray mass specrometry 
shows, that although all four ligands formed complexes with these metals, the copper 
complexes appeared to form the most avidly and cleanly for each ligand. Furthermore, 
visible photospectroscopy of all four ligands with Cu(II) and Cu(l) confirms that 
reduction of Cu(II) to Cu(l) is strongly favoured in both acetonitrile and methanol. 
Characterisation of the copper complexes of the ligands (with the metal present in either 
Cu(II) or Cu(l) oxidation state) looks promising for the formation of neutral complexes 
and suggsts that the radiolabelling of these ligands should be investigated. 
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4. Aza-Thiophosphinate Systems with More Rigid Skeletons 
The accessibility of further new amino-thiophosphinate ligands by the incorporation of 
more rigid (aromatic) units in the overall skeleton is discussed (4.1). Possible synthetic 
routes and the difficulties encountered towards the preparation of such systems are 
presented ( 4.2 ), together with suggestions for further systems and plausible synthetic 
pathways ( 4.3 ). 
4.1 Extending the Thiophosphinic Acid Series - Design of two new systems 
A useful extension to the aza-thiophosphinate ligand series was envisaged by altering 
the chelate ring system and including some rigid spacers. Added rigidity may have the 
effect of favouring a particular geometry and disfavouring undesired geometries such as 
tetrahedral and octahedral, thus increasing the selectivity for a particular metal ion (see 
section 3.2). In the thiophosphinate series described earlier (Ch.2), the ligands are 
disposed to form three five-membered chelate rings (5,5,5) or two five-membered and 
one six-membered chelate rings (5,6,5) upon metal complexation. The methylene 
linkers between the nitrogen donors and their adjacent thiophosphinate funtionality of 
the previous aza-thiophosphinate ligands (30) (Ch. 2) could each be replaced by an 
aromatic ring to increase the chelate ring size from five-membered to six-membered, 
giving a (6,5,6) ring system overall (Figure 4.1). 
Figure 4.1 
R 
;(_OH 
HN S 
C l R =alkyl, 11 N TI Ph,Bn Cr\OH 
(102) 
New ligand design with 6,5,6 chelate rings. 
The incorporation of an aromatic ring as part of the skeleton in the design of (102) may 
find further advantage as the nitrogen donor atoms of the ligand should be less readily 
protonated in acidic media. This is particularly attractive for oxotechnetium(V) and 
oxorhenium(V) complexes which require the deprotonation of one of the amines in 
addition to the thiophosphinate donors, in order to achieve charge neutrality. The 
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deprotonation of such aromatic nitrogen donor atoms upon formation of the oxo-
technetium complex is known for highly delocalised, unsaturated electron-rich ligands, 
such as a-phenylenediamine (pda).l Reduction of pertechnetate with sodium dithionite 
in the presence of excess phenylenediamine results in the formation of an anionic 
complex with a TcON4- core, whereas the absence of a reducing agent results in the 
formation of the tris-bidentate complex with a TcN6- core. In both complexes, the 
amines are deprotonated and act as negative nitrogen donor atoms. 
Another system, based on a 1,10-phenanthroline moiety (103), is also an attractive 
backbone to support the thiophosphinate functionality. With two suitably spaced 
nitrogen donor atoms capable of forming 5-membered chelates, it has already been used 
to form the basis of several ligands which bind many metals. The increasing application 
of phenanthroline-based systems to coordination chemistry results from their 
predisposition to metal binding which is manifested by their en tropic advantage. The 
two nitrogen donor atoms of 1,10-phenanthroline ligands are held in the same plane 
which has considerable advantage over ethylenediamine systems (104). The 
phenanthroline unit offers similar donor atoms and chelate ring size, but unlike 
ethylenediamine, there is no rotation about the C-C arid C-N sigma bonds (Figure 4.2). 
This advantage also holds over bipyridyl (bpy) systems (105) where rotation may occur 
around the central bond depending on whether both nitrogen atoms are cooperatively 
engaged in binding a proton in acidic media. 
";, OD (" 
N 1l 
NH o-o X 
(103) (104) (105) 
Figure 4.2 
Examples of 1,10-phenanthroline ligands in coordination and analytical chemistry are 
widespread and include applications in ionic and self-assembling systems2 and 
potentiometric sensors.3 Systems based upon 2,9-substituted phenanthrolines have 
been generally applied to the coordination chemistry of many metals. 4 Copper(!) 
generally adopts tetrahedral geometry by phenanthrolines and there are a variety of 
examples of 2,9-dimethyl-1,10-phenanthroline (neocuproine) complexing this metal ion 
as an [M~]+ complex (106).5,6 
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(106) 
A series of acyclic tetradentate phosphinic acid ligands based on 1,10-phenanthroline 
(Figure 4.3) was synthesised by George Bates.7 The subsequent study of these N202 
ligands showed that the hard phosphinate donors bound zinc(II) and nickel(II) ions and 
enhanced the stability of their phenanthroline complexes, while copper(II) was, 
unsurprisingly, bound only through nitrogen. 
/OH 
tl"'-R 
0 
(107) 
Figure 4.3 Phosphinate phenanthroline ligand system 
Analogous thiophosphinic acid ligand systems were proposed herein (108) (Figure 4.4), 
as an extension of the original thiophosphinate ligand series (Ch. 2) incorporating the 
phenanthroline unit for predisposition to metal binding. Use of sulfur donors should 
enable all four donor atoms to bind to copper, unlike the 'hard' phosphinate ligands, and 
the incorporation of the longer P=S and S-M compared with the P=O systems may give 
a geometry favourable for copper(II). 
(108) 
Figure 4.4 Design of new phenanthroline thiophosphinate ligands 
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4.2 Synthesis 
4.2.1 Phenylene aza-thiophosphinate system 
An additional advantage of the design of (102) was foreseen in the ligand synthesis, as 
disconnection between the aromatic ring and phosphorus may be possible giving an 
aromatic bromide skeleton and the appropriate phosphonous ester as the synthons in a 
palladium(O) coupling reaction (Scheme 4.1). Such couplings have been described by 
Xu and Huang8 and Hirao9 where palladium(O) in the form of [Pd(PPh3)4] effectively 
catalyses the reaction between aromatic bromides and phosphonous esters -
RP(O)H(OR) types. This coupling reaction is extremely tolerant of the presence of 
other functional groups. 
0 [Pd(PPh3)4] 0 
II NEts II 
Ar-Br + H--P-OR Ar--P-OR 
Ph/ toluene Ph/ 
Scheme 4.1 Pd(O) coupling 
The synthesis was designed with 2-bromoaniline as the starting compound for the 
preparation of the carbon skeleton (109) prior to the introduction of a phosphorus 
functionality (Scheme 4.2). Treatment with tosyl chloride at room temperature in 
pyridine gave the tosylated bromoaniline in 93% yield. Subsequent reaction with 1,2-
bis(p-toluenesulfonato )ethane in DMF and caesium carbonate in an analogous 
procedure to that reported by Parker, 10 required heating under reflux for 18 hours to 
give the product mixture as an oil. Crystallisation of the residue from ethyl acetate I 
light petroleum (40-60) afforded the aromatic bromide (109) as a colourless powder. 
NH2 !'r"'_T_s_CI~ U pyridine + (T' 
OTs 
Scheme 4.2 Synthesis of the ligand skeleton 
(109) 
The rest of the ligand synthesis was proposed (Scheme 4.3), and the next step was the 
carbon-phosphorus bond-forming reaction (see above) by treatment of the aromatic 
bromide (109) with the appropriate phosphonous ester. 
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Scheme 4.3 Proposed synthesis of aromatic thiophosphinate ligands 
Although the phenyl phosphonous ester was available commercially, the methyl 
analogue had first to be prepared. The synthesis of MeP(O)(H)OEt was carried out 
according to literature methods, 11.12 using dichloromethylphosphine and ethanol as a 
reagent in a solvent free procedure (Scheme 4.4). 
0 
MePCI2 + 2Et0H -------~~ 
II 
/p~H 
Me OEt 
Scheme 4.4 Preparation of methylethylhydrogen phosphonite 
The palladium coupling was then attempted with methylethyl phosphonite 
[MeP(O)H(OEt)] using the conditions described.9 The aromatic bromide (109), 
triethylamine and phosphonous ester were placed in dry toluene and the mixture was 
degassed using a freeze-thaw cycle under vacuum. A catalytic amount of Pd(PPh3)4 
was added to the mixture which was degassed again and heated under an inert 
atmosphere for 20 h. However, analysis of the products by 3lp and 1H NMR showed 
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that the phosphorus-carbon bond had failed to form and the aromatic bromide had been 
converted to its protonated form (110). This reaction was attempted several times with 
both ethylphenylphosphonite, [PhP(O)H(OEt)] as well as the methyl compound - using 
fresh catalyst, freshly distilled solvents and samples of the aromatic bromide (109) 
which had been dried in vacuo for several hours. Under all the conditions described, 
neither of the desired phosphinate esters was observed by 31 P NMR, 1 H NMR or 
ESMS. 
1\ 
ce::o 
(110) 
Consideration was therefore given to the mechanism,9 represented schematically below 
(Scheme 4.5). This involves oxidative addition of the Pd(O) species and aromatic 
bromide which results in the intermediate Pd(ll) species prior to attack by the phenyl 
phosphonite. 
( L=PPh3 ] 
reductive 
elimination 
H 0 
(IV) I II 
CX~-P\-OR Br Ph # 
0 -HBr / 
\\ / reductive 
L' /~OR elimination 
C(Pd(ll) Ph 'L # 
Scheme 4.5 Reaction of the phosphinous ester to give the desired P-aromatic bond 
The reaction product (110) suggests that elimination of HBr from the palladium 
complex (Figure 4.5) does not occur and instead, elimination of H-aryl unexpectedly 
takes place. There is no obvious reason for this occurrence, but speculation may involve 
steric arguments. 
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'·pd·'' Ph3P~!p~ 
Me"j~ # 
EtO 0 
TsN 
+ 
elimination 
__________ .._ 
Representation of the putative Pd(IV) intermediate 
Other Aryl-Phosphorus bond-forming reactions 
Literature methods of forming phosphorus-carbon bonds from suitable aromatic and 
phosphorus starting materials were investigated, and another method of performing this 
type of transformation was considered. The nickel-catalysed Arbuzov reaction of 
diethyl methylphosphonite with o-iodotoluene was reported by Grabiak to give the aryl 
phosphinate in excellent yield. 13,14 High temperatures were required and the 
preparation of anhydrous nickel chloride was achieved by drying under vacuum at 
20(tC. Another method involving irradiation of diethyl methylphosphonite with 
substituted o-iodobenzylamide was also reported by Grabiak14 to give the 
corresponding phosphinate ester. Nickel catalysed Arbuzov reactions have also been 
reported for 1-substituted-5-bromonaphthalenes using nickel bromide and diethyl 
methylphosphonite.l5 A more mild method of achieving such phosphorus substitution 
of an aryl system using diethyl methylphosphonite as a substrate was reported by 
Cadogan via nucleophilic displacement of a nitro group. 16 This reaction was reported to 
occur with several substituted phosphonites in acetonitrile without heating (Scheme 
4.6) and the aryl substrate required was 1,2-dinitro-benzene. Despite the apparent 
limitation imposed upon this reaction by the prerequisite nitro group, an extremely 
versatile precursor was foreseen simply by reduction of this nitro substituent to an 
amine. This concept led to the design of a whole new synthetic scheme based upon this 
mild reaction as the initial step (Scheme 4. 7). 
_.,OEt 
Me-P, 
OEt 
~N02 
~~OEt 
,~ 
Me 0 
Scheme 4.6 Substitution of a nitro group by phosphorus 
Alternative synthetic route requiring the arylphosphinate as starting material 
Consequently, an alternative synthesis was proposed involving the formation of the aryl 
carbon-phosphorus bond prior to elaboration of the structure and formation of the 
overall ligand skeleton (Scheme 4. 7). 
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~NHR 
~P-ester 
RQ 
e
N P-ester 
OTs 
C AN P-ester 
OTs K 
(R=HorTs) u 
Scheme 4. 7 Basis of alternative towards the synthesis of (102) 
First, P-methyl-o-nitrophenylphosphinate was prepared by the reaction of 
methyldiethoxyphosphine with dinitrobenzene in dry acetonitrile at room temperature 
as described previously. 17 The pure product was obtained by vacuum distillation in 
83% yield as an orange oil which crystallised upon cooling. Reduction of this material 
to the P-methyl-o-aminophenylethylphosphinate was carried out as described by Kyba 
and Clubb using iron powder in aqueous ammonium chloride and heating the mixture at 
reflux for 16 hours17 to give the product (112) in 82% yield following an aqueous 
work-up (Scheme 4.8). 
CXN02 p-OEt 
/~ 
Me 0 
(111) 
CXNH2 p-OEt 
/~ 
Me 0 
(112) 
Scheme 4.8 Reduction of the nitro group to an amine 
Amide refinement 
At this point, the original design (102) was refined to incorporate amide rather than 
amine nitro gens (113) (Scheme 4.9). It was envisaged that the amide nitrogen lone pairs 
may be sufficiently tied up in the amide bond that N-protection prior to the eventual 
sulfur-transfer step may not be required. The amide carbonyl groups could remain as 
part of the new ligand, similar to diamidodithiol (DADS) systems used for radionuclide 
complexation (see section 1.7), or be removed in the final step by some form of 
reduction to achieve the original system (102) proposed. 
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() ~Et 
Y"ll'-Me 
0 N 0 
OXN Me 
& I ~0 OEt 
(113) 
Scheme 4.9 Synthesis of an amido ligand skeleton 
Prep~ration of the diamide (113) was initially attempted by the addition of 
diethyloxalate to a stirred solution of two molar equivalents of the amine (112) and 
triethylamine in dichloromethane. Despite heating for 18 hours, no reaction was 
observed by tic analysis. The amido compound (113) was sucessfully prepared by the 
addition of oxalyl chloride to two equivalents of P-methyl-o-
aminophenylethylphosphinate (112) and triethylamine in dichloromethane. Aqueous 
work-up gave the product which was recrystallised from ethyl acetate/diethyl ether to 
give (113) as a white solid in 84% yield. The propane analogue (114) was also prepared 
in good yield using malonyl dichloride in place of oxalyl chloride in this procedure. 
This analogue would lead to a ligand with three 6-membered chelate rings in addition to 
the original ligand with a 6,5,6-ring system. The oxalyl ligand (113) was treated with 
lithium hydroxide (4M) at room temperature to hydrolyse the ethylphosphinate diester 
to the diacid (115). 
'!? 
~ I OEt 
N 0 
0 erN ~e P=O ~ \ 
I ~ OEt 
(114) (115) 
Preparation of the phosphinic chloride was necessary prior to the sulfur transfer step, 
and was attempted using oxalyl chloride in dichloromethane as described previously 
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(section 2.2). However, the phosphinic acid (115) proved insoluble in the solvent, 
unlike the systems prepared previously in this manner where the initial suspension 
formed a clear solution. Sulfur transfer was attempted in PSC13 which is also a 
chloiinating agent capable of forming the phosphinic chloride prior to sulfur transfer. 
However, 3lp NMR analysis showed that no.species with a chemical shift greater than 
50 ppm were present, suggesting that no disubstituted thiophosphinic chloride species 
were present. Another method of transforming P=O to P=S was attempted by treatment 
of the phosphinic acid with PC15 in carbon tetrachloride as described by Grabiak15 
followed by Lawesson's reagent (see section 3.2) but to no avail. Part of the problem 
perhaps lies with the lack of stability of the diamide system towards acidic conditions 
which dictated the base hydrolysis of the phosphinate ester, and from the formation of a 
6-membered chelate ring involving the amide N-H and the phosphinate. Attempts to 
free the phosphinate (115) from its lithium salt (to make the ligand more organically 
soluble by protonation) by careful addition of O.lM hydrochloric acid to pH7 resulted 
in amide hydrolysis (ESMS analysis). The original design (102) incorporating the 
ethane backbone with synthesis proceeding via the ditosylamide appeared to be a more 
favourable option at this stage. 
Attempted synthesis with an ethane backbone 
The synthetic route to couple of aromatic amine (112) with an ethane backbone from 
1,2-bis(paratoluenesulfonato)ethane was attempted (Scheme 4.7, above). The amine 
(112) was dissolved in acetonitrile and stirred with disodium orthophosphate as the base 
and a solution of 1,2-bis(paratoluenesulfonato)ethane was added. No reaction was 
observed (monitored by 31p NMR and ESMS analysis) even when the reaction mixture 
was heated under reflux for 24 h. Reaction of the two substrates was then attempted in 
dimethylformamide with caesium carbonate in a similar procedure to that described 
above for the preparation of the aromatic bromide skeleton (109). Despite heating at 
reflux for two days, there was still no reaction observed by mass spectrometry (DCI) 
and 31p NMR analysis. The only remaining pathway to attempt was the tosylation of 
the aromatic amine starting material prior to attempting the above reaction again 
(Scheme 4.10). Although tosylation would appear to make the amine more hindered, it 
would also make the remaining amine proton more acidic and more likely to be 
removed, allowing a more favourable starting material for treatment with 1,2-bis(p-
toluenesulfonato )ethane. 
-124-
CCNH2 P:""OEt 
. l~o Me 
(112) 
TsCI 
pyridine 
Chapter Four: Systems with more Rigid Skeletons 
fYNHTs 
~P:""OEt 
l~o Me 
(116) 
;---'\ 
TsO OTs 
................................... 
() p(OE1 Y""" 11-...Me 
N 0 
eN Me 
CY \ 0 OEt 
P-Methyl-o-aminophenylphosphinate was tosylated in pyridine with tosyl chloride in an 
analogous reaction to the tosylation of bromoaniline described above for (109). The 
crude product (116) was used without further purification for the subsequent reaction 
owing to the limited time available. A solution of 1,2-bis(paratoluenesulfonato)ethane 
in DMF was added dropwise to a stirred solution of the tosylamine (116) in DMF with 
caesium carbonate and the mixture was heated under reflux for 20 h. Only the starting 
materials were observed by 3lp and 1H NMR analysis. This single attempt to react 
(116) with the ethane derivative was not repeated or attempted under different 
conditions due to the limited time available. This reaction may be possible, analogous 
to the above reaction of the tosyl-bromo-aniline to form (109) (Scheme 4.2) which did 
not proceed readily at the first attempt. 
4.2.2 Systems based on 1,10-Phenanthroline 
The target ligand of this design initially chosen was the P-methyl substituted system 
(117), in order to keep the molecular weight of the ligand fairly low for potential 
radiopharmaceutical applications. One drawback to this choice was the relatively poor 
yield reported for the methylphosphinic ester derivative required (2.5% to 47%), in 
comparison to the yields of the phenyl and benzyl substituted analogues.8 Nevertheless, 
the synthesis was embarked upon. 
(117) 
~Et 
['Me 
·o 
The dihydrobromide salt of the dibromide (119) was synthesised by George Bates 
according to Scheme 4.11, and and stored for several months at -5°C. The first two 
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steps of the synthesis used literature reactions to form the alcohol (118), 18 while 
conversion to 2,9-dibromo-1,10-phenanthroline was achieved by treatment with 48% 
v/v HBr/acetic acid at 100T.l9 
CHa 
5%aqueous 
dioxane 
(84%) 
(119) 
Br 
Br 
0 
HBr/ 
acetic acid 
(84%) 
H 
H 
(118) 
Scheme 4.11 Synthesis of the dibromophenanthroline 
When required, the hydrobromide salt of (119) was neutralised with aqueous sodium 
carbonate and extracted into chloroform to give the pure dibromo-phenanthroline (119) 
as an orange solid prior to immediate reaction. The methylphosphinate ester (117) was 
prepared in the manner described earlier and was isolated and purified in approximately 
15% yield. Competitive halophilic abstraction by MeP(OEt)z may occur to generate the 
intermediate ylide which gives a methyl group upon protonation (Scheme 4.13) and 
hence reduce the yield of the Arbuzov product (Scheme 4.12). 
N 
(8( 
(f-Et 
Eta"""' Y 
e;-- Me 
N 
Scheme 4.12 Desired Arbuzov reaction 
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C\--OEI 
~ OEt 
U Br CH.J 
Scheme 4.13 Competing process 
There are literature examples of the latter process occurring with chloro and bromo 
ketOJ?-eS. Triphenylphosphine abstracts the halogen in the above manner to give an 
enolate which picks up a proton to form the methyl substituent of the ketone.20,21.22 
Ohta23 found that this process also occurred for the reaction of bromoacetophenone 
with triphenylphosphine in an attempt to prepare the corresponding phosphonium salt. 
The major product was acetophenone (Scheme 4.14), and the intended product formed 
in only 3% yield. However, when a catalytic amount of triethylamine was added, the 
desired phosphonium salt (120) was formed in 92% yield. These observations may be 
rationalised by consideration of the of the triethylamine as a better leaving group and 
also a far less favourable group than bromide to be abstracted by the phosphine 
(Scheme 4.15). 
0 
B~:PR3 
Scheme 4.14 Without triethylamine 
0 
--
(120) 
Scheme 4.15 With a catalytic amount of triethylamine 
0 
0 
Due to the similarity of the competing chemical mechanisms in the above work 
(Scheme 4.14) and the Arbuzov reaction undertaken herein (Scheme 4.11), this 
catalytic procedure was applied to the synthesis of phenanthroline phosphinate system. 
Diethylmethylphosphonite was added to a stirred suspension of the dibromide (119) in 
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dry acetonitrile and a catalytic amount of triethylamine was added. The reaction 
mixture was heated for 18 hours, the solvent was evaporated and the product was 
purified by chromatography on alumina to give (117) as a yellow oil in 70% yield 
(Scheme 4.15). Hydrolysis of the phosphinate ester in 6M hydrochloric acid as 
described,20 gave the phosphinic acid (121). 
Br 
F(OEt 
II'Me 
0 
MeP(OEth I 6MHCI 
acetonitrile Me NEts Me ~0 \~0 Br 
'OEt 'oH 
(119) (117) (121) 
Scheme 4.15 Synthesis of the phenanthroline-2,9-bis(methylenemethylphosphinic acid) 
Conversion to the thiophosphinic chloride was expected to be facile from the 
phosphinic acid, since no tosylation/detosylation steps were required which also 
lowered the overall yields of the thiophosphinate ligands previously synthesised 
(section 2.2). The methylphosphinic acid (121) was stirred in dichloromethane and 
oxalyl chloride was added. Mter only a few minutes, the reaction mixture had changed 
in appearance from a golden coloured solution to a deep green suspension, suggesting 
that some process other than the one desired had taken place. The intractable green 
solid was difficult to handle and 3lp NMR analysis of the chloroform-soluble material 
gave no phosphorus signal. A similar procedure was undertaken by very slow, drop wise 
addition of oxalyl chloride to a stirred solution of the phosphinic acid, but to no avail. 
Other chlorinating procedures such as treatment with thionyl chloride failed to give the 
desired phosphinic chloride. Treatment of the ester (117) directly with PCls in toluene 
was also attempted and initially looked promising as it gave one phosphorus peak by 
31P NMR analysis, shifted +8ppm from the starting ester. However, heating the 
material in PSCl3 under reflux for 20 hours gave no trace of any disubstituted P=S 
species by 3lp NMR analysis. 
One possible reason for the failure of this step especially in view of its success with 
similar systems may be derived from the greater acidity of the methylene protons as 
they are flanked by two electron withdrawing groups. If this were the case, then 
blocking the methylene position via methylation (122) may alleviate the problem and 
the corresponding methylated-methylene methylthiophosphinic acid may be accessed. 
The conversion of the methylene diester (117) to its tetramethylated analogue was 
attempted using sodium ethoxide in ethanol followed by addition of iodomethane, then 
repetition of the sequence. 1H NMR analysis revealed that the methylene protons were 
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still present in the same ratio as the starting compound. Another attempt was made 
using LDA in THF followed by iodomethane. Again, the methylene protons remained 
intact which was surprising given their ability to undergo H-D exchange in CD30D as 
docu~ented. 20 
A lack of time prevented a more thorough investigation of this situation and further 
attempts to transform the phosphinate ester (117) or phosphinic acid (121) to the 
desired thiophosphinate compound. The possibility of exploring the behaviour of an 
analogue of (117) with a different substituent at phosphorus, such as a phenyl group, in 
the above thiophosphorylating attempts was considered. Substituent-specific behaviour 
of many phosphorus compounds was described in chapter 2. However, in the other 
reported substituted-phosphinic acid phenanthroline analogues, the rate of H-D enolate 
exchange was found to be phenyl> benzyl=== methyl,20 thus any detrimental effect 
caused by these protons may be augmented further. 
Me 
~0 
'oEt 
(122) (123) 
4.3 Future Synthetic Work 
Although the work described above has not yielded the target ligands yet, some 
synthetic steps have been accomplished and some versatile intermediates have been 
prepared. A successful conclusion may be possible with more time to explore the 
remaining pathways discussed above from the compounds already prepared. 
There are many other similar ligand systems possible, based upon the new classes of 
ligands described in this chapter and the previous two chapters. For example, the 
dialkylthiophosphoryl functionality described previously (Ch. 3) could be combined 
with an amino-substituted phenanthroline skeleton (124). The aromatic system would 
render the amine proton quite acidic and hence liable to deprotonation upon 
complexation, as well as including a rigid structural unit described above (section 4.1). 
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(124) 
Alteration of the phosphorus substituents in this and other dialkylthiophosphoryl 
systems should have a tremendous impact upon the complexation behaviour of these 
ligands. For example, replacement of the P-methyl substituents of systems such as (84), 
(85) and (86) (Ch. 3) with methoxy groups should increase the donor ability of sulfur 
towards the metal cation without a significant alteration in the overalllipophilicity of 
the system. The scope for new ligands is enormous. 
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S. Radiolabelling 
Consideration is given to the tactics employedfor radiolabelling (5.1),followed by an 
investigation ofradiolabelling the aza-thiophosphinic acid ligands with technetium-
99m (5.2). The source of the less readily available copper-64 radionuclide is related to 
the radiolabelling process together with the search to find a means of assessing the 
degree of complexation (5.3). In vitro characterisation of the copper-radiolabelled 
complexes is addressed and conclusions drawn. 
The" ... chemist should be the designer of a tailor-made suit around technetium in 
such a way that it will last, at least for the duration of the wedding ceremony, that 
is, for clinical analysis." 
G. Bandoli, 19861 
The suits have now been fashioned and cut. How well will they fit 
technetium or copper? 
5.1 General considerations 
Complexes of a ligand and a radionuclide must be formed rapidly, preferably at room 
temperature and in good radiolabelling yield and radiochemical purity in' order to be 
clinically useful. Radiochemical purity provides a measure of the desired radiolabelled 
species as a percentage of the total amount of radioactivity present in a sample. 
Radiochemical impurities are therefore other forms of the radioactivity which are 
undesired. Another term, radionuclide purity, refers to the presence of radionuclides 
other than the one of interest which may form a complex with the ligand(s) present. 
Excess ligand is commonly used in the development of radiopharmaceuticals in order to 
asses how well the trace amount of radionuclide complexes with the particular ligand. 
The starting point for the synthesis of 99mTc complexes is the eluant from the 
99Mo,t99mTc generator, i.e. pertechnetate in physiological saline solution,2 which is the 
starting material for all 99mTc compounds in nuclear medicine. The anion Tc04- is then 
reduced (usually by the stannous ion)3 in the presence of the ligand to be labelled.4 For 
copper radiolabelling, generator-produced 62Cu (tv2 9.8 min) has a comparatively short 
half-life for studies in the development of new radiopharmaceuticals. Therefore 64Cu 
with a half-life of 12.7 hours is suitable for this type of study in the form of its 
dichloride salt in aqueous solution. 
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5.2 Radiolabelling with Technetium-99m 
The following work with 99mTc was undertaken at Amersham International with the 
assistance of Dr. Alex Gibson. The radiolabelling of the thiophosphinic acid ligands 
(48), (64), (65) and (66) (Figure 5.1) was studied with 99mTc eluted from the generator 
system in the presence of the standard reducing agent SnC12 in saline solution. Standard 
radio-HPLC and TLC methods were used to assess the species formed as the other 
technetium species normally competing in the radiolabelling process are pertechnetate 
[Tc04-] and reduced hydrolysed technetium (RHT) (or colloid) [Tc02l, and it is 
essential to identify these. 
Ph S Ph M\ S M\ S \~ 
'..::S 
Hlr( ~ ·H /p\ H /P\ H fp\ 
eN OH eN OH eN OH eN OH 
HN OH \_ OH N OH N OH 
H \._p' \._I H\._1 H I P.-:::::. P~s P.-:::::. 1 ~s p~ s M/ S Pli M/ 
(48) (64) (65) (66) 
Figure 5.1 Thiophosphinic acid ligands for radiolabelling with 99mTc 
Results and discussion 
Ligand ( 48) labels extremely rapidly at room temperature at pH 8 to give 
predominantly two species, presumably isomers of 99mTc0( 48) as shown by radio-
HPLC (Figure 5.2). The UV trace shows only the excess unbound ligand and the 
radiochromatogram shows the radiolabelled species and clear evidence that the ligand 
radio labels in high yield and radiochemical purity. The amount of Tc02 and Tco4-
observed by tlc was reasonably small (in the order of 5% and 30% respectively). The 
radio labelling efficacy is affected by the labelling conditions as shown by the formation 
of small amounts of other species when the complex is prepared at pH6 (Figure 5.3). 
The free ligand ( 48) was subjected to the labelling conditions in the absence of TeO 4-
which demonstrated that the ligand was indeed stable under these conditions. However, 
it is the stability of the complex which is questionable as it appeared to degrade after a 
period of roughly six hours. No assessment of the kinetic stability and dissociation time 
of the complex has yet been undertaken. 
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Figure 5.2 Radiochromatogram of 99mTc0( 48) prepared at pH8 
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Figure 5.3 Radiochromatogram of 99mTc0( 48) prepared at pH6 
The complex is likely to be cationic or neutral, in a similar manner to diaminodithiol 
(DADT) ligands5,6,7 (see section 1.6), depending upon the deprotonation of one of the 
amines upon coordination of the metal (Figure 5.4). The two major species observed in 
the radiochromatogram of 99mTc0( 48) in a 1: 1 ratio are due to two stereoisomers 
(meso and d,l) which arise from the two phosphorus stereo genic centres manifest in the 
ligand as diastereoisomers RS, RRISS at phosphorus. 
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Figure 5.4 Possible structures of cationic or neutral complexes of TeO( 48) 
The radiolabelling of the other ligands was undertaken with the same conditions at pH8. 
Some labelling of ligand (65) was observed although the labelling yield was low. 
Ligand (64) labels well but seemed to give many species. This behaviour may be a 
reflection of slight sulfur-containing impurities present in the ligand sample although 
these should not bind technetium themselves. Similarly, ligand (66) gives many species 
but the sample of the ligand used was only about 70% pure, as judged by 3lp NMR 
analysis. 
Conclusions 
Ligand (48) labels very efficiently with technetium-99m while ligands (64)-(66) show 
varying degrees of radiolabelling but extremely poor radiochemical purity. This may 
simply result from the fact that optimal conditions for their labelling were not found 
due to the limited time available. Their radiolabelling was only attempted under the 
conditions determined using ligand ( 48). Another contributory factor may be the small 
impurities present in the ligand samples (64)-(66) having some adverse affect upon the 
labelling process. The apparent lack of stability of 99mTc0( 48) should not be a 
deterrent from further studies and the subsequent development of this 
radiopharmaceutical as the stability of a radiopharmaceutical can be finite as long as it 
is stable for enough time to achieve its function. For ex:.ample, Amersham's own 
commercially available system, Ceretec (99mTcHMPAO) suffers from limited 
stability. 8,9 It must be prepared with freshly eluted technetium (no more than 2 h old) 
and the radiopharmaceutical used within 30 minutes of its preparation. It is possible that 
fresh eluant may also be required for the successful radiolabelling of ligands (64)-(66). 
5.3 Ra"iolabelling with Copper-64 
The following work with 64cu was carried out at the MRC Cyclotron Unit, 
Hammersmith Hospital with the assistance of Dr. Jamal Zweit. Firstly, a stock of 64Cu 
for the radiolabelling experiments was prepared. No carrier added (NCA) 64Cu was 
produced by the 64Ni(d, 2n)64Cu reactionlO on 96% enriched 64Ni and complete 
oxidation of the irradiated target to nickel(II) and copper(Il) was achieved by heating in 
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a solution of hydrochloric acid with aqueous hydrogen peroxide. The salt 64CuC12 was 
separated from the nickel(ll) and trace quantities of cobalt(lll) isotopes by anion 
exchange chromatography. Subsequent studies were carried out over four days, during 
which time the radioactive concentration of the stock solution of copper-64 fell from 
450 MBq ml-1 to 9.6 MBq ml-1 due to the decay (t112=12.7 h) of the radionuclide. The 
radiolabelling of the series of amino thiophosphinic acid ligands (48), (64), (65) and 
(66) ~as above) and the tetradentate dialkylthiophosphorylligands (84) and (85)(Figure 
5.5) were studied using this stock solution of copper-64. Suitable radiolabelling 
conditions, taking account of both ligand and complex solubility, as well as a method 
for assessing complex formation had first to be found. 
Figure 5.5 
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Dialkylthiophosphorylligands for radiolabelling investigations 
Initial investigations focused on ligand (48) as there was a more plentiful supply. By 
analogy with the 'cold' copper complexes (Ch.2), aqueous or methanol solutions of ( 48) 
were used initially for tracer preparation. Typical preparations of the copper-64 
radiolabelled complex were undertaken using an excess of ligand (48) dissolved in pure 
(MilliQ) water (with the addition of sodium hydroxide solution giving ca. pH 3). This 
was added to a solution of 64cuC12 buffered with sodium acetate solution giving an 
overall pH of 5.5. After thorough mixing of this preparation, the products were 
examined by thin layer chromatography (TLC) on silica with ethyl acetate as the 
mobile phase. This method of quality control has been used extensively for studies with 
complexes such as Cu-PTSMll as the free copper ions remain on the baseline while the 
complex moves up the plate. However, y-detection of the 'hot' spots on the silica plate 
of the 64cu( 48) preparation revealed that all forms of 64cu remained on the baseline. 
Alternative conditions of analysis were then sought Precipitation occurred when the 
above preparation was carried out with a solution of the ligand in ethanol (ethanol is 
biologically preferable to methanol). However, precipitation also occurred by merely 
adding an equivalent volume of water to an ethanol solution of the ligand. Several other 
solvent systems such as methanol, acetonitrile/water, were considered for TLC but 
allowed no differentiation between unbound 64CuC12 and complexed copper-64. 
Partitioning of the 64cu(48) mixture in octanollwater (see below) gave a log P value of 
0.65 showing that a complex had indeed been formed (as free 64cuC12 gives a negative 
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value as it remains in the water layer) and suggested that another method of quality 
control should be sought. 
The use of a radio-HPLC isochratic system with equal ratios acetonitrile/water or 40% 
acetonitrile/water also failed to separate the different forms of the copper-64 
radioactivity as both the ligand (UV detection) and the radioactive species were 
detected simultaneously. Clearly the same HPLC conditions used to analyse the 'cold' 
complexes employing gradient elution (Ch.6) were required. Successful analysis of 
64Cu( 48) and subsequent preparations of the other radio labelled ligands was achieved 
in this manner. Analytical HPLC was not only advantageous for the detection of the 
radiolabelled complexes but also allowed the collection of the pure species as it came 
off the HPLC column. The amino-thiophosphinate ligands (64), (65) and (66) were 
radiolabelled with 64cu in a similar manner, using water to dissolve the P-methyl 
substituted ligands (65) and (66), and methanol for the other P-phenyl substituted 
ligand, (64). Slight variations in the amount of activity (MBq) and the quantity of 
ligand used for each radiotracer preparation were found to have no effect upon complex 
formation. 
Results and Discussion 
HPLC analysis of a pure 64CuC12 solution showed a retention time of 2 minutes. A very 
small peak at 2 minutes - corresponding to unbound copper-64 - was observed in the 
radiochromatogram of 64Cu( 48) (Figure 5.6) in addition to a large peak at 10 minutes 
assigned to the radiopharmaceutical itself and a small peak at 7 minutes. These results 
correspond directly to the HPLC chromatogram of the 'cold' copper complex of (48) 
(Ch2), in that another minor 64cu-labelled species was abserved with a similar 
retention time in addition to the major species that was the copper-ligand complex 
under the HPLC conditions defined. · 
cps ,-------------------------------------------------------, 
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Figure 5.6 Radiochromatogram of 64Cu( 48) 
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Integration of these three peaks gave the area of each in terms of radioactivity from 
which the radiolabelling efficacy and radiochemical purity could be established 
quantitatively. Radiolabelling yields were calculated as the total amount of complexed 
64Cu as a percentage of the total amount of 64cu present. For example, from the 
chromatogram of 64Cu( 48) the counts under peak 3 (Rt=10 minutes) are expressed as a 
percentage of the total counts of peaks 1 +2+ 3. Radiochemical purity was expressed as a 
percentage of radioactivity from the desired 64cu-ligand complex of the total 
radioactivity detected in the radiochromatogram. Repetition of the preparation and 
HPLC analysis of 64cu(48) gave consistent results of 98% radiolabelling yield and a 
radiochemical purity of 87% prior to HPLC purification. It should be noted that this 
does not account for the excess ligand present. The radiolabelling of the other 
thiophosphinate ligands (64)-(66) and the dihydrazide ligand (84) was assessed in a 
similar manner. The results of 64cu radio labelling of the ligands are summarised in 
Table 5.1. 
Table 5.1 Summary of Radiolabelling Analysed by HPLC 
Species Conditions Retention Time Radiolabelling Radiochemical 
I minutes Yield/% Purity of crude 
preparation* I % 
64cucl2 diluted in H20 2.0 
64cuL(48) CH30H 10.1 98 85 
complex pH 5 10.1 99 89 
10.2 97 87 
64cuL(65) H20 2.5 94 94 
complex pH 5 
64cuL(64) CH30H 7.4 95 95 
64cuL(66) H20 6.5 62 62 
64CuL(84) CH3CNINEt3 17.1 100 73 
*Radiochemical purity of the HPLC-eluted Cu-complexes was assumed to be 100% 
The dimethylthiophosphoryldihydrazide ligands (84) and (85) were briefly examined in 
the rather limited time available. Owing to their poor solubility in methanol, acetonitrile 
was used to dissolve the compounds. Ligand (84) showed no evidence of any 
radiolabelling when a solution in acetonitrile was treated with a solution of aqueous 
64CuCl2. However, when the ligand solution was first treated with a little triethylamine 
prior to the addition of aqueous 64cuC12, the ligand radiolabelled very well. A large 
peak due to the radiotracer complex was observed at 17 minutes while no free copper-
64 was observed at 2 minutes. Some impurites - presumably adducts of copper-64 with 
triethylamine - appeared as broad peaks with very low peak intensity between 4 and 10 
minutes (Figure 5.7). Again, the pure complex, 64Cu(84), was collected as it eluted 
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the column. Complexation of ligand (85)was attempted under these basic conditions but 
there was no evidence for radiolabelling. Due to the structural similarities between 
ligands (84) and (85) (only the substituents on the carbon backbone are different) 
analogous metal-binding could be expected. Therefore, successful radiolabelling of this 
ligand may be possible if the appropriate conditions can be established. 
cps ~------------------------------------------------------, 
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Figure 5.7 Radiochromatogram of 64cuL(84) 
Characterisation of 64Cu Labelled complexes in vitro 
Iipophilicity Measurements 
Lipophilicity reflects the lipid solubility of a complex and hence its ability to penetrate 
the blood-brain barrier and diffuse through cell membranes, as discussed earlier (Ch.l). 
Measurement of lipophilicity is important when evaluating the suitability of a new 
radiopharmaceutical. The partition coefficients of the new radiotracers were measured 
between octanol and water (summarised schematically in Figure 5.8) as a measure of 
complex lipophilicity (assuming that the complex does not dissociate). The amount of 
radioactivity in each layer gives the partition coefficient according to the relationship: 
log10P = log10 [y-counts in octanol I y-counts in water] 
octanol 
water 
Figure 5.8 Schematic diagram of lipophilicity measurement 
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Schematic diagram of lipophilicity measurement 
Measurements were carried out in duplicate on each radiolabelled complex and are 
summarised in Table 5.2. As expected, the P-phenyl substituted thiophosphinate ligands 
show a higher propensity to accumulate in the organic phase than their P-methyl 
counterparts. The values found for samples which were taken directly from the 
radiotracer reaction mixture were found to be higher than for their HPLC-purified 
counterparts. This is surprising as the values of the 'crude' complex preparations should 
be slightly lower than the actual value due to the small percentages of unbound copper-
64 present in the sample. This anomaly may be a consequence of instability in the 
purified complexes which had been evaporated to near dryness under vacuum 
centrifugation with heating. 
Table 5.2 LogP values of 64Cu-ligand complexes 
Complex log P (prep) log P (HPLC 
64cu(48) 
64Cu(65) 
64Cu(64) 
64Cu(66) 
64Cu(84) 
64cucl2 
0.73 (MeOH) 
0.65 (aqueous 
pH5.5) 
-0.96 (H20) 
0.37 
-1.48 (H20) 
0.99 (CH3CN/NEt3) 
-2.06 
purified)* 
0.46 
-2.42 
-1.22 
-1.57 
* values may be affected by complex degradation during the solvent evaporation process 
Plasma-Protein Binding Studies 
Gel permeation chromatography was used to study the behaviour of the radio labelled 
complexes 64cu(48), 64cu(65) and 64cu(64) in human or rat plasma. This technique 
assesses whether there is any protein-bound radioactivity present after incubation of the 
copper-64 complex in plasma. The radiolabelled complex was incubated in plasma 
prior to loading onto a buffered gel permeation column that had been preconditioned 
with human serum albumin. The product was eluted with the same buffer solution and 
around fifteen fractions of 0.5 ml were collected and y-counted. The results are 
presented graphically in Figures 5.9 to 5.11. 
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Figure 5.9 Gel permeation profile of 64Cu(48) incubated in human plasma for 1 h. 
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Figure 5.10 Gel permeation profile of 64Cu(65) incubated in human plasma for 1 h. 
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Figure 5.11 Gel permeation profile of 64cu(64) incubated in human plasma for 1 h. 
The gel permeation profiles show that the active species elute in the later fractions 
where low molecular weight species are found. There is no radioactivity due to protein 
-bound species as 64Cu that has become bound to protein in serum elutes almost 
immediately (i.e. in fractions 1-3) while low molecular weight species take longer to 
elute. Therefore any 64Cu liberated as a result of complex degradation in human serum 
would be detected as the metal would rapidly bind to human serum albumin and show a 
similar elution to that of uncomplexed copper-64 which does bind to protein. This 
indicates that there is no non-specific binding of the complexes to serum proteins and 
confirms the stability of the complexes in plasma over the time period of 1 hour. 
Partitioning of 64Cu-Complexes Between Plasma and Red Blood Cells 
The uptake of the radio tracers into red blood cells with time was assessed by 
partitioning samples of the radiolabelled complexes which had been incubated in whole 
blood. Aliquots were removed after different time points - 10, 15, 30 and 60 minutes -
in duplicate and were separated into layers of plasma and red blood cells (RBC) for y-
counting. The resulting y-counts are expressed as a percentage uptake in red blood cells 
and plasma at the various time points. Studies focused on 64cu( 48) and 64Cu(64) which 
appeared the most promising in terms of lipophilicity: the results are summarised in 
Table 5.3. 
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Table 5.3 Summary of Blood-Plasma Partitioning Results for 64cu(48) and 64Cu(64) 
POST-MIXING TIME I minutes 
SYSTEM* I 10 15 15 30 30 60 60 
%counts 
64Cu(48) 93 90 72 81 87 88 86 
plasma 
64Cu(48) red 7 10 28 19 13 12 14 
blood cells 
64cu(64) 86 87 78 82 81 
plasma 
64Cu(64) red 14 13 22 18 19 
blood cells 
* studies using whole human blood 
64Cu(65) was studied in a similar manner with whole rat blood with time points of 15 
and 30 minutes and ')'-counts were recorded as percentages (Table 5.4) 
Table 5.4 Summary of Blood-Plasma Partitioning Results for 64cu(65) 
POST-MIXING TIME I minutes 
SYSTEM* I 15 15 15 30 30 30 
%counts 
64Cu(65) 93 91 92 53 54 52 
plasma 
64Cu(65) red 7 9 8 47 46 48 
blood cells 
* studies using whole rat blood 
64cu( 48) and 64cu(64) only show a slight increase of RBC uptake between 15 and 30 
minutes. 64Cu(65) shows high association with the plasma fraction up to 15 minutes. 
By 30 minutes the RBC uptake has increased significantly which may reflect an 
intracellular trapping mechanism of the 64Cu(65) complex. This may be due to some 
mechanism which may involve dissociation of the complex, possibly by intracellular 
reduction of the complex to the Cu(l) species, or by desulfurisation of the 
thiophosphinate to its 'hard' oxygen analogue. This behaviour follows a similar pattern 
of behaviour to the findings of Mathias12 for Cu-PTSM. This may indicate that 
64cu(48) and 64cu(64) are less susceptible to intracellular redox trapping compared to 
64cu(65). Alternatively this difference may simply result from interspecies variation, 13 
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as human blood was used for the former studies and rat blood was used for the latter 
studies. 
Aqueous Stability 
The absolute stability of the purified radio labelled complexes 64cu( 48) and 64Cu(65) in 
aqueous solution over 24 hours was assessed by analytical radio-HPLC. The 
radiochromatogram of the 64cu( 48) (Figure 5.12) had a similar appearance to that of 
the original crude preparation (Figure 5.6). By integration of the peaks, it was 
calculated that 70% of the total amount of activity detected was due to radio labelled 
species, with the desired tracer now accounting for about 60% of the total activity 
present, corresponding to dissociation of about 40% over 24 h. 
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Figure 5.12 Radiochromatogram of 64cu( 48) 24 h after complexation/purification 
The radiochromatogram of 64cu(65) showed no evidence of any free64Cu and only one 
species with a retention time corresponding to the complex. Therefore this complex was 
judged to be stable with respect to dissociation over the 24 hour period (ca. 2 half-
lives). 
Conclusions 
The amino thiophosphinic acid ligands ( 48), (64), (65) and (66) form complexes with 
copper-64 extremely rapidly in water or methanol solution at room temperature. 
Although good radiolabelling yields and radiochemical purity were achieved, these 
could be optimised by further investigation of the radiolabelling conditions such as 
variation of solvents and pH. Indeed, a dramatic effect upon complexation with a small 
change in the conditions was displayed by ligand (84). An excess of ligand to copper-
64 was used in all of the above studies to be consistent with current radio labelling 
methodology. However, HPLC studies with UV detection of the 'cold' copper 
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complexes (Ch.2) suggest that it may be possible to reduce the amount of ligand to 
copper-64 to as little as 1:1, although the rate may be slower. This would be 
advantageous preventing any unnecessary toxic effects that may be associated with 
administration of the free ligand with studies of the radiopharmaceutical in vivo. The 
use of a smaller amount of ligand is secondary, as the amounts of ligands used for this 
application are very small. 
It is not yet known whether the complexes investigated possess sufficient lipophilicity 
to enable them to cross the BBB. The highest log P value was around 1.0 (Cu(84)) 
whereas, a value nearer 2.0 would be more favourable. However, compounds with log P 
values between 0.9 and 2.5 have been reported to freely diffuse accross the BBB.14 
Lipophilicity is not the only factor which determines diffusion across the BBB as other 
factors such as molecular weight and charge are important (section 1.6). Furthermore, it 
is possible to modify the basic structUre of the ligands, and their metal complexes 
(sections 2.1 and 3.1) by the choice of substituents at phosphorus and on the carbon 
skeleton. The preparation of a series of more lipophilic derivatives would allow the 
assessment of the best candidate - a process which has proved fruitful in the discovery 
of Cu-PTSM.15 
In answer to the initial question: the suits fit both copper and technetium -
some of them very well indeed. The question remaining is, 'for how long 
can they be worn?' 
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6 Experimental Methods 
6.1 General 
All reactions were performed under an argon atmosphere in apparatus which had been 
oven dried and cooled under argon. Merck grade four molecular sieves were used, 
which were activated prior to use by heating while under high vacuum. 
Chromatography was performed using silica ( Merck Kieselgel 230-400 mesh) and 
alumina ( Merck Alumina activity II-III) that was soaked in ethyl acetate at least 24 h 
prior to use. In some cases, characterisation of a P(ll) precursor is limited to 31p NMR 
data due to practical difficulties which include air-sensitivity and stench of phosphorus 
species produced. However, this is sufficient to show the homogeneity of the sample, 
since often the only species studied are phosphorus-derived. All solvents were dried by 
distillation from the appropriate drying agent and water was purified by the PURITE 
system. 
Instrumentation 
Analytical and preparative HPLC were performed on a Varian Vista 5500 or a Varian 
Star 5065 instrument fitted with a reverse phase column, using gradient elution with 
water (0.1% TFA) and acetonitrile (0.1% TFA) at a flow rate of 1.4 ml min-1. 
All 31p NMR were recorded on a Broker AC250 spectrometer operating at 101 MHz. 
1 H and 13c NMR spectra were obtained with a Broker AC 250 operating at 250.13 
MHz and 62.9 MHz respectively, Varian Gemini 200 operating at 200 and 50 MHz 
respectively, Varian VXR operating at 200 MHz or a Varian VXR 400s operating at 
399.96 MHz and 100.58 MHz respectively. Spectra are described in ppm to higher 
frequency and downfield shift from TMS and reported consecutively as position (8H 
and OC), relative integral, multiplicity [singlet (s), doublet (d), doublet of doublets (dd), 
triplet (t), quartet (q), quintet (qnt), multiplet (m), broad (b)] and coupling constants (J 
Hz) if applicable. Infrared spectra were recorded on a Perkin-Elmer 1600 FT-IR 
spectrometer as a thin film, KBr disc or with a Graseby-Specac 'Golden Gate' diamond 
ATR accessory, and absorbance maxima are given in wavenumbers (cm-1). Ultra-
violet and visible spectra were recorded on a UVIKON 930 spectrometer using a 1 em 
pathlength cell. Absorbance maxima are quoted in nm. 
Mass spectra were recorded on a VG 7070E, operating in FAB, EI+ or DCI ionisation 
modes as stated and electrospray ionisation mass spectra were obtained on a VG 
platform-11 (Fisons Instruments). Major ions are quoted as a percentage of the base 
peak intensity, and, for some electrospray species, isotope patterns were modelled 
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using Mass Lynx software. Accurate mass spectroscopy was performed by the EPSRC 
Mass Spectroscopy service at Swansea. 
Combustion analysis was performed using an Exeter Analytical Inc CE440 elemental 
analyser. Metal concentration was determined by atomic absorption spectroscopy using 
a Perkin Elmer 5000 atomic absorption spectrophotometer. 
Melting points were determined on a Kofler block melting point apparatus and are 
uncorrected. 
NMR Titrations. 
NMR titrations were carried out in a single 5 mm oven dried tube. A solution of the 
ligand was prepared (typically 0.01M) in a suitable solvent (undeuterated where only 
the phosphorus shift is studied by 31p NMR) and a known amount (0.5-0.75 ml) of the 
solution transfered to the tube by Gilson pipette. A solution of the metal triflate was 
also prepared in the same solvent (typically 0.1M). The metal solution was then added 
in increments of known volume to the ligand solution and the shift of a given proton or 
phosphorous resonance monitored as a function of the MIL ratio. Typically the MIL 
ratios examined were 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0. The change in shift 
of the given resonance is then plotted against the MIL ratio and the curve analysed 
using a least squares procedurel to give an estimate of the effective stability constant, 
K. 
Speciation analysis by electrospray mass spectrometry. 
A stock solution of the ligand was prepared (typically 0.3 mmol) in freshly distilled 
methanol, a stock solution of the metal triflate or perchlorate was also prepared 
(typically about 1 mmol) in methanol. To a sample of the ligand solution (lml) and 
methanol (1ml) was added the appropriate volume of metal triflate solution to make a 
1:1 or 1:2 metal to ligand ratio. Using 10 ~1 of the test solution mass spectra were 
obtained with the ionisation mode ( + or - ) stated. 
HPLC analysis of copper complexes 
HPLC analysis of the ligands containing an aromatic group for UV detection at A=254 
nm was carried out to determine their retention times prior to analysis of their copper 
complexes. Solutions containing 1:1 and 2:1 ratio of ligand to copper with 
concentrations of the order of 5 mmol dm-3 were investigated as a preliminary study for 
radiolabelling to determine the number of species present and their retention times. 
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Chloroethoxyphenylphosphine2 (125) 
Cl 
PhP./ 
\ 
OEt 
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Dichlorophenylphosphine(0.98 ml, 7 mmol) was added to diethylphenylphosphonite 
(1.37 ml, 7 mmol) at OOC under an inert atmosphere with stirring to give a colourless 
liquid in quantitative yield, 31p NMR (CDCl3) Op 174; lH NMR (250.13MHz, CDCl3) 
OH 1.46 (3H, td, JH=7 Hz, Jp=l.l Hz, P-O-CH2CH3 ), 4.1 (2H, m, P-O-CH2CH3), 7.6 
(3H, br m, o-,p-, phenyl), 7.89 (2H, m, m-phenyl), 13C NMR (62.9 MHz, CDCl3) oc, 
16.43 (P-O-CH2CH3), 64.90 (d, Jp=8.7 Hz, P-O-CH2CH3), 128.49 (d, J=4.8 Hz, m-Ph), 
129.72 (d, J=25.7 Hz, o-Ph), 132.3 (p-Ph) 
Ethoxyphenyl-S-ethylphosphine (126) 
/SEt 
PhP\ 
OEt 
Sodium ethanethiolate (1.36 g, 15.4 mmol) was stirred in toluene at -50°C under an 
inert atmosphere. Chloroethoxyphenylphosphine (2.87 g 14 mmol) was added to the 
reaction mixture which was left to warm up to room temperature and stirred for 2 h. 
The solution was filtered and the solvent evaporated to leave a pale yellow oil (1.71 g, 
57% with -50% purity), 31p NMR (CDCl3) Op 145.8 
Phenyl-bis-S-ethylphosphine (127) 
/SEt 
PhP\ 
SEt 
The above method described for (126) was employed using sodium ethanethiolate (660 
mg, 7.4 mmol) in dichloromethane (4 ml) at -30°C with dichlorophenylphosphine (0.46 
ml, 3.39 mmol) to give a pale yellow oil (324 mg, 42%); 31p NMR (CDCl3) Op 74.4 
Attempted preparation of Diethyl-tetrahydroimidazole-N,N'-
bis( methylenedithiophenylphosphinate) (128) 
PI\_ S 
~ /'sEt 
CN> 
N SEt 
"-' p ,~s 
Ph 
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Ethylenediamine (0.26 ml, 3.9 mmol) and paraformaldehyde (0.71 g, 23.4 mmol) were 
stirred in dry THF (50 ml) and heated to reflux at lOO"C using a Soxhlet apparatus 
filled with molecular sieves (4A) under an inert atmosphere. Freshly prepared 
PhP(SEt)z (127) (2.24 g, 9.75 mmol) was added to the mixture, which was maintained 
under reflux for 48 h. 3lp NMR analysis of the reaction mixture showed that little or no 
reaction had taken place. 
Ethyl[(t-butyl dimethylsiloxy methylene)phenylphosphinate] (129) 
?i I Et0-~0-Si-Bu1 
~ I 
Ethyl[(hydroxymethylene)phenylphosphinate] (1.53 g, 7.65 mmol), t-butyl 
dimethylsilylchloride (8.4 mmol, 8.4ml of 1M solution in THF) and imidazole (1.14 g, 
16.8 mmol) were stirred in DMF (50ml) under an inert atmosphere for 3h at room 
temperature. The solvents were removed in vacuo leaving an oily residue which was 
dissolved in dichloromethane (40 ml), washed with sodium carbonate solution (10%, 3 
x 40ml), dried (Na2S04) and the solvent evaporated under reduced pressure to give a 
pale yellow oil (1.5g, 62%); 31p NMR (CDCl3) &> 37.7; lH NMR (250 MHz, CDCl3) 
DH -0.36 (6H, d, J=lO.l Hz, Si(CH3)2tBu), 0.81 (9H, s, C(Cfu)3), 1.34 (3H, t, J=7 Hz, 
OCH2CH3), 3.97 (4H, b s, PCfuOH, OCH2CH3), 7.45 (3H, m, o-,p-PhH), 7.85 (2H, m, 
m-PhH); rnlz (CD 315 (60%, MH+), 201 (100, MH2+-Si(Me)21Bu). 
Attempted preparation of ethyl[(t-butyldimethylsiloxymethylene) 
phenylphosphinthiolate] (130) 
. ~ I 
EtO-fY""O-Si-Bu1 
~ I 
Ethyl[(t-butyldimethylsiloxymethylene)phenylphosphinate] (129) (150 mg, 0.48 mmol) 
was stirred in toluene (15 ml) with di-phosphorus pentasulphide (0.25 g, 0.56 mmol) for 
1 h at room temperature under an inert atmosphere. 3Ip NMR analysis revealed a 
mixture of species, and the reaction was stirred until no further change in the 31 P NMR 
spectrum was detected (now several signals). The product mixture was filtered and the 
solvent removed under reduced pressure to leave a yellow oil (100 mg, 63%); 31 P 
NMR (CDCl3) 8p 37.2, 37.6, 79.9, 80.3, 83.6, 84.0 (mixture of species); 1H NMR (250 
MHz, CDCl3) DH 0.30 (6H, m, Si(CH3)2tBu ), 0.83-0.96 (9H, m, C(CH3)3), 1.33-1.37 
(3H, m, OCH2CH3), 4.05-4.75 (4H, bm, PCH20H, -OCH2CH3), 7.52 (3H, m, o-,p-
PhH), 7.96 (2H, m, m-PhH) consistent with the proposed structure but lacking 
resolution. 
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Dimethyltetrahydroimidazole-1,3-diyldimethylenebis(phenylphosphinate)P (39) 
p~ 0 
~ 
/'oMe 
CN> 
N OMe 
\....F( 
I 0 
Ph 
Synthesis of the title compound was carried out according to the procedure of Parker et 
al. 3 1,2-0iaminoethane (1.44 g, 24 mmol) and paraformaldehyde (1.2 g, 40 mmol) 
were stirred in THF (120 ml) under reflux for 30 mins under an inert atmosphere. 
Phenyldimethoxyphosphine (12.2 g, 11.3 ml, 72 mmol) was added to the reaction 
mixture and heating was continued for a further 18 h. The solvent was removed under 
reduced pressure and the residue purified by chromatography on alumina with gradient 
elution (dichloromethane to 2% methanol-dichloromethane) to give the colourless oil 
(7.1 g, 72%); 31p NMR (COCl3) Op 40.8; lH NMR (250.13 MHz, COCl3) OH 2.83 
(4H, s, NCH2CH2N), 3.05 (4H, d, 2J=9.1 Hz, PCfuN), 3.46 (2H, d, 4Jp=3.1 Hz, 
NC!lzN), 3.63 (3H, d, Jp=ll Hz, POCH3), 3.64 (3H, d, Jp=ll Hz, POCfu),-7.45-7.60 
(6H, m, m-,p-Ph), 7.75-7.83 (4H, m, o-Ph); 13C NMR (62.9 MHz, COCl3) Be 51.37 
(d, J;,6 Hz, POCH3), 53.88 (d, 2Jp=120 Hz, NCH2P), 53.99 (d, J=7.4 Hz), 79.17 (t, 
J=9.7 Hz, NCH2N ), 128.50 (d, Jp=12.6 Hz, m-Ph), 129.71 (d, Jp=124 Hz, PPh), 131.98 
(d, J=9 Hz, a-Ph), 132.6 (d, J=4 Hz, p-Ph); m/z (DCI) 409.89 (100%, MH+). 
Ethylenediiminodimethylenebis(phenylphosphinic) Acid3 ( 43) 
p~ 0 
~ H /P, 
eN OH 
N OH 
H\_' p~ 
I 0 
Ph 
Oimethyltetrahydroimidazole-1,3-diyldimethylenebis(phenylphosphinate ), (39), (5.5 g, 
13 mmol) was heated under reflux for 16 h in hydrochloric acid (6M, 100 ml). The 
solvent was removed under reduced pressure to give a white solid (5.2 g, 99% ); m.p. > 
250°C (lit.3 276-278°C); 31p NMR (020, p014) op 27.16; lH NMR (250.13 MHz, 
020~ p014) OH 1.57 (4H, d, J=2 Hz, NCH2CH2N), 1.86 (4H, d, J=11 Hz, PCfuN), 
6.59 (6H, m, o-, p-Ph), 6.77 (4H, m, m-Ph); 13C NMR (62.9 MHz, 020, p014) 0c 
48.53 (d, J=ll Hz, NC.H2C.H2), 48.80 (d, 1Jp=l03 Hz, NC.H2P), 128.23 (d, 3J=11.5 Hz, 
m-Ph), 130.64 (d, 2J=9 Hz, o-Ph ), 131.11 (s, p-Ph), 135.14 (d, 1 Jp=123 Hz, PPh); rnlz 
(ESMS-) 367.1 (100%, M-2H+); Found C, 51.8; H, 6.02; N, 7.28 C16H22N204P2.HCl 
requires C, 52.2; H, 6.02; N, 7.61 %. 
-153-
Chapter Six: Experimental Methods 
N ,N '-Bis- p-toluenesulfonyl-N ,N '-his[ methylene(phenylphosphinic )acid)]-1 ,2-
diaminoethane ( 44) 
Ph, 0 
TsrP: 
eN OH 
N OH 
Ts\_ ' p~ 
, 0 
Ph 
Ethy1enediiminodimethy1enebis(pheny1phosphinic) acid, (43) (5.7 g, 14.1 mmo1) was 
suspended in water (30 m1) and sodium hydroxide ( 4M) was added with stirring until 
the solids dissolved at pH 10. Tosyl chloride (5.91 g, 31 mmol) was added as a solid 
and the reaction mixture heated to 40 ·c for 36 h, maintaining a pH range of 8-10 by 
further additions of sodium hydroxide. The excess tosyl chloride was removed by 
filtration upon completion of the reaction. A fine solid was precipitated from the filtrate 
by addition of hydrochloric acid to pH2 and the remaining liquor was decanted after 
centrifugation. The solid was recrystallised from boiling water then filtered and dried to 
give a white solid (6.5 g, 65%); m.p. 294-296 "C (decomp.); 31p NMR (D20, pD14) Op 
25.02; 1H NMR (250.13 MHz, D20, pD14) OH 1.65 (6H, s, CH3), 2.35 (4H, s, 
NCH2CH2N), 2.88 (4H, d, 2Jp=7.1 Hz, PCH2N), 6.55 (4H, d, 3J=8 Hz, TsH), 6.77 (4H, 
d, 3J=8 Hz, TsH), 6.86 (6H, m, PhH), 7.13 (4H, m, PhH); 13C NMR (62.9 MHz, D20, 
pD14) Be 20.56, (s, CH3), 45.33 (s, NCHz,C.H2N), 47.87 (d, 1 Jp=109 Hz, NCHzP), 
126.78 (s, Ts), 128.10 (d, 3J=ll Hz, m-Ph), 129.52 (s, Ts) 131.07 (s, p-Ph), 131.33 (d, 
2J=8.7 Hz, a-Ph), 134.24 (s, Ts), 134.65 (d, 1 Jp=127 Hz, PPh), 144.11 (s, Ts); m/z 
(ESMS -, CH30H) 674.9 (100%, M-2H+); IR Vmax 3423 br, 2360, 1620 br, 1345, 
1160, 1129, 1043, 823, 739, 698, 625, 549, 525 cm- 1; Found 51.8, 4.82, 4.03; 
C3oH34N20sP2S2.H20 requires C, 51.9; H, 5.22; N, 4.03%. 
N,N'-Bis -p-toluenesulfonyl-N,N'-bis[methylene(phenylthiophosphinic) chloride]-
1,2-diaminoethane ( 46) 
Ph.. S 
TsrP: 
eN Cl 
N Cl 
TS\_ , p~ 
I S 
Ph 
N,N' -Bis-p-toluenesulfonyl-N,N'-bis[ methylene(phenylphosphinic )acid)]-1 ,2-
diaminoethane, (44), (2.13 g, 3.0 mmol) was dissolved in dry dichloromethane (50 ml) 
and oxalyl chloride (2.5 ml, 28 mmol) was added. The solution was stirred at room 
temperature under an inert atmosphere for 20 mins to give the intermediate acid 
chloride as a mixture of diastereoisomers (Op[CH2CI2] 46.8 and 47.0). The solvent was 
removed under reduced pressure and further portions of dichloromethane (2 x 25 ml) 
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were added and pumped off to remove any traces of unreacted oxalyl chloride. The 
crystalline solid was dried thoroughly in vacuo. 
Excess thiophosphoryl chloride (40 ml) was added to the solid followed by a catalytic 
amount of DMF and the reaction mixture was stirred at 110 OC for 16 h. The solvent 
was removed under reduced pressure and dichloromethane (3 x 5 ml) was added and 
removed under reduced pressure to remove any volatile material leaving a yellow 
crystalline solid (2.2 g, 94%), m.p. 42-44°C; 31p NMR (CDC13) (two diastereoisomers 
observed) 8p 79.75, 80.16; lH NMR (399.96 MHz, CDC13) (two diastereoisomers 
observed) 8H 2.33 (3H, s, Ts-CH3), 2.34 (3H, s, Ts-CH3), 3.49 (4H, m, NCH2CH2N), 
4.09 (1H, dd, 2JHaHb=15.2 Hz, JHaP=3.2 Hz, PCH2N), 4.16 (lH, dd, 2JHbHa=15.2 Hz, 
1p=3.2 Hz, PCfuN), 4.37 (1H, dd, 2JHaHb=15.2 Hz, PCfuN), 4.51 (lH, dd, 
2JHaHb=15.2 Hz, PCHzN), 7.17 (4H, m, TsH), 7.44-7.48 (6H, m, m-,p-PhH), 7.50-7.54 
(4H, m, Ts.H), 7.92 (4H, m, o-Ph.H); 13C NMR (62.9 MHz, CDCl3) 8c 22.29 (s, Ts-
.C.H3), 48.67 (s, N.C.Hz,CH2N), 57.87 (d, Jp=107 Hz, N.C.HzP), 59.06 (d, Jp=107 Hz, 
NCHzP), 128.46 (Ts), 129.35 (d, 3J=14 Hz, m-Ph), 130.50 (Ts), 131.48 (Ts), 132.72 (d, 
1=24 Hz, PPh), 134.08 (s, p-Ph), 135.27, (d, 1p=5 Hz, o-Ph), 145.62 (Ts); m/z (ESMS -, 
CH3CN) 744.6 (100%, M- ); IR Vmax 1700, 1600 w, 1440, 1340-1260, 1155 s, 1090, 
1000-900 br, 810-830, 740-690 m, 650-610 s, 550 s, 500-470 br, cm-1; Found: C, 44.8, 
H, 4.27; N, 3.52; C30H32Cl2N20 4P2S4.CH2Cl2 requires C,44.8; H, 4.13; N, 3.37% 
N,N'-Bis-p-toluenesulfonyl-N,N'-bis[methylene(phenylthiophosphinic) acid] -1,2-
diaminoethane ( 47) 
p~ s 
Tsr-P: 
eN OH 
N OH 
Ts\..._ ' p~ 
I S 
Ph 
Compound ( 46) (3 g, 4.0 mmol) was heated under reflux in a solution of potassium 
hydroxide (5M, 50 ml) for 12 h. The solution was acidified to pH2 with hydrochloric 
acid (4 M) and the aqueous phase decanted leaving an extremely viscous oily residue. 
This was washed with water (2 x 20 ml) and dried (Na2S04) to give a yellow 
crystalline solid in quantitative yield; m.p. 96-100°C; 31p NMR (CDCl3) 8p 58.1, 
58.26; 1H NMR (250.13 MHz, CDCI3) 8H 2.33 (6H, s, Ts-CH3) 3.15-3.51 (4H, br m, 
NCH2CH2N), 3.51-3.88 (4H, br m, PCHzN), 7.06 (4H, d, 1=7.5 Hz, TsH), 7.16 (6H, br, 
m, m-, p-Ph.H), 7.39 (4H, t, Jp=9 Hz, Ts.H), 7.85 (4H, q, o-PhH.); 13C NMR (100.51 
MHz, CDCl3) (two diastereoisomers observed) 8c 21.50 (s, Ts-C.H3), 49.99 
(N.C.H2CH2N), 50.55 (NC.H2CH2N), 56.23 (d, Jp=80 Hz, NC.HzP), 56.72 (d, Jp=80 Hz, 
NC.HzP), 127.62 (s, m-Ts), 128.48 (d, 31=13 Hz, m-Ph), 129.96 (s, o-Ts) 131.37 (d, 
21=6 Hz, o-Ph ), 131.48 (d, 2J=6 Hz, o-Ph ), 131.69 (d, 11p=108 Hz, PPh), 132.46 (d, 
31=7 Hz, p-Ph), 133.23 (s, NTs), 144.50 (s, STs); m/z (ESMS-, CH3CN) 707.2 (100%, 
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M - H+); IR Vmax 2930 br, 1600 (Ar-H), 1440, 1340-1260, 1150 s, 1090, 900, 820, 
720-690, 650 cm-1; Found: C, 48.7; H, 4.70; N, 3.85; C3oH34N206P2S4 .HCl requires 
C, 48.4; H, 4.73; N, 3.76 %. 
Ethylenediiminodimethylenebis(phenylthiophosphinic acid) ( 48) 
p~ s 
HrP: 
eN OH 
N OH 
H \..._I p~ 
I S 
Ph 
The ditosylamide, (47), (1.06 g, 1.5 mmol) was added portionwise to a solution of 
phenol (1.4 g, 15 mmol) in HBr in glacial acetic acid (45%, 30 ml). The mixture was 
stirred at 40 OC for 3 days and the resulting precipitate was separated from the liquor 
after centrifugation. The solid was washed with ether (4 x 35 ml) to remove the 
remaining phenol and dried to give the dihydrobromide salt of ( 48) as a pale yellow 
solid (650 mg, 77%); m.p. 183-185°C; 31p NMR (020/NaOO, pD14) Op 62.79; lH 
NMR (250.13 MHz, D20/NaOD, pD14) 0tr 2.09 (4H, s, NCH2CH2N), 2.96 (4H, dd, 
2JHaHb=12 Hz, 2JHaP=5.9 Hz, PCH2N), 7.49 (6H, m, m-, p-ArH), 7.74-7.82 (4H, m, o-
ArH); 13C NMR (62.9 MHz, 0 20/NaOO, pD14) Be 50.98 (d, 3Jp=9.7 Hz, 
NCH2,CHzN), 57.52 (d, Jp=77 Hz, NCH2P), 131.17 (d, 2J=11Hz, o-Ar), 133.04 (d, 
3J=9.1 Hz, m-Ar), 133.87 (s, p-Ar), 141.09 (d, 1Jp=96.1 Hz, PPh); rn!z (ESMS-, 
CH30H) 421 (100%, M-2H+ + Na+); IR Vmax 2970 br, 2750 br, 1440 s, 1110-1000, 
900 s, 730-690,620 br cm-1; Found: C, 33.9; H, 4.24; N, 4.81; C16H22N202P2S2. 2HBr 
requires C, 34.2; H, 4.30; N, 4.98%. 
Dimethylhexahydropyrimidine-1 ,3-diyldimethylenebis(phenylphosphinate )3 ( 49) 
p~ 0 
r.? 
/'oMe 
C) 
\._ ,OMe 
p~ 
p~ 0 
Using the same procedure as (39),3 1,3-diaminopropane (1.74 g, 24 mmol) was treated 
with paraformaldehyde (2.8 g, 93 mmol) and phenyldimethoxyphosphine (11.34 ml, 72 
mmol) in dry tetrahydrofuran (170 ml). Purification of the crude product by 
chromatography on alumina, with gradient elution (dichloromethane to 2% methanol-
dichloromethane) gave a colourless oil (4.5 g, 44%); 31p NMR (CDCl3) 8p 40.73; lH 
NMR (250.13 MHz, CDCl3) DH 1.51 (2H, t, 3J=5 Hz, NCH2CH2), 2.67 (4H, m, 
NCH2CH2), 2.85 (4H, d, 2J=9 Hz, PCH2N), 3.34 (2H, d, 4Jp=5.4 Hz, NCH2N), 3.61 
(3H, d, 3Jp=4 Hz, POCH3), 3.65 (3H, d, 3Jp=4 Hz, POCH3), 7.41 (6H, m, PhH), 7.73 
(4H, m, PhH); 13C NMR (62.9 MHz, CDCl3) 8c 21.33 (s, NCH~H2), 51.59 (d, J=6 
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Hz, PO.C.H3), 52.10 (d, 1=6 Hz, PO.C.H3), 53.10 (d, 1=120 Hz, N.C.H2P), 77.75 (s, 
N.C.H2N ), 129.08 (d, 1p= 12Hz, m-Ph), 132.35 (d, 1p=129 Hz, PPh), 132.67 (d, 1=9 Hz, 
o-Ph), 132.98 {s, p-Ph); rn/z (OCI) 423 (100%, MH+); IR Vmax 2600-3100 br (C-H), 
1590, 1450 w (PPh), 1440 m (POMe), 1170-1300 br s (tertiary amine and P=O), 1120 
br (POMe), 800-700 cm-1 (POMe). 
Propylenediiminodimethylenebis(phenylphosphinic) Acid3 (52) 
Ph 
'~0 rr:."' 
c"N 'o" 
. N OH 
H \..__p' 
I ~0 
Ph 
Oimethylhexahydropyrimidine-1,3-diyldimethylenebis(phenylphosphinate) ( 49) (2 g, 
4.7 mmol) was hydrolysed as described for (43) to give a white solid in quantitative 
yield (1.98 g); m.p. > 25o·c; 31p NMR (101.26 MHz, ~0/NaOO, p014) op 20.26; 
lH NMR (250.13 MHz, 020/NaOO, p014) OH 1.99 (2H, t, J=8 Hz, NCH~H2), 3.07 
(4H, t, J=8 Hz, NCH2CH2N), 3.30 (4H, d, 31p=12.8 Hz, PCH2N), 7.57 (6H, m, m-, p-
PhH), 7.74 (4H, m, o-PhH); 13C NMR (62.9 MHz, 0 20/NaOO, p014) oc 21.6 (s, 
NCH~H2), 45.81 (d, N.CH2CH2, 4J=7 Hz), 46.59 (d, 21p=81 Hz, N.CH2P), 128.65 {d, 
3J=12 Hz, m-Ph), 130.96 (d, 2J=9 Hz, o-Ph), 133.20 (d, 1 Jp=130 Hz, PPh), 134.24 (s, p-
Ph!:!); rn/z (ESMS+, CH30H) 409.36 (75%, M+Na+), 382.96 (100%, MH+); IR Vmax 
3000 br, 2780 br, 1590, 1440, 1200-1180, 1130-1100, 960-880, 810, 740, 690, 540 em 
-1 
N ,N 'Bis- p-toluenesulfonyl-N ,N' -bis[ methylene(phenylphosphinic) acid]-1 ,2-
diaminopropane (55) 
Ph 
\~0 
T~f\ 
C OH N OH 
Ts\._ 1 p~ ptf 0 
Ligand (52) (2.3 g, 5.5 mmol) was treated with tosyl chloride (2.3 g, 12 mmol) 
following the same procedure as for (44). A fine solid was precipitated by addition of 
hydrochloric acid (4 M) to pH 2.5, and was isolated by filtration and dried to give a 
white solid (2.3 g, 58%); m.p. 190-192.C; 31p NMR (020, p014) op 25.32; tu NMR 
(250.13 MHz, 020/NaOO, p014) OH 1.03 (2H, m, NCH2CH2), 2.35 (6H, s, TsCH3), 
2.50 (4H, t, J=8.9 Hz, NCH2CH2), 3.20 (4H, d, 2Jp=8.7 Hz, PCH2N), 7.27 (8H, dd, 
J=8.3 Hz, J=6.8 Hz, Ts!:!), 7.47-7.54 (6H, m, m-Ph!!), 7.59-7.66 (4H, m, o- p-PhH); 
Be NMR (62.9 MHz, 0 20/NaOO, p014) oc 23.41 (s, NCH:z,CH2), 25.15 (s, .CH3), 
47.60 (s, NC,H2CH2), 49.09 (d, Jp=l07 Hz, N.CH2P), 129.47 (s, Ts), 131.19 (d, 31=12 
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Hz, m-Ph), 132.78 (s, Ts), 133.98 (s, p-Ph), 134.20 (d, 21=8 Hz, o-Ph), 137.17 (s, Ts), 
137.69 (d, 11p=128.6 Hz, PPh), 147.65 (s, Ts); rnlz (ESMS+, CH30H) 757.35 (100%, 
M -2H+ + 2-0CH3); IR Vmax 3450; 3060, 2955, 2920, 2250, 1600, 1490, 1440, 1160, 
1090, 960, 815, 740, 690, 650, 550, 520 cm-1; Found: C, 52.6; H, 5.23; N, 3.80; 
C31H36N20sP2S2.H20 requires C, 52.5; H, 5.40; N, 3.95%. 
N,N'-Bis-p-toluenesulfonyl-N,N'-bis(methylenephenylthiophosphinic chloride) -1,2-
diaminopropane (58) 
Ph 
\~S 
T~l\ 
C Cl N Cl 
Ts\.._p' 
1 ~s 
Ph 
The phosphinic acid, (55), (0.95 g, 1.38 mmol) was converted to the thiophosphinic 
chloride by an analogous procedure to (46). Initial treatment of (55) with excess oxalyl 
chloride (1.5 ml, 17 mmol) in dichloromethane (40 ml) gave the intermediate 
phosphinic chloride as a white solid (op[CH2Cl2] 47.07). This was heated with 
thiophosphoryl chloride (30 ml) in the presence of a catalytic drop of DMF for 40 h to 
give a glassy pale brown solid (1.09 g, 96%); m.p. 64-68°C; 31p NMR (CDC13 ) Op 
79.57; tu NMR (400 MHz, CDC13) (two diastereoisomers observed) OH 1.84 (2H, t, 
1=1.6 Hz, NCH2CH2), 2.42 (6H, s, CH3), 3.17 (2H, m, NCH2CH2), 3.47 (2H, m, 
NCH2CH2), 4.17 (IH, dd, 21HaHb=15.2 Hz, 1Hap=3.6 Hz, PCH2N), 4.18 (IH, dd, 
21HbHa=15.2 Hz, 1p=3.6 Hz, PCfuN), 4.47 (lH, d, 21HaHb=15.2 Hz, PCfuN), 4.48 
(lH, d, 21HaHb=15.2 Hz, PCH2N), 7.51 (4H, dd, 1=8 Hz, 1=2.8 Hz, TsH), 7.24 (4H, d, 
1=8 Hz, TsH), 7.57 (4H, m, m-PhH), 7.65 (2H, m, p-PhH), 8.03 (4H, dd, 1=8 Hz, J=15 
Hz, o-PhH.); 13C NMR (62.9 MHz, CDCl3) oc 22.29 (s, Ts.C.H3), 25.87 (s, NCH~H2), 
47.08 (s, NCH2CH2), 57.33 (d, 1p~75 Hz, N.C.H2P), 128.15 (s, Ts), 129.47 (d, 3J=14 
Hz, m-Ph), 130.58 (s, Ts) 132.63 (d, 21=12.3 Hz, a-Ph), 132.36 (d, 1 1p=84.5 Hz, PPh), 
134.13 (s, NTs), 136.19 (s, p-Ph), 144.75 (s, STs); rnlz (ESMS -, CH3CN) 721 (100%, 
M-Cl2+0H+H+); IR Vmax 1596, 1436, 1335, 1155, 1087,986,924, 814,726, 688, 645, 
609, 550,500,470 cm-1. 
N ,N' -Bis-p-toluenesulfonyl-N ,N' -bis[methylene(phenylthiophosphinic) acid)]-1,2-
diaminopropane (61) 
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Compound (58) (680 mg, 0.90 mmol) was heated under reflux in a solution of 
potassium hydroxide (5M, 30 ml) for 12 h. The mixture was acidified to pH 2 with 
hydrochloric acid ( 4 M) and extracted into dichloromethane (3 x 30 ml), dried 
(Na2S04) and the solvent evaporated under reduced pressure to give a pale yellow 
crystalline solid (450 mg, 69%); m.p. 85-8TC; 31p NMR (CDCl3) (two 
diastereoisomers observed) Op 74.88, 74.48; lH NMR (250.13 MHz, CDCl3) OH 1.73 
(2H, br m, NCH2CH2), 2.42 (6H, s, Ts-CH3) 3.10 (4H, br m, NCH2CHv, 3.66 (4H, br 
m, PCH2N), 7.28 (4H, d, 1=1.6 Hz, TsH), 7.45 (6H, m, m-,p-PhH), 7.58 (4H, d, 1p=7.6 
Hz, TsH), 7.90 (4H, m, o-Phl:!); 13C NMR (62.9 MHz, D20) be 23.57 (s, Ts-,CH3), 
25.71 (s, NCH~H2), 47.64 (s, N.CH2CH2), 56.31 (d, 1p=80 Hz, NCH2P), 57.19 (d, 
1p=80 Hz, N.CH2P), 129.46 (s, Ts), 130.97 (d, 31=10.7 Hz, m-Ph), 132.51 (s, Ts) 133.64 
(s, Ts) 133.87 (d, 21=18.7 Hz, Ph), 137.47 (s, Ph), 140.80 (d, 1 1p= 98.75 Hz, Ph), 
146.84 (s, Ts); m/z (ESIMS -, MeOH) 360 (100%, [M-2H+]f2); IR Vmax 2950 br, 1600 
(Ar-H), 1440, 1330-1300, 1150 s, 1110, 1090, 900, 810, 730-690, 650 cm-1; Found: C, 
50.1, H, 5.07, N, 3.89; C31H36N206P2S4.H20 requires C, 50.3; H, 5.17; N, 3.78%. 
Propylenediiminodimethylenebis (phenylthiophosphinic acid) (64) 
Ph 
'~s ~~\ 
C OH N OH 
H\_p' 
1 <:::-s 
Ph 
The ditosy1amide, (61), (320 mg, 0.46 mmo1) was added portionwise to a solution of 
phenol (1 g, 10 mmol) in HBr in glacial acetic acid (45%, 30 ml). The mixture was 
stirred at 40-50°C for 3 days then slowly dropped into diethyl ether (800 ml) with 
vigorous stirring to precipitate the solid product. The solid was isolated by 
centrifugation, redissolved in methanol (1.5 ml) and slowly dropped into fresh ether 
(800 ml) with vigorous stirring. Again, the precipitate formed was isolated by 
centrifugation and the resolvation/precipitation process was repeated and the resulting 
solid dried to give a dark yellow solid (110 mg, 58%); m.p. > 250°C; 3tp NMR 
(CD30D) Op 67.63; lH NMR (250.13 MHz, D20) OH 1.89 (2H, m, NCH2CH2), 2.98 
(4H, t, 1=8.1 Hz, NCH2CH2), 3.61 (2H, dd, 21HaHb=14.3 Hz, 21HaP=5.3 Hz, PCfuN), 
3.84 (2H, dd, 21HbHa=l4.3 Hz, 21HbP=11.4 Hz, PCH2N), 7.30 (6H, m, m-,p-Ph!:D, 7.72 
(4H, m, o-PhH); 13C NMR (62.9 MHz, CD30D) oc 24.27 (s, NCHzCH2) 48.65 (d, 
31p=6.2 Hz, N,CH2CH2), 52.89 (d, 1p=77.8 Hz, N.CH2P), 131.04 (d, 21= 13.1 Hz, o-Ph), 
133.67 (d, 3J=11.3 Hz, m-Ph), 135.09 (s, p-Ph), 136.19 (d, 1 Jp=llO Hz, PPh); rnlz 
(ESMS -, CH30H) 413.21 (100%, M-H+); (ESMS+) 436.4 (M + Na+); IR Vmax 2920, 
2730, 1585, 1540, 1435-1300, 1170, 1113,910 br, 735-715,690,624,600,573 cm-1. 
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Dimethyltetrahydroimidazole-1,3-diyldimethylenebis( methylphosphinate )3 (50) 
ME\ 0 
~ f 'oMe CN> 
N 
\._ ,OMe 
p~ 
I 0 
Me 
Synthesis of the title compound was carried out according to the procedure for (39).3 
Ethane-1,2-diamine (1.47 g, 1.64 ml, 24.5 mmol) was treated with paraformaldehyde 
(2.8 g, 93 mmol) and diethoxymethylphosphine (10 g, 73 mmol) in dry tetrahydrofuran 
(150 ml). Purification of the crude product by chromatography on neutral alumina with 
gradient elution (dichloromethane to 2% methanol-dichloromethane) gave a pale yellow 
oil (3.8 g, 50%); 31p NMR (CDCl3) 8p 51.53; lH NMR (250.13 MHz, CDCl3) 8H 1.31 
(6H, t, 31=7.1 Hz, POCH2Cfu), 1.51 (6H, d, 21=14 Hz, PCH3), 2.88 (4H, d, 21=10 Hz, 
PCfuN), 2.94 (4H, s, NCfuCH2); 13C NMR (62.9 MHz, CDCl3) 8c 12.93 (d, 1p=94 
Hz, PCH3), 16.90 (d, 1= 6 Hz, POCH~H3), 54.36 (d, 1=115 Hz, NCH2P), 54.56 (d, 
1=8.3 Hz, POCH2CH3), 60.55 (d, 1= 5Hz, NCH2CH2), 79.64 (t, 1=5 Hz, NCH2N); m/z 
(DCI) 313 (100%, MH+). 
Ethylenediiminodimethylenebis(methylphosphinic) Acid3 (53) 
Me, 0 P.~ 
H
,,
N OH 
eN OH 
H\_' p~ 
I 0 
Me 
Dimethyltetrahydroimidazole-1 ,3-diyldimethylenebis(methylphosphinate) (50) (2.5 g, 8 
mmol) was hydrolysed as described for (43) to give a white solid in quantitative yield; 
m.p. 242-244°C (lit.3 246-248°C); 31p NMR (D20/NaOD, pD14) 8p 39.45; tu NMR 
(250.13 MHz, D20/NaOD, pD14) 8H 1.26 (6H, d, 21=14 Hz, PCH3), 2.69 (4H, d, 
21=11.5 Hz, PCH2N), 2.77 (4H, s, NCH2CH2), 3.58 (2H, s, NCH2N), 4.08 (4H, p, 
31p=7.3 Hz, POCH2CH3); 13C NMR (62.9 MHz, D20/NaOD, pD14) 8c 17.35 (d, 
1p=91 Hz, PC.H3), 52.09 (d, 1=12.6 Hz, NCH2CH2), 52.36 (d, 1=99 Hz, NCH2P); rnlz 
(ESMS-, CH30H) 242.9 (100%, M-H+). 
N,N'-Bis-p-toluenesulfonyl-N,N'-bis[methylene(methylphosphinic)acid]-1,2-
diaminoethane (56) 
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Tosylation was achieved using the same procedure as ( 44). Tosyl chloride (3.4 g, 18 
mmol) was added to a solution of ethylenediiminodimethylenebis(methylphosphinic) 
acid, (53), (2 g, 7.13 mmol) in water ( 40 ml) with the addition of sodium hydroxide to 
pH 10. The mixture was heated at 50°C for 3 days, maintaining pH 10 by further 
addition of sodium hydroxide. The solution was cooled and excess tosyl chloride was 
removed by filtration. The filtrate was acidified with hydrochloric acid (6M) to pH 1 to 
precipitate a fine white solid which was isolated by centrifugation. The solid was 
washed with minimal volume of cold water to remove the inorganic salts and p-
toluenesulfonic acid, and dried to give a white solid (2.4 g, 60% ); m.p. 108-111 oc; 31 p 
NMR (101.26 MHz, CDCI3) bp 47.74; lH NMR (250.13 MHz, CDC13) bH 1.51 (6H, 
d, 1p=9.6 Hz, PCH3) 2.46 (6H, s, Ts-CH3), 3.43 (4H, d, 1p=9.6 Hz, PCHzN), 3.48 (4H, 
s, NCHzCHz), 7.36 (4H, d, 21HaHb=8.2 Hz, TsJ::D, 7.72 (4H, d, 21HbHa=8.2 Hz, TsB.); 
13C NMR (62.9 MHz,) be 13.50 (d, Jp=lOO Hz, PCH3), 22.28 (s, TsCH3 ), 49.98 (d, 
1p=107 Hz, NCHzP), 50.84 (s, NCH2CH2), 128.20 (s, m-Ts), 130.77 (s, o-Ts), 134.93 
(NTs), 144.99 (s, STs); m/z (ESMS-, CH30H) 573.21 (M-2H+ + Na+); IR Vmax 1350, 
1330, 1310, 1270, 1150 s, 1090,990 960 s cm-1; Found: C, 42.1; H, 5.61; N, 4.74; 
CzoH3oNz08P2S2 requires C, 42.1; H, 5.65; N, 4.91 %. 
N,N'-Bis- p-toluenesulfonyl-N,N' -bis{methylene( methylthiophosphinic)chloride ]-1 ,2-
diaminoethane (59) 
Me 
'""s 
Ts/P( 
( a 
N a 
Ts\__' P.;:.-
' s Me 
The reaction was carried out as for (46) using N,N'-bis-p-toluenesulfonyl-N,N'-bis 
[methylene(methylphosphinic)]acid-1,2-ethanediamine (56) (0.5 g, 0.9 mmol) and 
oxalyl chloride (0.7 ml, 8 mmol) in dichloromethane (40 ml) to give the phosphinic 
chloride ( bp[CH-,Ch] 58.45 and 58.55 corresponding to two diastereoisomers). 
Thiophosphorylchloride (35 ml) was added to the phosphinic chloride with a catalytic 
amount of DMF and the resulting solution stirred at 110oC for 32 h. Upon cooling, a 
pale yellow solid precipitated and was isolated by filtration and dried in vacuo (416 
mg, 76%); m.p. 114-116oC; 31p NMR (CDCI 3) (two diastereoisomers observed) bp 
86.83, 87.0; lH NMR (400 MHz, CDC1 3) bH 2.37 (6H, d, 1Jp=13.2 Hz, PCH3), 2.47 
(6H, s, Ts-CH3), 3.18-3.32 (4H, m, NCH2CH2N), 3.78 (lH, dd, 1HaHb=15.6 Hz, 1p=3.2 
Hz, PCH2N) and 4.22 (lH, dd, 21HbHa=15.6 Hz, PCH2N), 3.85 (lH, dd, 1Hb'Ha'=15.6 
Hz, Jp=3.2 Hz, PCH2N) and 4.07 (lH, br d, 2JHa'Hb'=15.6 Hz, 2Jp=3.6 Hz, PCH2N). 
7.39 (4H, d, 31=8.0 Hz, TsB.), 7.80 (4H, t like dd, 1=8 Hz, PhH); 13C NMR (62.9 MHz, 
CDCI3) Oc 22.36 (s, Ts-CH3), 23.03 (d, 11p=85 Hz, PCH3), 51.77 (d, 31p=l7 Hz, 
NCH£H2N), 60.55 (d, Jp=73 Hz, NCH2P), 60.76 (d, Jp=73 Hz, NCH2P), 
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128.54 (s, m-Ts), 130.93 (s, o-Ts), 134.41 (s, NTs), 145.63 (s, STs); IR Ymax 1600, 
1350-1260, 1160 s, 1090, 1000-890, 710-700, 650, 540-450 cm-1; m/z (ESMS -) 
596.67 (100%, M- Cl2 + OCH3 + o-). 
N,N'-Bis-p-toluenesulfonyl-N,N'-bis[methylene(methylthiophosphinic)acid-1,2-
diaminoethane (62) 
Me 8 ' .. 
Tslp; 
( OH 
N OH 
Ts\_ 1 p~ 
I S 
Me 
Compound (59) (200 mg, 0.20 mmol) was heated under reflux in a solution of 
potaSsium hydroxide (6 M, SO ml) for 12 h. The mixture was acidified to pH 2 with 
hydrochloric acid (4 M) and extracted with dichloromethane (3 x 40 ml). The combined 
extracts were dried (Na2S04) and the solvent evaporated to give a pale yellow 
crystalline solid (160 mg, 85%); m.p. 185-188"C; 31p NMR (D20, pD14) 8p 64.27; tu 
NMR (250.13 MHz, D20, pD14) 8tJ 1.57 (6H, d, 1=13 Hz, PCH3), 2.32 (6H, s, Ts-
CH3), 3.35 (4H, s, NCH2CH2N), 3.47 (4H, d, 1p=5.5 Hz, PCfuN), 7.32 (4H, d, 31=8.1 
Hz, Ts.H.), 7.57 (4H, d, 31=8.1 Hz, Ts.H); 13C NMR (62.9 MHz, D20, pD14) 8c 23.71 
(s, Ts-CH3), 25.82 (d, 1=72 Hz, P.C.H3), 49.78 (s, NCH~H2), 57.18 (d, 1p=76 Hz, 
NC.H2P), 129.82 (s, m-Ts), 132.63 (s, o-Ts), 137.25 (NTs), 147.09 (s, Ts); rnlz (ESMS 
-, CH30H) 582.69 (100%, M-H+); IR Ymax 3350 b, 1600, 1325-1290, 1150, 1100-
1070, 880, 810, 730-690, 660, 540 cm- 1; Found: C, 39.9, H, 4.81; N, 4.39; 
C2oH29N206P2S4.0.S HCl requires C, 39.6; H, 4.82; N, 4.62%. 
Ethylenediiminodimethylenebis( methylthiophosphinic) Acid ( 65) 
Me, S 
P.~ 
Hf\. N OH 
eN OH 
H\._1 p~ 
I S 
Me 
The ditosylamide, (62), (150 mg, 0.26 mmol) was added portionwise to a solution of 
phenol (490 mg, 5.2 mmol) in HEr/glacial acetic acid (45%, 3 ml). The mixture was 
stirred at 40-50"C for 3 days then slowly dropped into diethyl ether (400 ml) with 
vigorous stirring to precipitate the solid product. The solid was isolated by 
centrifugation, redissolved in methanol (0.5 ml) and slowly dropped into fresh ether 
(300 ml) with vigorous stirring. The precipitate formed was isolated by centrifugation 
and the resolvation/precipitation process repeated and the resulting solid dried to give a 
pale yellow solid (37 mg, 51%); m.p. 166-173"C; 31p NMR (101.26 MHz, D20) 8p 
67.46; tu NMR (400 MHz, D20) 8H 1.49 (6H, d, 1=13 Hz, PCH3), 2.68 (4H, s, 
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NCH2CH2N), 2.69 (2H, dd, 1Hab=14 Hz, 1p=8.8 Hz, PCfuN), 2.84 (2H, dd, 1Hba=14 
Hz, Jp=8.8 Hz, PCfuN); 13C NMR (62.9 MHz, D20) 8c 25.24 (d, 1p=71 Hz, P.C.H2N), 
51.38 (d, 1=11.5 Hz, N.C.H~H2), 58.27 (d, 1p=88 Hz, N.C.H2P); rnlz (ESMS-, CH30H) 
275.10 (100%, M- H+); IR 3400, 2980, 2770, 2200, 1330, 1150, 930, 880, 820, 710, 
660, 550 cm-1. 
Dimethyltetrahydroipyrimidine-1 ,3-diyldimethylenebis( methylphosphinate )3 (51) 
Me 0 '~ l 'oEt 
c> N\_ ,0Et 
p<:> 
I 0 
Me 
Synthesis was carried out according to the procedure described for (39).3 Propane-1,3-
diamine (2.02 g, 2.27 ml, 27 mmol) was treated with paraformaldehyde (2.8 g, 93 
mmol) and diethoxymethylphosphine (lOg, 73 mmol) in dry tetrahydrofuran (150 ml). 
Purif}.cation of the crude product by chromatography on neutral alumina, with gradient 
elution (dichloromethane to 2% methanol-dichloromethane) gave a pale yellow oil 
(3.85 g, 44%); 31p NMR (CDCl3) Op 52.56; lH NMR (250.13 MHz, CDC13) OH 1.30 
(6H, t, 31=7.1 Hz, POCH2CH3), 1.49 (6H, d, 21=14 Hz, PCH3), 1.63 (2H, t, 1=5 Hz, 
NCH2CH2), 2.73 (4H, d, 21=10 Hz, PCfuN), 2.75 (4H, m, NCH2CH2) 3.48 (2H, br s, 
NCH2N), 4.04 (4H, qnt, POCH2CH3); rnlz (DCI) 327 (100%, MH+); IR Vmax 2900-
2800 (C-H), 1670, 1450-1380 (P-OEt), 1295 (PCH3), 1200 br s (tertiary amine and 
P=O), 1040 br s (POEt), 950 s (PCH3), 800-730 (POEt) cm-1. 
Propylenediiminodimethylenebis(methylphosphinic) Acid3 (54) 
Me 
\~0 
~f\ 
C OH N OH 
H \.._p' 
I ~0 
Me 
The ~iiester (51) (2.85 g, 8.74 mmol) was heated under reflux in hydrochloric acid (6M, 
35 ml) for 16 h. The solvent was removed under reduced pressure to leave a white solid 
in quantitative yield (3.48 g); m.p. "C (litR. 244-246"C); 31p NMR (D20) Op 39.45; tu 
NMR (250.13 MHz, D20) OH 1.43 (6H, d, 21=15 Hz, PC.fu), 1.99 (2H, m, NCH2CH2), 
3.06 (4H, s, NCH2CH2), 3.24 (4H, d, 2J=10 Hz, PCH2N); 13C NMR (62.9 MHz, D20, 
NaOD, pD14) oc 18.07 (d, 1 1p=98 Hz, PCH3), 24.86 (s, NCH2CH2), 49.06 (d, 31p=6 
Hz, NCH2CH2), 49.15 (d, 11p=89 Hz, PCH2N); rnlz (ESMS-, CH30H) 256.86 (100%, 
M-H+); IR Vmax 3360, 2600 br, 1610-1590, 1460-1415, 1280, 1210, 1150-1120, 1010, 
980-910, 830, 795, 735, 690, 660, 640 cm- 1; Found: C, 25.9; H, 6.83; N, 9.18; 
C7H2oN204P2.2HCl requires C, 25.4; H, 6.70; N, 8.46%. 
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N ,N' -Bis-p-toluenesulfonyl-N ,N' -his[ methylene( methylphosphinic )acid]-1 ,2-
diaminopropane (57) 
Me 
\~0 
TF.Jl\ 
C OH N OH 
Ts\._ I p~ 
I 0 
Me 
The amino phosphinic acid (54) (3.0 g, 9.0 mmol) was treated with tosyl chloride (3.8 
g, 20 mmol) with the addition of sodium hydroxide in the same procedure described for 
(44). The mixture was heated at 50°C for 4 days, maintaining pH 10 by addition of 
sodium hydroxide as required. The excess tosyl chloride was removed by filtration. The 
filtrate was acidified with hydrochloric acid to pHI to precipitate a fine white solid 
which was isolated by centrifugation. The solid was washed with sparing amounts of 
cold water to remove the salts and p-toluenesulfonic acid, and dried to give a white 
solid (0.6 g, 12%); m.p. 188-193 OC; 3tp NMR (D20, NaOD, pD14) 8p 34.74; tu 
NMR (250.13 MHz, D20, NaOD, pD14) DH 1.19 (6H, d, 2Jp=l3.5 Hz, PCH3) 1.41 
(2H, m, NCH2CH2), 2.44 (6H, s, Ts-CH3), 2.96 (4H, t, 3J=7.5 Hz, NCH2CH2), 3.06 
(4H, ·d, Jp=9 Hz, PCH2N), 7.31 (4H, d, 3J=7.7 Hz, TsH), 7.54 (4H, d, 3J=8 Hz, TsH); 
13C NMR (62.9 MHz, D20, NaOD, pD14) Sc 17.00 (d, 1Jp=95 Hz, P.C.H3), 23.39 (s, 
Ts.C.H3), 25.94 (s, NCH£H2), 48.34 (s, NC.H2CH2), 49.49 (d, 1 Jp=l03 Hz, N.CH2P), 
129.62 (s, m-Ts), 132.87 (d, o-Ts), 137.15 (s, NTs) 147.83 (s, STs); m/z (ESMs-, 
CH30H) 564.78 (40%, M- H+ ), 282.06 (100%, [M- 2H+]/2); IR Vmax 1600 w, 1335, 
1150 s, 1090, 970 s, 890-750, 730, 660, 550, 450 cm-1; Found: C, 43.9; H, 5.65; 4.87; 
C21H32N20sP2S2.0.5H20 requires C, 43.8; H, 5.77; N, 4.87%. 
N ,N' -Bis- p-toluenes ulfonyl-N,N '-his-[ methylene( methylthiophosphinic) chloride-] ,2-
diaminopropane (60) 
Me 
\~S 
TF.Jf\ 
C Cl N Cl 
Ts4' 
1 ~s 
Me 
The -reaction was carried out as for (46) using N,N' -bis-p-toluenesulfonyl-N,N'-
bis[methylene(methylphosphinic)acid]-1,3-propanediamine (57) (200 mg, 0.35 mmol) 
and oxalyl chloride (0.7 ml, 8 mmol) in dichloromethane (40 ml) to give the phosphinic 
chloride ( 8p[CH2Clv 57.90 and 58.11). 
Thiophosphorylchloride (35 ml) was added to the solid phosphinic chloride with a 
catalytic drop of DMF and the reaction mixture was stirred at 115°C for 18 hours. The 
solvent was removed under reduced pressure to give a pale yellow solid (165 mg, 70%), 
m.p. 75-78°C, 31p NMR (CDC13) 8p 85.94, 86.01; tu NMR (250.13 MHz, CDC13) DH 
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2.01 _(2H, d m, NCH2Cfu), 2.38 (6H, d, 1Jp= 13Hz, PCH3), 2.44 & 2.45 (6H, s, Ts-
CH3 diastereoisomers), 3.15-3.40 (4H, m, NCfuCH2), 3.76 (2H, m, PCH2N), 4.19 (2H, 
m, PCH2N), 7.35 (4H, m, TsH), 7.69 (4H, m, Ts.H); 13C NMR (62.9 MHz, CDC13) 0c 
22.29 (s, Ts-C.H3), 26.81 (s, NCH2CH2), 27.94 (d, Jp=58 Hz, PCH 3), 48.34 (s, 
NCH2CH2), 58.03 (d, Jp=72 Hz, NC.H2P), 128.08 (s, Ts), 130.90 (s, Ts) 135.41 (s, 
NTs), 145.37 (s, STs); m/z (ESMS -, MeOH) 597.08 (100%, M- Cl2 + OH + o- ); IR 
Vmax 2850 br, 1597, 1450, 1400, 1330, 1290, 1150, 1190, 920 br, 895, 810, 730-710, 
655, 600, 550 cm-1; Found C, 38.2; H, 5.44; N, 4.28; C21Cl2H32N204P2S4 .H20 
requires C, 38.6; H, 4.93; N, 4.29% . 
N,N'-Bis-p-toluenesulfonyl-N,N'-bis[methylene(methylthiophosphinic)acid]-1,2-
diaminopropane (63) 
Me 
\~S 
Ts.t\ 
c: :: 
Ts\.._p' 
,~ 
Me 8 
Ligand (60) (100 mg, 0.16 mmol) was heated under reflux in a solution of potassium 
hydroxide (4M, 50ml) for 12 h. The mixture was acidified to pH3 with hydrochloric 
acid (4M) and extracted with dichloromethane (4 x 40 ml). The combined extracts were 
dried (Na2S04) and the solvent evaporated to give a pale yellow crystalline solid (75 
mg, 79%); m.p. 68-71 OC; 3lp NMR (CD30D) Op 86.00, 86.46; lH NMR (250.13 
MHz, CDCl3) OH 1.91 (6H, d, Jp=13.5 Hz, PCH3), 2.52 (6H, s, Ts-CH3) 3.2-3.54 (6H, 
m, NCH2CH2 and PCH2N), 3.70-3.91 (2H, m, PCH2N), 5.86 (2H, br, PO.ID. 7.31 (4H, 
m, Ts.H), 7.65 (4H, m, TsH); 13C NMR (62.9 MHz,) <>c 22.30 (s, Ts-CH3), 26.82 (s, 
NCH:£H2), 27.96 (d, Jp=58 Hz, PCH3 ), 48.35 (s, NCH2CH2), 58.04 (d, Jp=72 Hz, 
NC.H2P), 128.09 (s, m-Ts), 130.92 (s, o-Ts) 135.43 (s, NTs), 145.38 (s, STs); m/z 
(ESMS-, CH30H) 596.74 (100%, M-H+), 298.20 (30%, [M-2H+]/2); IR Vmax 2930 br, 
1597, 1330-1290, 1153, 1090, 1020, 940, 887, 815, 650, 545 cm-1. 
Propylenediiminodimethylenebis( methylthiophosphinic acid) ( 66) 
Me 
\~S 
~f\ 
·eN :: 
H \.._p' 
1 ~s 
Me 
The ditosylamide, (63), (70 mg, 0.12 mmol) was added portionwise to a solution of 
phenol (0.22 g, 2.4 mmol) in HBr in glacial acetic acid (45%, ml). The mixture was 
stirred at 40-50°C for 3 days then slowly dropped into diethyl ether with vigorous 
stirring to precipitate the solid product as described previously for (65). The solid was 
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washed with ether and dried to give a pale yellow oil (16 mg, 48%);31p NMR (D20) Op 
63.06; 1H NMR (250.13 MHz, D20) OH 1.79 (6H, d, 1=13.5 Hz, PCH3), 2.17 (4H, m, 
NCH2CH2), 3.15 (2H, m, PCHzN), 3.26 (4H, m, NCfuCH2), 3.42 (2H, m, PCH2N); 
13C NMR (62.9 MHz,) oc 26.14 (s, NCHz,CH2), 26.34 (d, 1p=75 Hz, PCH3), 49.0 (d, 
1=6 Hz, NC.H2CH2), 53.33 (d, Jp=66 Hz, NC.H2P), m/z (ESMS -, CH30H) 288.89 
(100%, M- H+), 730.73 (90%, M + Br"). 
Ethylenediimino-N,N'-dimethyldimethylenebis(phenylphosphinic) acid (68) 
-method A 
p~ 0 
~ 
"r-P, 
eN OH 
N OH 
/ \_p'._ 
1"'0 
Ph 
The title compound was prepared following the reductive methylation procedure of 
Pine and Sanchez.4 Formic acid (1 ml, 1.1 mmol) was added to ethylenediimino-
dimethylenebis(phenylthiophosphinic )acid.2HBr ( 48) (200 mg, 36 mmol) at o·c. 
Formaldehyde (0.8 ml) was added and the reaction mixture heated at so·c for 16h. All 
volatile material was removed from the mixture under reduced pressure to give a pale 
yellow solid (120 mg, 85%); m.p. 160-162.C; 3lp NMR (101.26 MHz, 0 20) Op 19.15; 
lH NMR (250.13 MHz, D20) OH 2.91 (6H, s, NCH3), 3.47 (4H, d, 2Jp=8.9 Hz, 
PCH2N), 3.64 (4H, s, NCH2CH2), 7.48-7.53 (6H, m, m-,p- Ar), 6.77 (4H, m, o-Ar); 
13C NMR (62.9 MHz, D20) Oc 46.29 (s, NCH3) 54.35 (s, NC.H2CHz), 58.82 (d, 1J= 91 
Hz, NC.H2P), 131.67 (d, 3J=12 Hz, m-Ph), 133.74 (d, 2J=9.3 Hz, a-Ph), 135.43 (s, p-
Ph), 135.47 (d, 1Jp=137 Hz); m/z (ESMS-, CH30H) 394.94 (100%, M- H+); IR Vmax 
2790 br, 1440, 1350, 1220, 1125, 1100, 1070,990,915, 840, 780, 745, 690, 860 cm-1. 
methodB 
Following the mild conditions for reductive methylation described by Hemo and 
Charles5, a solution of formaldehyde (35% in H20, 2.25 mmol) was added to a stirred 
solution of ethylenediiminodimethylenebis(phenylthiophosphinic)acid.2HBr (48) (90 
mg, 0.22 mmol) and the reaction mixture heated at 6o·c for 0.5 h. Sodium borohydride 
(200 mg tablet) was added and the mixture stirred for a further 3 h. All volatile material 
was removed from the mixture under reduced pressure leaving a pale yellow solid 
containing a single phosphorus-containing species, 3tp NMR (101.26 MHz, 020) Op 
19.15 as above; crude product not purified. 
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Ethylenediiminodimethylenebis(plumylthiophosphinate) me till oligomeric complexes 
Copper(m (131) 
Ligand (48) (50 mg, 0.09 mmol) was dissolved in methanol (2 ml) and crushed K2C03 
(24 mg) was added. Copper triflate (32 mg, 0.09 mmol) was added as a solution in 
methanol and a precipitate formed. The solid was isolated by centrifugation, washed 
with methanol (2 ml) then with water (2 ml) and dried in vacuo to give an insoluble 
green solid (40 mg, 97%); IR Vmax 1435, 1164, 1140, 1102, 1023 w, 980 w, 734, 715, 
692, 585, 575, 552, 515, 460 cm- 1; Found C, 37.2; H, 4.06; N, 5.26; 
C16H19N202P2S2CuK.H20 requires C, 37.1; H, 4.09; N, 5.41% 
Zinc(II) (132) 
Ligand (48) (50 mg, 0.09 mmo1) was dissolved in methanol (2 ml) and crushed K2C03 
(24 mg) was added. Zinc triflate (32 mg, 0.09 mmol) was added as a solution in 
methanol and a precipitate formed. The solid was isolated by centrifugation and washed 
with methanol (2 ml), water (2 ml) and dried in vacuo to give an insoluble white solid 
(42 mg, 98%); IR Vmax 1435, 1130, 1091, 1023,956 w, 870-850 w, 736, 715, 696, 591, 
574, 513 cm-1; Found C, 40.9; H, 4.33; N, 5.91; C16H2oN202P2S2Zn. 0.5H20 requires 
C, 40.7; H, 4.48; N, 5.93% 
Nickel(ll) (133) 
A similar procedure to the above was employed using ligand ( 48) (50 mg, 0.09 mmol) 
dissolved in methanol (2 ml) with the adition of crushed K2C03 (24 mg). Nickel(ll) 
chloride (21 mg, 0.09 mmol) was added as a solution in methanol and a pale green 
precipitate formed. The solid was isolated by centrifugation and washed with methanol 
(2 ml), water (2 ml) and dried in vacuo to give an insoluble pale green solid (42 mg, 
98%); IR Vmax 1435, 1127, 1095, 1050-1030, 992 w, 737, 715, 695, 588, 513 cm-1; 
Found C, 40.78; H4.48; N, 5.87; C16H2oN202P2S2Ni.H20 requires C, 40.45; H, 4.67; 
N, 5.89% 
Cadmium(II) (134) 
A similar procedure to the above was employed using ligand ( 48) (50 mg, 0.09 mmol) 
dissolved in methanol (2 ml) with the adition of crushed K2C03 (24 mg). Cadmium(ll) 
triflate (37 mg, 0.09 mmol) was added as a solution in methanol and a pale green 
precipitate formed. The solid was isolated by centrifugation and washed with methanol 
(2 ml), water (2 ml) and dried in vacuo to give an insoluble colourless solid (43 mg, 
93%); IR Vmax 1435, 1130, 1097, 998 w, 934 w, 860, 736, 714, 696, 599, 513, 465 em· 
1; Found C, 36.8; H, 3.95; N, 5.40; C16H2oN202P2S2Cd.0.5H20 requires C, 37.0; H, 
4.02; N, 5.39% 
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Ethylenediiminodimethylenebis(phenylthiophosphinate) copper( II) Cu( 48) 
p~ 0 
H /p: 
e
N S 
' / Cu 
/ ' N S 
H \.__ I p~ 
I 0 
Ph 
To a solution of Cu(BF4h (8 mg, 0.03 mmol) in methanol (3 ml) was added a solution 
of the dihydrobromide of (48) (16 mg, 0.03 mmol) in methanol (5 ml). The resultant 
dark green coloured solution was formed instantly and left to stand, however, 
crys~allisation did not occur. ESMs- (MeOH) 541.77 (CuLBr-) isotope model 
C16H2oN202P2S2CuBr 541.89; Amax (H20), 598, E=300 mol-1 dm3 cm-1, 332, E=8.3 x 
103 mol- 1 dm3 c m- 1; HPLC: Cl8 reversed phase (1.4 ml min-1), elution 
A=CH3CN/TFA; B=H20/TFA from 80% B/20% A to 100% A over 25 minutes, 
observed 1..=254 nm, Rt=11 minutes. 
Propylenediiminodimethylene bis (Phenylthiophosphinate) copper(II) Cu(64) 
Ph 
\~0 
H..'' C-., /s N"c~s 
H\_ I p~ 
p~ 0 
To a solution of Cu(BF 4>2 (8 mg, 0.03 mmol) in methanol (3 ml) was added a solution 
of the dihydrobromide of (64) (17 mg, 0.03 mmol) in methanol (5 ml). The dark green 
colour of the solution was instantly visible; ESMS- (MeOH) 555.82 (CuLBr) isotope 
model C17H22N202P2S2CuBr 555.91; Amax (H20), 628, E=350 mol- 1 dm3 cm-1; 
HPLC: C18 reversed phase (1.4 ml min-1), elution A=CH3CN/TFA; B=H20/TFA from 
80% B/20% A to 100% A over 25 minutes, observed 1..=254 nm, Rt=12.5 minutes. 
Ethylenediiminodimethylene bis (Methylthiophosphinic Acid) Copper (II) Cu(65) 
Me 0 \ "" 
H /p; 
eN, /s Cu / ' N S 
H \.__ I p~ 
I 0 
Me 
To a solution of Cu(BF4h (5 mg, 0.02 mmol) in water (2 ml) was added a solution of 
the dihydrobromide of (65) (10 mg, 0.02 mmol) in water (4 ml). The pale green colour 
of the solution was instantly visible; ESMs- (MeOH) 440.62 (CuLNaBr) isotope model 
C6H l6N202P2S2CuBrNa 440.85; Amax (H20), 598, E=150 mol-1 dm3 cm-1, 334, E=104 
mol-1 dm3 cm-1. 
Oxotrichlorobis( triphenylphosphine )rhenium(V)6 (135) 
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The oxorhenium complex was prepared according to the procedure of Wilkinson et az.6 
A boiling solution of triphenylphosphine (5g) in ethanol (5 ml) was added carefully to a 
boiled but cooling solution of perrhenic acid (1 ml, 8.6 mmol) and concentrated 
hydrochloric acid (1 ml) in ethanol (10 ml) and heated at reflux for 10 minutes. A 
yellow-green precipitate formed which was recrystallised from hot toluene (5.73 g, 
80%); IR Vmax 1480, 1433, 1092, 1030,969 (Re=O), 740, 690, 520, 500 cm-1; Found: 
C, 51.8; H, 3.66; C36H3oCl30P2Re requires C, 51.9; H, 3.63%. 
[ReOCI2(0CH2CH3)(PPh3hl (136) 
The above procedure (135), carried out in a hot but not boiling solution, gave rise to a 
dark green solid and was recrystallised in toluene to give brown crystals (5.6 g, 77% ); 
IR Vmax 1480, 1433, 1094, 1074, 997, 947 (Re=O), 906 (OCH2), 742, 690, 570, 506; 
FouQd: C, 54.2; H, 4.14; C3gH35Cl202P2Re requires C, 54.2; H, 4.19%. 
Conversion to [ReOCl3(PPh3h] was achieved by the method described by Wilkinson et 
al.6 The solid [ReOCl2(0CH2CH3)(PPh3nl was stirred in dichloromethane and stirred 
vigorously with an equal volume of 6M hydrochloric acid for 1 h. A yellow-green 
powder precipitated from the mixture and was isolated by filtration and dried in vacuo 
(g, %); Found: C, 51.7; H, 3.58% characterisation of [ReOCl3(PPh3h] as above. 
Ethylenediiminodimethylenebis(phenylthiophosphinate) oxorhenium(V) ReO( 48) 
Ph \~0 
r-P, 
C~ fj> /s Re / ' 
HN S \__, p~ 
I o 
Ph 
Oxotrichlorobis(triphenylphosphine)rhenium(V) (67 mg, 0.9 mmol) was suspended in 
hot benzene (20 ml) and stirred under an inert atmosphere and a methanol solution of 
(48) (50 mg, 0.9 mmol) was added to the reaction mixture which was then heated at 
reflux for 18 h. Upon cooling, the solvent was removed under reduced pressure and the 
remaining solid was washed with benzene (2 x 10 ml), then dichloromethane (5 ml) and 
dried in vacuo to give a deep pink coloured solid (43 mg, 80%); 31p NMR (CH30H) 8p 
100.7; IR Vmax 1110, 1030, 997, 927, 859, 800, 738, 713, 1120, 950, 910, 800, 775, 
740 cm-1; Amax 526 (£=240 dm3 mol-1 cm-1); ESMs- (CH30H) 599.11 and 597.13 
(55% and 100% respectively corresponding toRe isotopes, Re0(48) -H+), no other 
species observed. 
Chapter 3 
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Me s 
Me-'p_Ff' // ,-Me 
S Me 
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The title compound (77) was prepared according to the literature procedure.1·8•9 A 
solution of methylmagnesium bromide (2M in diethyl ether, 120 ml, 240 mmol) was 
cooled to -15°C under an inert atmosphere. To this was slowly added a solution of 
thiophosphoryl chloride (13.5 g, 80 mmol) in diethyl ether (30 ml) maintaining a 
temperature of -20° to -10°C. The reaction mixture was stirred for 1 h, after which time 
the resultant white precipitate was poured slowly onto crushed ice (300 g). Sulfuric acid 
(10%, 90 ml) was added with stirring and the white precipitate was removed by 
filtration, washed with water and recrystallised from ethanol to give white needle-like 
crystals (4.16 g, 56%) m.p. 225-227°C (lit.ref 225-229°C); 3tp NMR (CDCl3) ()p 35.5; 
lH NMR (250.13 MHz, CDCl3) ()H 2.07 (dd, Jp=ll.55 Hz, Jp2=5.8 Hz); 13C NMR 
(62.9 MHz, CDCl3) ()c 16.20; IR Vmax 1400, 1280, 935, 880, 860, 820, 730 b, 560 cm-
1; Fo.und: C, 25.9; 6.29; C4H12P2S2 requires C, 25.8; H, 6.50. 
Dimethylthiophosphinic Bromide 10,11 (76) 
s 
II p Me" ,-sr 
Me 
Tetramethyldiphosphine disulphide (77) (370 mg, 1.98 mmol) was suspended in dry 
carbon tetrachloride (7 ml) and a solution of bromine (316 mg, 1.98 mmol) in carbon 
tetrachloride ( 4 ml) was added dropwise maintaining the temperature around 0°C. 
Removal of the solvent at atmospheric pressure gave a residue which was purified by 
distillation under reduced pressure to yield a colourless liquid which solidified upon 
standing (0.5 g, 75% ); m.p. 32-34°C (lit.IO 34°C); 3lp NMR (CDCl3) ()p 65.62; lH 
NMR (250.13 MHz, CDCl3) ()H 2.59 (d, Jp=l3.1 Hz); 13C NMR (62.9 MHz, CDCl3) 
3c 33.12 (d, Jp=57.2 Hz). 
Benzildihydrazone12,13 (81) 
PhXN'NH2 
Ph ~N ... NH2 
Preparation of the title compound was carried out according to the standard 
procedure12,13 of Cope et al. To a solution of benzil (5 g, 24 mmol) stirred inn-butanol 
(15 ml) was added hydrazine hydrate (3.09 g, 3 ml, 62 mmol). The resulting solution 
was heated at reflux for 48 h. Upon cooling to 0°C, a precipitate formed which was 
isolated by filtration, washed with cold ethanol and dried at the pump to give fine 
needle-like white crystals (4.5 g, 79%), m.p. 138-139°C (lit.12 150-151.SCC); lH NMR 
(250.13 MHz, CDCl3) ()H 5.74 (4H, b s, NH2), 7.25-7.32 (6H, m, m-p-PhH), 7.52-7.55 
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(4H, m, a-PhH); 13C NMR (62.9 MHz, CDCl3) Oc 51.9 (Ph-Q, 126.18 (m-Ph), 129.48 
(a-Ph), 135.22 (p-Ph), 142.86 (Ph); m/z (ESMS+ CH30H) 499.13 (25%, M2Na+), 
260.99 (100%, MNa+), 238.99 (30%, MH+); IR Vmax 3290 (Ar-H), 1580, 1560, 1490, 
1410, 1380, 1290, 1125, 1070, 1035, 1010, 950, 910, 860, 770, 740, 690, 600 cm·1; 
Found: C, 70.4; H, 5.94, N, 23.5; C14H14N4 requires C, 70.6; H, 5.92; N, 23.5% 
Butane-2,3-dihydrazone (82) 
MeyN'NH2 
MeAN_.NH2 
Preparation of the title compound was carried out using an analogous procedure to that 
for (81). Butane-2,3-dione (2.11 ml, 24 mmol) was treated with hydrazine hydrate (3.09 
g, 3 ml, 62 mmol) inn-butanol (15 ml) to give white needle-like crystals (2.3 g, 84%), 
m.p. 153-154°C (lit.l4 155-157°C); lH NMR (250.13 MHz, CDCl3) OH 1.96 (6H, s, 
CH3), 5.31 (4H, b s, NH2); 13C NMR (62.9 MHz, CDCl3) 8c 9.22 (s, .C.H3), 149.21 (s, 
.C..=N); rnlz (DCI) 115 (100%, MH+), 87 (100%, MH+ - N2); IR (KBr) Vmax 1640, 
1575, 1460, 1440, 1360, 1280, 1130, 1080, 940, 740, 450 cm-1; Found: C, 42.1; H, 
8.83, N, 49.1; C4H10N4 requires C, 42.3; H, 8.98; N, 49.3% 
Diplienyl-1,2-ethane-1,2-bis[(dimethylthiophosphoryl)hydrazide] (84) 
~~-\( 
PhxN S 
Ph ~N hS ~-rz 
To a solution of dimethylthiophosphinic bromide (2.9 mmol) in carbon tetrachloride 
(10 ml) was added benzildihydrazone (81) (328 mg, 1.4 mmol) and triethylamine (0.42 
ml, 3.03 mmol). The reaction mixture was stirred under an inert atmosphere for 15 h 
resulting in the formation of a white precipitate. The solid was removed by filtration 
and the solvent was evaporated from the mother liquor under reduced pressure to leave 
an orange oil. This was dissolved in ether and dark yellow crystals formed. If crystals 
did not from easily, the ether solution was, instead, washed with water (3 x 30 ml), 
dried (Na2S04) and the solvent was removed under reduced pressure to give the pale 
orange solid product (4.0 g, 70%); m.p. 164-16TC; 31p NMR (CDCl3) 8p 66.71; 1H 
NMR (250.13 MHz, CDCl3) OH 2.05 (12H, t-like dd, 2Jp=12.1 Hz, P(S)(CH3n), 6.15 
(2H, d, 2Jp=21.4 Hz, PNHN), 7.26-7.37 (6H, m, m-, p-PhH), 7.51-7.55 (4H, m, o-PhH); 
Be NMR (62.9 MHz, CDCl3) 8c 22.71 (d, Jp=68 Hz, -P(S)C.C.H3h), 23.20 (d, Jp=68 
Hz, -P(S)(.C.H3h), 126.52 (m-Ph), 129.74 (a-Ph), 130.88 (p-Ph), 133.53 (PPh), 143.00 
(d, 1= 14.5 Hz, Ph-.C.=N-NH-); rnlz (ESMS+ MeOH) 423.07 (100%, MH+); IR Vmax 
3290,1440,1380,1290,1125,1060,1035,1010,990,950,910,860, 740s,670s,600 
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s cm-1; Found: C, 51.3; H, 5.78; N, 13.0; C1sH24N4P2S2 requires C, 51.2; H, 5.73; N, 
13.3;% Amax (acetonitrile) 280, E = 3.1 x 104 mol-1 dm3. 
for crystal data, see Appendix B 
Butane-2,3-bis[(dimethylthiophosphoryl)hydrazide] (85) 
,~-< M"XN S 
Me ~N S 
, II 
~-:" 
To a solution of dimethylthiophosphinic bromide (27.6 mmol) in carbon tetrachloride 
(lOml) was added butane-2,3-dihydrazone (82) (1.5 g, 13.2 mmol) and triethylamine (3 
g, 30 mmol). The reaction mixture was stirred under an inert atmosphere for 15 h. A 
yellow precipitate formed which was isolated by filtration and washed thoroughly with 
water to remove the triethylamine salts. The pale yeliow solid was dried in vacuo (3.5 
g, 89%); m.p. > 250.C; 31p NMR (CDCl3) Op 65.43; tu NMR (250.13 MHz, CDCl3) 
OH 1.92 (12H, d, J=13.5 Hz, P(CH3h) 1.98 (6H, s, CH3C), 5.99 (2H, d, J=21.3 Hz, 
PNHN); 13C NMR (62.9 MHz, CDCl3) oc 9.93 (C-CH3), 22.64 (d, J=68.2 Hz, 
P(S).CH3h) 148.30 (s, CH3-C.=NNP); m/z (EI+) 298 (20%, M+), 205 (100%, M-
P(S)(CH3h); IR Vmax 3270 br (NH), 1580, 1410-1400, 1375, 1350, 1290, 1280, 1060 s, 
940, 900, 850, 730, 630, 580 cm-1; Found: C, 31.8; H, 6.67; N, 18.3; CgH1gN4P2S2 
requires C, 32.2; H, 6.76; N,18.8%; Amax 274, E=3.1 x lcf mol-1 dm3. 
for crystal data, see Appendix B 
2-(Dimethyl thiophosphoramino )-6-picoline (86) 
j)NH 
1
-Me s~~ 
Me 
To a solution of dimethylphosphinic bromide (76) (5.46 mmol) in carbon tetrachloride 
(50 ml) was added 2-amino-6-picoline (1.78 g, 16.4 mmol) and the resultant solution 
stirred for 5 h at room temperature under an inert atmosphere. A white precipitate 
formed and was isolated by filtration then washed thoroughly with diethyl ether. White 
crystals formed in the ether layer and were isolated by filtration and dried in vacuo (0.9 
g, 82%); m.p. 138-140.C; 31p NMR (CDCl3) Op 59.96; tu NMR (250.13 MHz, 
CDCl3) OH 2.17 (6H, d, 2Jp=14.17 Hz, P(CH3h), 2.41 (3H, s, py-CH3), 5.14 (lH, br s, 
NB.), 6.41 (lH, d, 3J=8.15 Hz, Py-H(3)), 6.68 (lH, d, 3J=7.39 Hz, Py-H(4)), 7.41 (1H, t, 
3J=7.9 Hz); 13C NMR (62.9 MHz, CDCl3) Oc 23.53 (d, Jp=68.2 Hz, PCH3), 24.74 (s, 
.CH3), 130.81, 131.31, 131.82, 162.17, 169.65, 192.72; IR Vmax 3280 (Ar-H), 1600 (Ar-
H), 1570, 1450-1370, 1280 s, 950 s, 910-860, 780, 740 s, 700, 580, 530 cm-1; m/z 
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(DCI) 201 (100%, MH+), 185 (5%, M-CH3); Found: C, 47.6; H, 6.50; N, 13.80; 
CgH13N2PS requires C, 48.0; H, 6.54; N, 13.99%; Amax (acetonitrile) 232, E=1.6 x Hf 
mol-1 dm3; 286, E= 6.3 x 103 mol-l dm3. 
for crystal data, see Appendix B 
2,6,-Bis( dimethylthiophosphoramino )pyridine (89) 
0 HN)lN~NH 
. I I Me-p P.~Me 
' ~s s~' Me Me 
To a stirred solution of dimethylphosphinic bromide (76) (4.28 mmol) in carbon 
tetrachloride (15 ml) was added 2,6 diaminopyridine (110 mg, 1.02 mmol) and 
triethylamine (0.31 ml, 2.24 mmol) and the reaction mixture stirred for 16 h at room 
temperature under an inert atmosphere. A white precipitate formed which was isolated 
by filtration, washed with water and dried in vacuo (0.75 g, 60%); m.p. 199-203°C 
(decomp.); 31p NMR (CDCl3) Op 56.99; tu NMR (250.13 MHz, CDCl3) OH 2.14 
(12H, d, J=13.7 Hz, P-(CH3n). 5.19 (2H, d, 2Jp=5.5 Hz, N.H.), 6.31 (2H, d, 3J=8 Hz, 
Py-H..(3), lli5)), 7.43 (1H, t, 3J=8 Hz, Py-lli4)); 13C NMR (62.9 MHz, CDCl3) Be 
24.06 (d, Jp=68 Hz, P~H3h), 104.42 (d, J =4.3 Hz, Py-Q3) & Q5)), 140.92 (Py-
Q4)), 153.9 (Py-Q2) & C(4)); IR Vmax 3150 (Ar-H), 1600 s, 1580 s, 1450 s, 1400, 
1290, 1210, 1160, 1040, 950-930, 890, 790 s, 720 s, 650, 850; rnlz (DCI) 294 (100%, 
MH+), 202 (20%, M - P(S)Me2 + 2H+); Found: C, 36.1; H, 5.81; N, 14.17; 
C9H17N3P2S2.0.5H20 requires C, 35.8, H, 6.00; N, 13.90%; Amax (acetonitrile) 244, 
E=7.5 x 103 mol-1 dm3, 300, E=6 x 1<P mol-1 dm3. 
Dimethylthiophosphorylhydrazine (95) 
s H2N-~-P~ 
A solution of dimethylthiophosphinic bromide (76) (2.7 mmol) in carbon tetrachloride 
(20 ml) was added dropwise to hydrazine hydrate (200 mg, 4 mmol) under an inert 
atmosphere. The reaction mixture was stirred for 15 hand the solvents were removed 
under reduced pressure to give a colourless oil (325 mg, 97%); 31p NMR (101.26 
MHz, CDCl3) Op 68.74; lH NMR (250.13 MHz, CDCl3) OH 1.88 (6H, d, Jp=l3.1 Hz, 
PCH3n), 3.5 (s, br, -NH2), 4.1 (1H, d, P-NH); 13C NMR (62.9 MHz, CDCl3) Be 33.12 
(d, Jp=57.2 Hz, PC.H3n); m/z (ESMS+, MeOH) 124.85 (MH+) IR Vmax 3330 b, 3180 
b, 1610 b, 1420, 1290, 1050, 930, 860, 710, 550 cm-1. 
Tetrakis( acetonitrile )copper(/ )tetrafluoroborate (137) 
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This preparation was carried out in a similar manner to Kubas's synthesis of 
Cu[(CH3CN)4] [PF6]. 15 To a stirred suspension of copper(!) oxide (9g, 63 mmol) in 
acetonitrile (200 ml) was added fluoroboric acid (20 ml of 40% solution) in roughly 2 
ml portions over 15-20 min. After stirring for 1 h, some red solid still remained. The 
reaction mixture was heated gently for 10 mins to give a pale blue solution and was 
filtered to remove any traces of undissolved solid. The solution was kept at -20°C while 
large white crystals formed. The crystals were isolated by filtration and recrystallised 
from acetonitrile (120 ml) to give large colourless crystals (15.6 g, 79% ); m/z (ESMS+, 
144.80 (100%, Cu(CH3CNh), 103.82 (45%, Cu(CH3CN)); Found: C, 30.5; H, 3.83; N, 
17.5; CsH12N4CuBF4 requires C, 30.6, H, 3.85; N, 17.8%. 
Butane-2,3-bis[(dimethylthiophosphoryl)hydrazide] Copper(/) Cu(/)(85) 
Me 
,N=r(Me 
M):N'- /S 
Cu 
Me =:::..N/ ··~,s 
\ 1/ 
~-~'Me 
Me 
To a solution of [tetrakis(acetonitrile)copper(l)]tetrafluoroborate (295 mg, 0.94 mmol) 
in acetonitrile (35 ml) was added a solution of butane-2,3-
bis[(dimethylthiophosphoryl)hydrazide] (85) (280 mg, 0.94 mmol) in dichloromethane 
(30 ml). After mixing the deep orange coloured solution, a precipitate formed which 
was isolated by centrifugation, washed with acetonitrile (2 x 10 ml) and dried in vacuo 
to give an orange solid (350 g, 85%); 31p NMR (101.26 MHz, CH3CN) bp 66.74; rnlz 
(ESMS+, CH30H) 360.82 (CuL+); Found: C, 26.5, H, 5.47; N, 15.1; CgH19N4P2S2Cu 
requires C, 26.6; H, 5.30; N, 15.5%; A-max (acetonitrile), 274, £=3.5 x 1o4 M-1 cm-1, 
430, dm3, £=2.0 x 103 M-1 cm-1. 
Butane-2,3-bis[( dimethylthiophosphoryl)hydrazide] Copper( II) Cu(Il)( 85) 
Me 
,N=~Me 
MeyN'\. /S 
MeAN/c~s 
' I N=~'Me 
Me 
To a stirred solution of Cu(II)triflate (120 mg, 0.34 mmol) in dry acetonitrile (7 ml) was 
added solid butane-2,3-bis[(dimethylthiophosphoryl)hydrazide] (85) (100 mg, 0.34 
mmol). The reaction mixture immediately turned deep green and was heated at 80°C for 
4 h then left to cool. Diethyl ether (15 ml) was added and the solution left to stand at 
-5°C, however, crystallisation failed to occur. The solvents were removed under 
reduced pressure to give a green oil. Crystallisation was attempted using 
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tetrahydrofuran but no solid was formed although visible spectroscopy and mass 
spectral analysis confirmed the formation of the complex; m/z (ESMS+, CH30H) 
360.29 (100%, M+), 363.02 (50%) corresponding to Cu isotopes; "-max (acetonitrile) 
206, £=1.96 x 104 mol-1 dm3, 302, £=1.25 x 1o4 mol-1 dm3, 392, £=4.7 x 1o3 mol-l 
dm3, 636, £=210 mol-1 dm3. 
Diphenyl-1 ,2-ethane-1 ,2-bis[( dimethylthiophosphoryl)hydrazide] copper( I) 
Cu(l) (84) 
Me 
I Me· 
,N=P( p:XN' /s Cu 
P ~N/ ···~s 
" I N=~'Me 
Me 
To a solution of [tetrakis(acetonitrile)copper(l)]tetrafluoroborate (37 mg, 0.12 mmol) in 
acetonitrile (5 ml) was added a solution of (84) (50 mg, 0.12 mmol) in acetonitrile (5 
ml). Mter mixing, the yellow coloured solution was cooled to -SOC but crystallisation 
failed to occur, even following the dropwise addition of diethyl ether. Visible 
spectroscopy and mass spectral analysis confirmed the formation of the complex; 
ESMS+ (MeOH) 485.02 C18H23N4P2S2Cu .H+ (CuL 485.02 with Cu isotope pattern by 
modelling) A..nax (acetonitrile), 280, £=7.8 x 104 M-1 cm-1. 
Chapter 4 
N-Tosyl-2-bromoaniline (138) 
Tosyl chloride (8.0 g, 46.5 mmol) was added to a stirred solution of 2-bromoaniline 
(8.87 g, 46.5 mmol) in pyridine (100 ml). The yellow solution was stirred for 20 h at 
room temperature and poured over crushed ice to precipitate the solid product which 
was isolated by filtration then dried. Recrystallisation from diethyl ether/light 
petroleum gave pale orange crystals (14.2 g, 93%); m.p. 90-93°C; lH NMR (250.13 
MHz, CDCl3) 8H 2.29 (3H, s, Ts-CH3), 6.91 (1H, t, J=7.7 Hz, AriD, 6.94 (1H, s, NH), 
7.13 (2H, d, J=8.3 Hz, TsH), 7.19 (lH, t, J=7 Hz, ArH), 7.32 (lH, d, J=7.8 Hz, ArH), 
7.57 (2H, d, J=8.3 Hz, TsH), 7.59 (lH, d, J=7.5 Hz, ArH); 13C NMR (62.9 MHz, 
CDCl3) 8c 22.27 (TsC.H3), 116.37 (Ar), 123.22 (Ar), 126.94 (Ar), 128.01 (m-Ts), 
129.25 (Ar), 130.34 (o-Ts), 133.25 (Ar), 135.37 (NTs), 136.49 (Ar), 144.93 (STs); m/z 
(DCI) 345 (100%, M + NH3); (ESMS +, CH30H) 327.84 (100%, MH+); IR Vmax 3300 
-175-
Chapter Six: Experimental Methods 
br, 2360-2340, 1600 s, 1480, 1400, 1330 s (-S(O)z-N), 1180-1160 s (-S(O)z-N) 1090, 
910, 820, 760, 650, 620, 530, 500-440 cm-1; Found: C, 48.4; H, 3.79; N, 4.20 %; 
C13H12NOS2 requires C, 47.9; H, 3.71; N, 4.29%. 
N ,N '-Bis-p-toluenesulfonyl- N ,N'-bis( o-phenylenebromide )-1,2-diaminoethane (109) 
n 
Ts.J--\ eN Br 
T~ Br 0 
A solution of 1,2-bis(p-toluenesulfonato)ethane (0.73 g, 2.0 mmol) in DMF (12 ml) was 
added dropwise over a period of 1 h to a stirred mixture of N-tosyl-2-bromoaniline (1.3 
g, 4 mmol) and Cs2C03 (1.37 g, 4.2 mmol) in DMF (12 ml) under an inert atmosphere. 
The reaction mixture was stirred for 18 h with heating at reflux. The volume of solvent 
was reduced prior to the addition of water (30 ml) and extraction into CH2CI2 (3 x 30 
ml). The combined organic extracts were dried (Na2S04) and the solvent removed 
under reduced pressure to leave a yellow oil. Crystallisation from ethyl acetate/light 
petroleum afforded a white solid (0.88 g, 65%); m.p. 173-176°C; lH NMR (250.13 
MHz, CDCl3) OH 2.43 (6H, s, TsCH3), 3.75 (4H, m, NCH2CH2N), 7.07-7.26 (lOH, m, 
Ar), 7.49-7.63 (6H, br m, Ar); 13C NMR (62.9 MHz, CDC13) Oc 22.23 (Ts,CH3), 50.67 
(NCH~H2N), 126.08 (ArC.Br), 128.49 (m-Ts), 128.89 (ArBr), 130.22 (o-Ts), 130.67 
(ArBr), 132.56 (ArBr), 134.67 (ArBr), 136.40 (NTs), 138.90 (ArBr), 144.51 (STs); m/z 
DCI 695 (15%, M + NH3), 678 (10%, M+), 524 (25%, M-Ts + H+); IR Vmax 1600, 
1470,1340,1150,1090,1040,930,810,770,760, 710,660,570,550cm-l:FoundC, 
49.3; H, 3.80; N, 4.04; C2gH26Br2N204S2 requires C, 49.6; H, 3.86; N, 4.13%. 
P-Methyl-o-nitrophenylphosphinate 16 (111) 
~N02. 
~p-OEt 
,~ 
Me 0 
Dinitrobenzene (713 mg, 4.24 mmol) and methyldiethoxyphosphine (7.63 mmol, 20 ml 
of a 0.38 M solution in ether) were stirred in dry acetonitrile for 24 h. The solvent was 
removed under reduced pressure and vacuum distillation gave an orange oil (810 mg, 
83%); 31p NMR (CDCl3) Op 38.87; lH NMR (250.13 MHz, CDCl3) OH 1.23 (3H, t, 
3J=7 Hz, POCH2CH3), 1.90 (3H, d, 2J=15 Hz, PCfu), 3.83 (lH, m, POCH2CH3), 4.05 
(lH, m, POCH2CH3), 7.69 (2H, m, ArH), 7.85 (2H, m, ArH); 13C NMR (62.9 MHz, 
CDCl3) 8c 16.76 (s, POCH£H3), 17.61 (d, Jp=108 Hz, P.C.H3), 62.03 (d, 3Jp= 5Hz, 
POCH2CH3), 124.82 (d, 1=5.5 Hz Ar), 127.36 (d, 1Jp=119 Hz, Ar), 133.33 (d, J=ll Hz, 
Ar), 133.76 (s, Ar), 135.83 (d, 1=5.5 Hz), 152.48 (s, Ar-N02); m/z (DCI) 230 (100%, 
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MH+); IR Vmax 1532 s (N02), 1360 (N02), 1300 (P-0), 1210, 1130, 1023 s, 950, 900-
850, 780, 730 s, 490 cm-1. 
P-Methyl-o-aminophenylphosphinate 17 (112) 
CCNH2 p-OEt 
,~ 
Me 0 
P-Methyl-o-nitrophenylphosphinate (111) (700 mg, 3.06 mmol) was added to a stirred 
mixture of iron powder (570 mg, 10.3 mmol) and ammonium chloride (150 mg, 2.8 
mmol) in water (15 ml) and heated under reflux for 16 h. The black powder was 
removed by filtration and the aqueous solution was made basic by addition of sodium 
hydroxide solution (10%) to pH 10.5. This was extracted with ethyl acetate (3 x 30 ml), 
dried (K2C03) and the solvent was removed under reduced pressure to give a yellow oil 
which solidified upon cooling (500 mg, 82%); m.p. 59-62"C (lit. m.p. not reported); 
3Ip NMR (CDCl3) Op 47.63; lH NMR (250.13 MHz, CDCl3) OH 1.31 (3H, t, 3J=7 Hz, 
POCH2CH3), 1.66 (3H, d, 2J=15 Hz, PCfu), 3.91 (1H, m, POCfuCH3), 4.06 (lH, m, 
POCfuCH3), 5.32 (2H, s, NH2), 6.61-6.73 (2H, m, ArH), 7.22-7.35 (2H, m, ArH); 13C 
NMR (62.9 MHz, CDCl3) Oc 16.89 (d, Jp=104 Hz, PCH3), 17.06 (s, POCH:£H3), 
61.18 (d, 3Jp= 6Hz, POC.H2CH3), 117.21 (d, J=10 Hz Ar), 117.66 (d, J=12 Hz, Ar), 
132.80, 132.96, 134.27, 152.34; rnlz (DCI) 200 (100%, MH+); IR Vmax 3410 s, 3300 s, 
2990-2900, 1620 S, 1600, 1480, 1550, 1330, 1300, 1170-1120, 1020 S, 950 S, 890-880, 
780-730 cm-1; C9H14N02P.H+requires 200.0840; found 200.0840. 
N,N'-bis[phenyl(2-ethoxymethylphosphinyl)] oxamide (113) 
,oEt 
P, 
H II Me 
0 N 0 
OXN Me 
;~L), 0 u OEt 
Oxalyl chloride (50 J.ll, 0.58 mmol) was added to a stirred solution of P-Methyl-a-
aminophenylethylphosphinate (112) (260 mg, 1.2 mmol) and triethylamine (0.2 ml, 1.4 
mmol) in dichloromethane (6 ml) under an inert atmosphere. After 2 h the reaction 
mixture was washed with HCl (0.5 M, 2 x 10 ml) and water (10 ml) and dried over 
(K2C03). The solvent was evaporated under reduced pressure to give a pale yellow 
solid which was recrystallised from ethyl acetate/diethyl ether to give a white solid (220 
mg, 84%); m.p. 167-170"C (decomp.); 3lp NMR (CDCl3) Or 46.30; lH NMR (250.13 
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MHz, CDCl3) OH 1.32 (6H, t, 31=7 Hz, POCH2CH3), 1.74 (6H, d, 21=15 Hz, PCfu), 
4.01 (2H, dm, POCH2CH3), 7.21 (2H, m, ArH ), 7.54 (2H, q, ArH ), 8.88 (2H, dd, 
ArH), 10.99 (2H, s, br, NH); 13C NMR (62.9 MHz, CDCl3) 3c 15.82 (s, POCH2CH3), 
17.13 (d, 1p=79 or 85Hz, PC.H3), 61.18 (d, 31p=6 Hz, PO,CH2CH3), 118.05 (d, 1p=120 
Hz, P-Ar), 121.09 (d, 1p=8.7 Hz, Ar), 124.11 (d, 1p=12 Hz, Ar), 131.84 (d, 1p=8.8 Hz, 
Ar), 133.74 (d, 1=2.3 Hz, Ar), 141.68 (d, 1p=5 Hz, N-Ar), 158.41 (s, C=O); m/z (ESMS 
-, CH30H) 450.91 (100%, M-H+); IR Vmax 3200-2900 br (NH), 1690 s (C=O), 1600, 
1580 S, 1510 S, 1460-20, 1300 S, 1190-1130, 1080 W, 1040-1020, 950 S, 880-860, 800, 
750, 720, 670 cm-1; Found C, 52.8; H, 5.81; N, 6.13; C2oH26N206P2 requires C, 53.1; 
H, 5.79; N, 6.19%; C2oH26N20#2 .H+ requires 453.1344; found 453.1344 
N,N'-bis[phenyl(2-methylphosphinoxy)] oxamide (115) 
The diester (113) (150 mg, 99 mmol) was stirred in a solution of lithium hydroxide 
(0.5M, 10 ml) for 24 h at room temperature. The solvent was removed under reduced 
pressure to give a white solid in quantitative yield; m.p. >250°C; 31p NMR (D20) Op 
32.18; tu NMR (250.13 MHz, D20) OH 1.16 (6H, d, 21=14 Hz, PCfu), 6.62 (4H, m, 
ArH ), 7.09 (2H, t, 1=8 Hz, ArH), 7.30 (2H, dd, 1=8 Hz, 1=13 Hz, ArH); 13C NMR (50 
MHZ, D20) Oc 21.27 (d, 1p=97 Hz, PCH3), 121.46 (d, J=8.8 Hz, m-Ar), 122.85 (d, 
Jp=11.3 Hz, m-Ar), 125.44 (d, Jp=123 Hz, PAr), 136.43 (d, Jp=8.3 Hz, o-Ar), 136.62 
(d, 1=2 Hz, p-Ar), 152.53 (d, 1=6.5 Hz, NAr), 176.39 (s, C=O); IR Vmax 3670, 2710, 
1660 s (C=O), 1600, 1470-1440, 1320, 1300, 1135, 1090, 1030 br, 890,750 cm-1. 
N,N'-bis[phenyl(2-ethoxymethylphosphinyl)] malonamide (114) 
~ ~I OEt 
p" 
N 0 
0()-N to ~ \ I~ OEt 
Malonyl dichloride (61 mg, 42 J..Ll, 0.43 mmol) was added to a stirred solution of P-
methyl-o-aminophenylethylphosphinate (112) (180 mg, 0.91 mmol) and triethylamine 
(0.2 ml) in dichloromethane (5 ml) under an inert atmosphere. Mter 2 h the reaction 
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mixture was washed with hydrochloric acid (0.5 M, 2 x 10 ml) and water (10 ml) and 
dried over (K2C03). The solvent was evaporated under reduced pressure to give a dark 
yellow oil which was recrystallised from CH2Cl2/ light petroleum to give a pale orange 
oil (150 mg, 75%) with slight impurities observed by NMR analysis; 31p NMR 
(CDCl3) 8p 47.60; Iu NMR (250.13 MHz, CDCl3) DH (6H, t, 31= Hz, POCH:zkH3), 
(6H, d, 21=15 Hz, PCH3), (2H, dm, POCfuCH3), (2H, m, ArH ), (2H, q, ArH ), (2H, 
dd, ArH), (2H, s, br, NH); 13C NMR (100 MHz, CDCl3) 8c 16.19 (d, 1p=13.6 Hz, 
POCH2,C.H3), 16.57 (d, 21p=210 Hz, P.C.H3), 47.86 (s, C(O).C.H2), 61.16 (d, 31p=12.6 
Hz, PO.C.H2CH3), 116.8 (d, 1p=238 Hz, ArC_(2)P), 121.26 (d, 1p=17.3 Hz, ArC_3), 
123.35 (d, 1p=24.5 Hz, ArArC_4), 131.41 (d, 1p=18 Hz, Are_5), 133.65 (d, 1=4 Hz, 
ArC6), 142.71 (d, 1p=11.6 Hz, N-C.Ar), 164.92 (s, C=O); rnlz (ESMS -) 466 (100%, M-
H+), IR Vmax 3460, 3250, 2980, 1685 (C=O), 1610, 1580, 1520, 1440, 1290, 1180, 
1020, 950, 880, 790, 760,490 cm-1. 
N-Tosyl- P-methyl-o-aminophenylphosphinate (116) 
0=~ 
CCNH p-OEt 
/~ 
Me 0 
The amine (112) (0.91 g, 4.56 mmol) was stirred in pyridine (20 ml) and tosyl chloride 
(1.83 g, 9.6 mmol) was added. The solution was strried at room temperature for 18 h 
then poured over crushed ice. The aqueous mixture was extracted with CH2Cl2 (3 x 40 
ml) and the combined organic extracts were washed with Na2C03 (10%, 40 ml) and 
water (3 x 30 ml), and dried over Na2S04. The solvent was removed under reduced 
pressure to give a pale orange oil (1.01 g, 63%); 31p NMR (CDCl3) 8p 48.21; Iu 
NMR (250.13 MHz, CDCl3) DH 1.27 (3H, t, 31=7.1 Hz, POCH~H3), 1.51 (3H, d, 
21=15.1 Hz, PCfu), 2.43 (3H, s, TsCH3), 3.60 (lH, m, POCH2CH3), 3.93 (lH, m, 
POCH2CH3), (2H, m, ArH ), 7.29 (2H, d, 1=8.2 Hz, TsH), 7.82 (2H, d, 1=8.2 Hz, Ts.H), 
(2H, m, ArH), 10.94 (lH, s, N!!); 13C NMR (62.9 MHz, CDCl3) 8c 16.46 (d, 1=4.8 
Hz, POCH~H3), 16.69 (d, 1p=106 Hz, P.C.H3), 21.75 (s, TsCH3), 61.38 (d, 31p=5.7 Hz, 
PO.C.H2CH3), 117.53 (d, 1=119.6 Hz, Ar), 120.92 (d, 1=8.6 Hz, Ar), 124.37 (d, 1=11.9 
Hz, Ar), 127.77 (s, Ts), 129.85 (s, Ts), 132.34 (d, 1=9.1 Hz, Ar), 134.24 (s, Ts), 136.77 
(s, Ar), 142.82 (d, 1=4.3 Hz, Ar), 144.17 (s, Ts); m/z (ESMS+, CH30H) 353.96 (100%, 
MH+); IR Vmax 3000, 1600, 1580, 1500, 1350, 1160, 1100, 1040, 970-900, 820-710, 
660, 560,490 cm-1. 
Diethyl-1,10-phenanthroline-2,9-bis[methylene(methylphosphinate)P (117) 
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The title compound was prepared using a modified literature procedure. 3 
Diethylmethylphosphonite (5.0 g, 36 mmol) and one drop of triethylamine were added 
to a suspension of2,9-dibromo-1,10-phenanthroline (4.5 g, 12 mmol) in dry acetonitrile 
(120 ml). The mixture was stirred for 2 h at room temperature, resulting in a dark 
brown solution which was heated at 80°C for 18 h to give a golden coloured solution. 
The solvent was removed under reduced pressure and the residue was purified by 
chromatography on alumina with gradient elution (dichloromethane to 1.5% methanol) 
to give a crystalline solid (3.5 g, 70%); 31p NMR (CDCl3) &> 51.24; tu NMR (250.13 
MHz, CDCl3) OH 1.28 (6H, t, 3J=7 Hz, POCH2CH3), 1.61 (6H, d, 2J=14 Hz, PCfu), 
3.76 (4H, d, 2J=18 Hz, PCH2N), 4.10 (4H, qnt, J=7 Hz, POCfuCH3), 7.65 (2H, dd, 
4Jp=l.64, 3JH=8.3 Hz, ArH(3), H(8)), 7.76 (2H, s, ArH(5), H(6)), 8.20 (2H, d, J=8.4 
Hz, ArH(4), H(7)); 13C NMR (62.9 MHz, CDCl3) oc 14.51 (d, Jp=96 Hz, P.CH3), 
17.27 (s, POCH£,H3), 42.03 (d, 1Jp=84 Hz, AI"CH2P), 61.25 (d, J=6 Hz, PO.CH2CH3), 
124.88 (Ar-C3), 126.74 (Ar-C5), 128.08 (Ar-C4a), 137.52 (Ar-C4), 146.08 (Ar-C10b), 
154.40 (d, 2Jp= 6, Ar-C2); m/z (DCO 421 (100%, MH+); IR Vmax 3758, 3436 br, 2986, 
2928, 2864, 2366, 2340 s, 1565, 1504, 1370, 1302, 1206, 1040,964, 864, 670 cm-1. 
1,10-Phenanthroline-2,9-diylmethylenebis(methylphosphinic acid) (121) 
~0 7-oH 
Me 
The diester (117) (1.0 g, 2.4 mmol) was heated under reflux in HCl (6M) for 20 has 
described previously. 3 The solvent was removed under reduced pressure to give a 
yellow glassy solid in quantitative yield (0.96 g); 31p NMR (D20) op 46.37; tu NMR 
(250.13 MHz, D20) OH 1.47 (6H, d, 2J=14 Hz, PCH3), 3.71 (4H, d, 2J=17 Hz, PCH2N), 
7.43 (2H, s, ArH(3), H(8)), 7.66 (2H, d, J=8 Hz, ArH(5), H(6)), 8.26 (2H, d, J=8.5 Hz, 
ArH(4), H(7)); nc NMR (62.9 MHz, D20) oc 17.44 (d, Jp=95 Hz, P.CH3), 41.75 (d, 
1 Jp=75.4 Hz, ArC.H2P), 125.1 (Ar-C3), 129.34 (Ar-C5), 130.69 (Ar-C4a), 139.33 (Ar-
C4), 144.66 (Ar-C10b), 156.20 (d, 2Jp= 8Hz, Ar-C2). 
6.3 Radiolabelling 
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Technetium Radiolabelling procedures 
General 
Pertechnetate-99m was eluted from an Amertec generator using saline solution. 
activities were measured on a Capintec CRC-15R ion chamber. HPLC analysis was 
carried out using Gilson Gradient HPLC with a Gilson UV detector and a gamma 
detector with a C18 reversed phase column with gradient elution of 100% water (0.1% 
TFA) to 100% acetonitrile (0.1% TFA) at a flow rate of lml min-1. Gilson 715 software 
was used to analyse the HPLC chromatograms. TLC was carried out using three 
different systems simultaneously: (1) silica gel paper in MEK (methylethylketone) (2) 
silica gel paper in saline (3) Watman no.l paper in 50:50 acetonitrile:water, and the 
results scanned on a Packard Instantlmager. 
99mTc Complex preparation 
A solution of ligand (48) (100 ~1 of 5 mg ml-1) in methanol was placed in a sealed 
sample vial together with NaOH solution (20 ~1, 1M), saline (1 ml) and 
99mpertechnetate (1 ml, 0.4 GBq ml-1). To this was added a solution of stannous 
chloride in saline (10 ~g. 0.1 ml). The preparation was pH6 and 0.345 GBq and was left 
to stand for 30 min prior to TLC analysis and HPLC injection. 
The above procedure was carried out using NaOH (0.1 M) raising the pH of the 
preparation to 8. 
Preparations of ligands (64)-(66) with technetium-99m were carried out in an analogous 
manner to that described above, at pH 8. 
Copper Radiolabelling procedures 
General 
HPLC analysis was carried out using a Thermo Separation Products Spectral System 
P2000 equipt with a 50~1 injection loop, a Bioscan gamma-detector and a 
Spectrasystem UV2000 UV detector. 
Production of64CuiS 
No carrier added (NCA) 64cu was produced by the 64Ni(d, 2n)64Cu reaction on 96% 
enriched 64Ni. Approximately 50 mg enriched 64Ni metal powder was pressed into a 10 
mm diameter disc. Once assembled inside an aluminium target holder, the nickel pellet 
was irradiated with a beam of deuterons (16.5 MeV) from the MC-40 Cyclotron at the 
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Hammersmith Hospital. Mter bombardment the target was allowed to cool for several 
hours prior to chemical processing. The target was dissolved in a small volume of 
hydrochloric acid (7M) and a few drops of aqueous hydrogen peroxide with heating. 
The solution was concentrated at 60°C, redissolved in hydrochloric acid (7M) and 
loaded onto an anion exchange column (AG-1 x 8 resin, 100-200 mesh) of 3 em x 1.1 
em diameter, preconditioned with HCI solution (7M). Elution of the column with 
hydrochloric acid (7M) removed the nickel(ll) and trace amounts of cobalt(lll) isotopes 
was followed by elution with water to elute the 64-copper(ll) which was concentrated 
under reduced pressure and taken up into fresh water (2.5 ml). The initial concentration 
of the stock solution of copper-64 was 450 MBq ml-1 decaying to 9.6 MBq ml-1 due to 
the decay (T 112=12. 7 h) of the radionuclide. 
Preparation of 64Cu-ligand complexes 
Initial preparations of copper-64 radiolabelled complex were undertaken using ligand 
(48) (0.7 mg) dissolved in pure water (20 ~)and NaOH (1M, 20 j.!l). This was added to 
a solution of 64CuC12 (20 ~.from the stock prepared above) and sodium acetate (3M, 
20 jll) (pH of the 64cuC12 solution pH 5.5) and mixed thoroughly with a vortex mixer. 
For HPLC-analysed preparations, typically, a solution of ligand ( 48) in methanol (20 Ill 
of a 5-10 mg mt-1 ) was mixed thoroughly by vortex mixing with a solution of the stock 
solution of activity (20-60 j.!l) (depending upon the radioactive concentration of the 
sample as it decayed). The pure radiolabelled species was collected as it eluted from the 
HPLC system. Slight variations in the amount of activity (MBq) and the quantity of 
ligand used for each radiotracer preparation were found to have no effect upon complex 
formation. The control for HPLC analysis was the analysis of the 64CuC12 stock 
solution (20 j.!l in 40 ~ water). 
Radiolabelling of ligands (64)-(66) was carried out in a similar manner described 
above, using water to dissolve ligands (65) and (66), and methanol for ligand (64). 
The dimethylthiophosphoryldihydrazide ligand (84) (15 mg mi- 1 in acetonitrile) 
showed no evidence of radio labelling with 60 .Ill of the stock solution of aqueous 
64CuC12. Successful radiolabelling was achieved when the ligand solution (60 jll, 15 
mg ml-1 in acetonitrile) was treated with 20 j.!l triethylamine and mixed for 0.5 minutes 
with a vortex mixer prior to the addition of 60 j.!l of the aqueous 64CuCl2 solution. This 
was mixed with a vortex mixer and analysed immediately by HPLC. 
A solution of ligand (85) (5 mg ml-1 in acetonitrile) was attempted under the conditions 
described for (84), but showed no radiolabellling. 
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Lipophilicity measurements 
Typically, a 10 J..Ll solution of each radiolabelled complex was added to a 
microcentrifuge tube containing 0.5 ml water and 0.5 ml octanol. A vortex mixer was 
used to mix the contents of the tube thoroughly for 2 minutes and centrifugation for 5 
minutes (1000 rpm) ensured complete separation of the two layers. A portion of 200 J..Ll 
from each layer was carefully removed and its radioactivity was counted using an LKB 
Wallac automatic gamma-counter. Each radiotracer was partitioned in duplicate. 
Samples were taken from the reaction mixture directly or from the HPLC-purified 
complex which had been evaporated to near dryness and taken up into fresh solvent 
(usually water). 
Plasma-Protein Binding Studies 
Whole human blood was centrifuged for 5 minutes (4000 rpm) to separate the plasma 
and the blood elements. A sample of the radiolabelled complex (typically 50 J..Ll and 0.5-
2 MBq) was added to a sample of 0.5 ml serum, 'vortexed' for 2 minutes and incubated 
at 3TC for 1 h. The sample was loaded onto a POlO column (Sephadex 025, 
Pharmacia UK) pre-equilibrated with 5 ml phosphate buffered saline (PBS) (pH 7 .4, 
physiological saline) and preconditioned with 0.5 ml human serum albumin (2 mg ml-1) 
followed by more PBS. The column was eluted with the same PBS solution and around 
fifteen fractions of 0.5 ml were collected andy-counted. 
Partitioning of 64Cu-Complexes Between Plasma and Red Blood Cells 
Typically, 64Cu(48) (ca. 0.5 MBq) (200 J..Ll) was added to human blood (2 ml) in a 
microcentrifuge tube. The contents of the tube were mixed thoroughly by a vortex 
mixer and aliquots of 250 J..Ll were incubated at 3TC. Samples were removed after 10, 
15, 30 and 60 minutes in duplicate and were centrifuged for 5 minutes (1000 rpm) to 
separate the blood samples into two layers of plasma and red blood cells. The plasma 
was withdrawn and placed in a counting tube and PBS (pH 7.4) was used to transfer the 
thick blood elements into a separate counting tube. 
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Experimental 
Appendices 
Experimental for X-ray crystal structures ( 43), (84), 
(85) and (86) 
X-Ray diffraction experiments were carried out on a Siemens SMART 3-circle 
diffractometer with a CCD area detector, using graphite-monochromated Mo-Ka 
radiation (A=0.71073 A) and a Cryostream open-flow cryostat. Data were collected by 
scanning over a full hemisphere of reciprocal space in frames of 0.3° ro and corrected 
for absorption by a semi-empirical method based on Laue equivalents of strong 
reflections. The data for (43) was corrected for absorption errors using SADABS. 1 
Structures (84), (85) and (86) were solved by direct methods and refined by full martix 
least squares against F2 of all data, using SHELXTL software.2 All non-H atoms were 
refined with anisotropic displacement parameters, all H atoms were located from 
difference Fourier map and refined in isotropic approximation. Atomic coordinates and 
displacement parameters, bond distances and angles have been deposited at the 
Cambridge Crystallographic Data Centre. 
1. G.M. Sheldrick, SADABS 1996, Program for the correction of Area Detector 
data, University of Gottingen, Germany. 
2. G.M. Sheldrick, SHELXTL Version 5NMS, 1995, Analytical X-Ray Systems 
GmbH, Madison, WI, USA. 
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Appendix B X-ray crystal structure ( 43) 
Table 1. Crystal data and structure refinement for (43). 
Empirical formula 
Formula weight 
C16 H22 N2 06.50 P2 
408.30 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Number of reflexions used 
150(2) K 
.71073 A 
Monoclinic 
P2tlc 
a = 7 .590(2) A 
b = 23.469(5) A 
c= 11.312(3)A 
2012.4(1) A3 
4 
16056 
4599 
alpha = 90 deg. 
beta= 92.91(2) deg. 
gamma = 90 deg. 
Total 
Unique 
Observed 2847 [Fo > 4.sigma(Fo)] 
Crystal description Plate 
Crystal colour Pale Yell ow 
Density (calculated) 1.348 glcm3 
Absorption coefficient 0.252 mm-1 
F(OOO) 856 
Crystal size 0.40 x 0.20 x 0.20 mm 
Theta range for data collection 1. 7 4 to 27.48 de g. 
Index ranges -9<=h<=8, -27<=k<=30, -14<=1<=14 
Experiment device Siemens SMART -CCD 
Experiment methods Omega scans 
Reflections collected 15808 
Independent reflections 4599 [R(int) = 0.0867] 
Refinement method Full-matrix least-squares on F2 
Data I restraints I parameters 4593 I 0 I 317 
Goodness-of-fit on F''2 1.062 
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Final R indices [I>2sigma(I)] R1 = 0.0621, wR2 = 0.1418 
R indices (all data) R1 = 0.1180, wR2 = 0.1794 
Largest diff. peak and hole 0.756 and -0.617 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(A2 x 103) for (43). Ueq is defined as one third of the trace of the orthogonalized Uij 
tensor. 
X y z Ueq 
P(l) 2596(1) 5910(1) 1218(1) 18(1) 
P(2) -7372(1) 4108(1) 1264(1) 18(1) 
0(1) 3907(3) 5631(1) 2089(2) 24(1) 
0(2) 2290(3) 5659(1) 10(2) 25(1) 
0(3) -8488(3) 4436(1) 2103(2) 24(1) 
0(4) -7262(3) 4309(1) 13(2) 25(1) 
N(l) -525(4) 5373(1) 1741(3) 17(1) 
N(2) -4180(4) 4656(1) 1768(3) 18(1) 
C(l) 455(5) 5925(2) 1896(4) 20(1) 
C(2) -1842(5) 5306(2) 2674(3) 22(1) 
C(3) -2698(5) 4725(2) 2682(3) 21(1) 
C(4) -5121(5) 4101(2) 1929(3) 20(1) 
C(11) 3101(5) 6661(2) 1125(3) 19(1) 
C(12) 2463(5) 6981(2) 148(4) 24(1) 
C(13) 2790(6) 7559(2) 92(4) 31(1) 
C(14) 3726(6) 7832(2) 1017(4) 32(1) 
C(15) 4355(6) 7521(2) 1997(4) 31(1) 
C(16) 4057(5) 6940(2) 2053(3) 24(1) 
C(21) -7954(5) 3362(2) 1319(3) 20(1) 
C(22) -7425(5) 2995(2) 431(3) 24(1) 
C(23) -7785(6) 2414(2) 494(4) 30(1) 
C(24) -8682(6) 2203(2) 1445(4) 35(1) 
C(25) -9235(6) 2566(2) 2318(4) 31(1) 
C(26) -8869(5) 3145(2) 2258(4) 26(1) 
0(1S) 4253(5) 5755(2) 4498(3) 55(1) 
0(2S) -7477(5) 4636(2) 4428(3) 64(1) 
0(3S) 591(16) 6057(5) 5003(10) 104(3) 
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Table 3. Selected Intermolecular bond lengths [A] and angles [deg] for (43). 
Distance O .. H 
1.827 (0.046) 03- H2N_$1 
1.800 (0.055) 04- H1N_$2 
1.842 (0.054) 01 - H3N_$3 
2.518 (0.041) 01- H2B_$3 
Distance O .. N 
2.708 (0.004) 03- N1_$1 
2.641 (0.004) 04- N1_$2 
2.742 (0.004) 01- N2_$3 
Distance O .. C 
3.349 (0.005) 01- C2_$3 
AngleXHY 
165.50 ( 3.92) 03- H2N_$1- N1_$1 
142.90 ( 4.58) 04- H1N_$2- N1_$2 
166.25 ( 4.66) 01- H3N_$3- N2_$3 
137.21 ( 2.86) 01 - H2B_$3- C2_$3 
Symmetry transformations used to generate equivalent atoms: 
$1: X-1, Y, Z 
$2: -X-1, -Y+1, -Z 
$3: X+1, Y, Z 
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Table 4. Bond lengths [A] and angles [deg] for (43). 
P(l)-0(2) 
P(1)-0(1) 
P(l)-C(11) 
P(l)-C(l) 
P(2)-0(4) 
P(2)-0(3) 
P(2)-C(21) 
P(2)-C(4) 
N(l)-C(2) 
N(1)-C(l) 
N(l)-H(2N) 
N(l)-H(lN) 
N(2)-C(3) 
N(2)-C(4) 
N(2)-H(3N) 
N(2)-H(4N) 
C(l)-H(lA) 
C(1)-H(1B) 
C(2)-C(3) 
C(2)-H(2B) 
C(2)-H(2A) 
C(3)-H(3A) 
C(3)-H(3B) 
C(4)-H(4B) 
C(4)-H(4A) 
C(l1)-C(12) 
C( 11 )-C( 16) 
C(l2)-C(13) 
C(l2)-H(l2) 
C(13)-C(14) 
C(l3)-H(13) 
C( 14 )-C( 15) 
C(14)-H(14) 
C( 15)-C( 16) 
C(15)-H(15) 
C( 16)-H( 16) 
C(21)-C(26) 
C(21 )-C(22) 
C(22)-C(23) 
C(22)-H(22) 
C(23 )-C(24) 
C(23)-H(23) 
C(24 )-C(25) 
C(24)-H(24) 
C(25)-C(26) 
C(25)-H(25) 
C(26)-H(26) 
0(2)-P( 1 )-0( 1) 
0(2)-P(l)-C(l1) 
0(1)-P( 1)-C(11) 
0(2)-P(l)-C(1) 
0(1)-P( 1)-C(l) 
C(11)-P(1)-C(1) 
0( 4)-P(2)-0(3) 
0(4)-P(2)-C(21) 
0(3)-P(2)-C(21) 
1.495(3) 
1.514(3) 
1.807(4) 
1.832(4) 
1.499(3) 
1.514(3) 
1.807(4) 
1.831(4) 
1.498(5) 
1.499(5) 
0.90(5) 
0.97(5) 
1.497(5) 
1.502(5) 
0.92(5) 
0.95(4) 
1.00(4) 
0.99(4) 
1.511(5) 
1.03(4) 
1.02(5) 
1.02(4) 
0.99(5) 
1.00(4) 
0.96(4) 
1.403(5) 
1.407(5) 
1.381(6) 
0.99(4) 
1.391(6) 
0.89(4) 
1.392(6) 
0.93(5) 
1.384(6) 
0.95(4) 
1.01(4) 
1.395(5) 
1.398(5) 
1.392(6) 
1.00(4) 
1.394(6) 
0.99(4) 
1.385(6) 
0.99(5) 
1.389(6) 
0.94(4) 
1.00(4) 
119.4(2) 
110.8(2) 
109.0(2) 
106.9(2) 
107.6(2) 
101.6(2) 
119.4(2) 
111.3(2) 
109.0(2) 
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0(4)-P(2)-C(4) 
0(3)-P(2)-C(4) 
C(21)-P(2)-C(4) 
C(2)-N( 1 )-C( 1) 
C(2)-N(l)-H(2N) 
C( 1 )-N( 1 )-H(2N) 
C(2)-N(l)-H(1N) 
C(1)-N(l)-H(1N) 
H(2N)-N(1)-H(1N) 
C(3)-N(2)-C(4) 
C(3)-N(2)-H(3N) 
C(4)-N(2)-H(3N) 
C(3)-N(2)-H(4N) 
C(4)-N(2)-H(4N) 
H(3N)-N(2)-H(4N) 
N(1)-C(1)-P( 1) 
N(1)-C(1)-H(1J\) 
P(l)-C(l)-H(li\) 
N(l)-C(l)-H(lB) 
P(1)-C(l)-H(1B) 
H(li\)-C(l)-H(lB) 
N ( 1 )-C(2 )-C(3) 
N(1)-C(2)-H(2B) 
C(3)-C(2)-H(2B) 
N(1)-C(2)-H(2J\) 
C(3 )-C(2 )-H(2J\) 
H(2B )-C(2)-H(2J\) 
N(2)-C(3)-C(2) 
N(2)-C(3)-H(3J\) 
C(2 )-C(3 )-H(3J\) 
N(2)-C(3)-H(3B) 
C(2)-C(3)-H(3B) 
H(3J\)-C(3)-H(3B) 
N(2)-C( 4)-P(2) 
N(2)-C(4)-H(4B) 
P(2)-C(4)-H(4B) 
N(2)-C(4)-H(4J\) 
P(2)-C(4)-H(4J\) 
H(4B)-C(4)-H(4J\) 
C(l2)-C(11)-C(l6) 
C(12)-C(11)-P(l) 
C(16)-C(11)-P(1) 
C(13)-C(12)-C(11) 
C( 13)-C(12)-H(12) 
C(11)-C(12)-H(l2) 
C(12)-C( 13)-C( 14) 
C(12)-C(13)-H(13) 
C( 14)-C( 13)-H(13) 
C( 13)-C( 14 )-C( 15) 
C( 13 )-C(14 )-H(14) 
C( 15)-C( 14 )-H( 14) 
C( 16)-C( 15)-C( 14) 
C(16)-C(15)-H(15) 
C(14)-C(15)-H(15) 
C(15)-C(16)-C(11) 
C( 15)-C( 16)-H( 16) 
C(11)-C(16)-H(16) 
C(26)-C(21 )-C(22) 
C(26)-C(21 )-P(2) 
C(22 )-C(21 )-P(2) 
107.2(2) 
106.7(2) 
101.7(2) 
110.7(3) 
109(3) 
115(3) 
112(3) 
109(3) 
100(4) 
110.8(3) 
108(3) 
118(3) 
108(3) 
109(3) 
102(4) 
112.3(2) 
109(2) 
110(2) 
110(3) 
111 (3) 
106(3) 
113.7(3) 
109(2) 
109(2) 
109(3) 
106(3) 
110(3) 
113.7(3) 
109(2) 
102(2) 
109(3) 
112(3) 
112(4) 
112.5(2) 
109(2) 
109(2) 
106(3) 
112(3) 
109(3) 
118.9(3) 
120.1(3) 
120.9(3) 
120.4(4) 
121(2) 
118(2) 
120.3(4) 
121(3) 
118(3) 
120.0(4) 
120(3) 
120(3) 
120.2(4) 
121(3) 
119(3) 
120.3(4) 
121(2) 
118(2) 
119.6(4) 
120.8(3) 
119.5(3) 
Appendices 
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C(23 )-C(22)-C(21) 
C(23)-C(22)-H(22) 
C(21)-C(22)-H(22) 
C(22)-C(23 )-C(24) 
C(22)-C(23)-H(23) 
C(24 )-C(23 )-H(23) 
C(25)-C(24 )-C(23) 
C(25)-C(24 )-H(24) 
C(23 )-C(24 )-H(24) 
C(24 )-C(25)-C(26) 
C(24 )-C(25)-H(25) 
C(26)-C(25)-H(25) 
C(25)-C(26)-C(21) 
C(25)-C(26)-H(26) 
C(21 )-C(26)-H(26) 
120.2(4) 
120(2) 
120(2) 
119.5(4) 
121(3) 
120(3) 
120.6(4) 
125(3) 
115(3) 
119.9(4) 
121(3) 
119(3) 
120.2(4) 
120(3) 
120(3) 
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Table 5. Anisotropic displacement parameters (A2 x 103) for (43). The anisotropic 
displacement factor exponent takes the form: -2 n2 [h2 a *2 U 11 + ... + 2 h k a * b * U 12 ] 
Ull U22 U33 U23 U13 U12 
P(l) 13(1) 18(1) 23(1) -2(1) 3(1) -1(1) 
P(2) 13(1) -18(1) 23(1) 2(1) -1(1) 0(1) 
0(1) 19(1) 22(1) 30(1) 1(1) 0(1) 3(1) 
0(2) 21(1) 29(2) 25(1) -4(1) 5(1) - -3(1) 
0(3) 18(1) 25(2) 29(2) -1(1) 0(1) 4(1) 
0(4) 21(1) 27(2) 26(1) 6(1) -2(1) -2(1) 
N(l) 16(2) 16(2) 20(2) -1(1) 3(1) 0(1) 
N(2) 14(2) 18(2) 20(2) 2(1) 1(1) -1(1) 
C(l) 15(2) 16(2) 30(2) -3(2) 4(2) 0(1) 
C(2) 17(2) 28(2) 21(2) -6(2) 6(2) -4(2) 
C(3) 16(2) 28(2) 20(2) 0(2) -1(2) -4(2) 
C(4) 17(2) 15(2) 27(2) 1(2) 1(2) -1(2) 
C(11) 15(2) 17(2) 25(2) -3(2) 3(1) -3(1) 
C(12) 19(2) 25(2) 29(2) 1(2) -2(2) -3(2) 
C(13) 29(2) 27(2) 35(2) 9(2) -1(2) -1(2) 
C(14) 30(2) 18(2) 46(3) 2(2) 1(2) -7(2) 
C(15) 34(2) 27(2) 31(2) -7(2) -4(2) -7(2) 
C(16) 25(2) 24(2) 25(2) 0(2) -3(2) -3(2) 
C(21) 13(2) 21(2) 25(2) 1(2) -4(1) -2(1) 
C(22) 21(2) 25(2) 25(2) -1(2) -1(2) -4(2) 
C(23) 32(2) 25(2) 33(2) -3(2) -4(2) -4(2) 
C(24) 36(3) 25(2) 42(3) 3(2) -7(2) -11(2) 
C(25) 32(2) 31(2) 30(2) 9(2) 0(2) -9(2) 
C(26) 22(2) 29(2) 28(2) 1(2) 1(2) -4(2) 
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Table 6. Hydrogen coordinates (X 104) and isotropic displacement parameters cA3 X 
103) for (43). 
X y z U(eq) 
H(3N) -4835(74) 4985(21) 1746(44) 50(15) 
H(16) 4515(53) 6707(17) 2749(34) 22(10) 
H(lA) -287(55) 6236(17) 1530(34) 23(11) 
H(2N) 155(61) 5059(18) 1727(36) 28(11) 
H(12) 1769(58) 6781(18) -495(36) 30(11) 
H(3A) -3202(56) 4714(18) 3502(37) 28(11) 
H(14) 3911(60) 8225(21) 988(38) 36(12) 
H(22) -6772(51) 3146(16) -247(32) 17(10) 
H(2B) -2814(53) 5610(17) 2553(33) 19(10) 
H(25) -9827(56) 2424(17) 2968(37) 27(11) 
H(2A) -1220(60) 5351(19) 3491(40) 37(12) 
H(23) -7390(58) 2149(19) -116(38) 33(12) 
H(1B) 604(59) 6022(18) 2749(39) 34(12) 
H(15) 5016(59) 7709(19) 2611(37) 31(12) 
H(3B) -1839(61) 4417(20) 2578(38) 35(12) 
H(l3) 2350(59) 7770(19) -506(38) 32(12) 
H(4B) -5178(47) 4018(15) 2790(33) 13(9) 
H(26) -9294(61) 3405(19) 2879(39) 34(12) 
H(4A) -4401(58) 3818(18) 1584(36) 29(11) 
H(4N) -3689(57) 4656(18) 1010(38) 29(11) 
H(24) -8860(61) 1786(21) 1438(39) 41(13) 
H(lN) -1071(71) 5360(22) 945(47) 55(15) 
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Appendix C X-ray crystal structure (84) 
Table 1. Crystal data and structure refinement for (84). 
Empirical formula --- C18 H24 N4 P2 S2 
Formula weight 422.47 
Temperature 150(2) K 
Wavelength 0.71073 A 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a= 9.588(1) Ao alpha= 69.43(1) deg. 
b = 11.402(1) {\ beta= 87.11(1) deg. 
c = 11.620(1) A gamma= 69.74(1) deg. 
Volume 1112.1(2) A3 
z 2 
Density (calculated) 1.262 glcm3 
Absorption coefficient 0.393 mm-1 
F(OOO) 444 
Crystal size 0.5 x 0.5 x 0.3 mm 
Crystal colour- pale yellow 
Theta range for data collection 1.88 to 25.52 deg. 
Index ranges -11<h<11, -7<k<l3, -11<1<13 
Reflections collected 4911 
Independent reflections 3567 [R(int) = 0.0270] 
Observed reflections I> 2sigma(l) 3 319 
Absorption correction Semi-empirical (equivalents) 
Max. and min. transmission 0.906 and 0.828 
Refinement method Full-matrix least-squares on f2 
Data I restraints I parameters 3545 I 0 I 332 
Goodness-of-fit on F2 1.054 
Final R indices [1>2sigma(l)] R1 = 0.0324, wR2 = 0.0846 
R indices (all data) R1 = 0.0354, wR2 = 0.0944 
Extinction coefficient 0.010(2) 
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Largest shift/e.s.d. ratio -0.006 
Largest diff. peak and hole 0.264 and -0.300 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x 103) for (84). U(eq) is defined 
as one third of the trace of the orthogonalized U ij tensor. 
X y z U(eq) 
P(l) 6937(1) 7056(1) 3556(1) 27(1) 
P(2) 2389(1) 8494(1) 5837(1) 28(1) 
S(l) 6134(1) 8943(1) 2571(1) 42(1) 
S(2) 1323(1) 7654(1) 5189(1) 40(1) 
N(l) 7176(2) 5633(2) 5935(1) 29(1) 
N(2) 6933(2) 6879(2) 5054(2) 37(1) 
N(3) 4993(2) 7602(2) 7132(1) 28(1) 
N(4) 4029(2) 7301(2) 6535(2) 32(1) 
C(l) 6925(2) 5554(2) 7057(2) 25(1) 
C(2) 6348(2) 6770(2) 7423(2) 25(1) 
C(3) 5894(4) 6085(3) 3401(3) 56(1) 
C(4) 8820(3) 6182(3) 3352(3) 61(1) 
C(5) 1500(2) 9142(2) 6980(2) 35(1) 
C(6) 2823(3) 9844(2) 4719(2) 41(1) 
C(11) 7129(2) 4223(2) 7996(2) 24(1) 
C(12) 7776(2) 3057(2) 7727(2) 29(1) 
C(13) 7859(2) 1828(2) 8584(2) 36(1) 
C(14) 7303(3) 1739(2) 9725(2) 39(1) 
C(15) 6673(2) 2882(2) 10007(2) 35(1) 
C(16) 6587(2) 4119(2) 9153(2) 29(1) 
C(21) 7366(2) 7009(2) 8163(2) . 26(1) 
C(22) 8900(2) 6386(2) 8197(2) 37(1) 
C(23) 9859(3) 6573(2) 8916(2) 43(1) 
C(24) 9301(3) 7379(2) 9601(2) 41(1) 
C(25) 7785(3) 8007(2) 9568(2) 41(1) 
C(26) 6809(2) 7830(2) 8854(2) 34(1) 
Table 3. Bond lengths [A] and angles [deg] for (84). 
P(l)-N(2) 
P(1)-C(3) 
P(1)-C(4) 
P(l)-S(1) 
P(2)-N(4) 
P(2)-C(5) 
P(2)-C(6) 
P(2)-S(2) 
N(l)-C(l) 
N(l)-N(2) 
N(3)-C(2) 
1.680(2) 
1.784(2) 
1.785(3) 
1.9346(8) 
1.689(2) 
1.782(2) 
1.794(2) 
1.9469(7) 
1.292(2) 
1.376(2) 
1.291(2) 
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N(3)-N(4) 
C(l)-C(ll) 
C(l)-C(2) 
C(2)-C(21) 
C(ll)-C(16) 
C(ll)-C(12) 
C(l2)-C(13) 
C(l3)-C(14) 
C( 14 )-C(15) 
C( 15)-C( 16) 
C(21)-C(22) 
C(21 )-C(26) 
C(22)-C(23) 
C(23)-C(24) 
C(24 )-C(25) 
C(25)-C(26) 
N(2)-P(1)-C(3) 
N(2)-P(l)-C(4) 
C(3)-P(l)-C(4) 
N(2)-P(l)-S(l) 
C(3)-P(l)-S(1) 
C(4)-P(l)-S(1) 
N(4)-P(2)-C(5) 
N(4)-P(2)-C(6) 
C(5)-P(2)-C(6) 
N(4)-P(2)-S(2) 
C(5)-P(2)-S(2) 
C( 6)-P(2)-S(2) 
C(1)-N(1)-N(2) 
N(l)-N(2)-P(l) 
C(2)-N(3)-N(4) 
N(3)-N(4)-P(2) 
N ( 1 )-C(l )-C(11) 
N(l)-C(l)-C(2) 
C( 11 )-C( 1 )-C(2) 
N(3)-C(2)-C(21) 
N(3)-C(2)-C(l) 
C(21 )-C(2 )-C( 1) 
C(16)-C(11)-C(12) 
C(16)-C(11)-C(l) 
C(12 )-C( 11 )-C( 1) 
C(l3)-C(12)-C(11) 
C(12)-C(13)-C( 14) 
C( 15)-C( 14 )-C( 13) 
C( 14 )-C( 15)-C( 16) 
C( 15)-C( 16)-C( 11) 
C(22)-C(21 )-C(26) 
C(22)-C(21 )-C(2) 
C(26)-C(21 )-C(2) 
C(23 )-C(22 )-C(21) 
C(24 )-C(23 )-C(22) 
C(25)-C(24 )-C(23) 
C(24 )-C(25)-C(26) 
C(25)-C(26)-C(21) 
1.380(2) 
1.478(3) 
1.506(2) 
1.483(3) 
1.397(3) 
1.397(3) 
1.383(3) 
1.387(3) 
1.381(3) 
1.387(3) 
1.390(3) 
1.394(3) 
1.388(3) 
1.377(3) 
1.376(3) 
1.390(3) 
104.85(13) 
105.03(12) 
105.6(2) 
108.72(7) 
115.42(9) 
116.21(11) 
105.77(10) 
106.82(10) 
104.97(11) 
107.18(6) 
115.52(8) 
115.86(9) 
118.1(2) 
119.30(13) 
117.9(2) 
119.89(13) 
118.2(2) 
122.5(2) 
119.2(2) 
118.8(2) 
122.4(2) 
118.8(2) 
118.7(2) 
120.0(2) 
121.2(2) 
120.5(2) 
120.2(2) 
119.8(2) 
120.3(2) 
120.4(2) 
119.0(2) 
119.9(2) 
121.0(2) 
120.3(2) 
120.4(2) 
119.8(2) 
120.6(2) 
120.0(2) 
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Table 4. Anisotropic displacement parameters (A2 x 103) for (84). 
The anisotropic displacement factor exponent takes the form: 
-2 n2 [ h2 a*2 U 11 + ... + 2 h k a* b* U 12] 
U11 U22 U33 U23 U13 U12 
P(l) 30(1) 26(1) 24(1) -8(1) 2(1) -10(1) 
P(2) 30(1) 24(1) 26(1) -9(1) -1(1) -6(1) 
S(l) 62(1) 27(1) 31(1) -4(1) 5(1) -14(1) 
S(2) 42(1) 35(1) 43(1) -18(1) -10(1) -9(1) 
N(l) 35(1) 24(1) 25(1) -5(1) 4(1) -11(1) 
N(2) 60(1) 23(1) 25(1) -8(1) 10(1) -14(1) 
N(3) 31(1) 27(1) 27(1) -9(1) 1(1) -10(1) 
N(4) 32(1) 26(1) 39(1) -17(1) -7(1) -4(1) 
C(l) 24(1) 25(1) 24(1) -8(1) 2(1) -9(1) 
C(2) 29(1) 24(1) 22(1) -6(1) 5(1) -10( 1) 
C(3) 74(2) 40(1) 55(2) -5(1) -26(1) -28(1) 
C(4) 44(2) 66(2) 44(2) -8(1) 15(1) 2(1) 
C(5) 35(1) 33(1) 31(1) -13(1) 1(1) -6(1) 
C(6) 45(1) 31(1) 37(1) -4(1) 6(1) -10(1) 
C(11) 21(1) 26(1) 26(1) -8(1) 0(1) -9(1) 
C(12) 32(1) 29(1) 28(1) -11(1) 5(1) -11(1) 
C(13) 46(1) 24(1) 37(1) -11(1) 2(1) -12(1) 
C(14) 50(1) 30(1) 33(1) -1(1) 1(1) -20(1) 
C(15) 38(1) 37(1) 27(1) -7(1) 7(1) -15(1) 
C(16) 28(1) 30(1) 28(1) -10(1) 2(1) -9(1) 
C(21) 33(1) 24(1) 22(1) -5(1) 3(1) -13(1) 
C(22) 32(1) 40(1) 43(1) -21(1) 6(1) -14(1) 
C(23) 31(1) 49(1) 56(1) -21(1) 1(1) -16(1) 
C(24) 48(1) 46(1) 37(1) -11(1) -3(1) -27(1) 
C(25) 51(1) 43(1) 39(1) -22(1) 6(1) -23(1) 
C(26) 35(1) - 33(1) 36(1) -15(1) 4(1) -12(1) 
Table 5. Hydrogen coordinates ( x 104) and isotropic 
displacement parameters (A2 x 103) for (84). 
X y z U(eq) 
H(2N) 6627(25) 7567(25) 5242(21) 38(6) 
H(4N) 4361(25) 6630(24) 6323(21) 36(6) 
H(3A) 5928(33) 6144(30) 2601(30) 68(9) 
H(3B) 4876(42) 6536(36) 3596(32) 91(11) 
H(3C) 6348(32) 5170(32) 3920(28) 65(8) 
H(4A) 8865(35) 6259(32) 2517(33) 80(10) 
H(4B) 9209(35) 5232(35) 3883(31) 77(9) 
H(4C) 9391(48) 6617(42) 3517(39) 116(16) 
H(5A) 591(29) 9876(26) 6646(23) 50(7) 
H(5B) 2132(28) 9449(24) 7294(23) 47(7) 
H(5C) 1243(27) 8475(27) 7615(25) 50(7) 
H(6A) 1896(29) 10566(26) 4407(23) 47(7) 
H(6B) 3299(27) 9552(24) 4111(23) 45(7) 
H(6C) 3465(30) 10111(26) 5146(24) 54(7) 
H(12) 8095(23) 3092(20) 6981(21) 29(5) 
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H(l3) 8294(26) 1089(25) 8393(21) 
H(l4) 7339(26) 956(26) 10266(23) 
H(15) 6284(26) 2845(23) 10799(23) 
H(16) 6167(24) 4900(23) 9345(20) 
H(22) 9279(26) 5834(24) 7719(22) 
H(23) 10884(32) 6136(26) 8904(24) 
H(24) 9995(27) 7506(23) 10087(22) 
H(25) 7389(27) 8568(24) 10035(23) 
H(26) 5794(27) 8275(23) 8824(20) 
Table 6. Torsion angles (degrees) for (84). 
S( 1 )-P(l )-N(2)-N(l) 
P( 1)-N(2)-N(l)-C(1) 
N(2)-N(1)-C(l)-C(2) 
N(l)-C(l)-C(2)-N(3) 
C( 1)-C(2)-N(3)-N( 4) 
C(2)-N(3)-N(4)-P(2) 
N(3)-N(4)-P(2)-S(2) 
167.36(13) 
-168.68(14) 
1.4(3) 
71.9(2) 
4.4(3) 
-165.62(14) 
-177.05(13) 
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42(6) 
45(6) 
42(6) 
35(6) 
45(6) 
56(7) 
43(6) 
47(7) 
39(6) 
AppendixD X-ray crystal structure (85) 
Table 1. Crystal data and structure refinement for (85). 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
ps 
C8 H20 N4 P2 S2 
298.34 
120(2) K 
0.71073 A 
Monoclinic 
P 1 21/n 1 
Appendices 
Unit cell dimensions a= 6.2200(1) A 
b = 12.1463(2) A 
c = 10.1414(1) A 
alpha = 90 deg. 
beta= 97.937(1) deg. 
gamma = 90 deg. 
Volume 758.84(2) A3 
z 2 
Density (calculated) 1.306 glcm3 
Absorption coefficient 0.545 mm-1 
F(OOO) 316 
Crystal size 0.40 x 0.20 x 0.15 mm 
Theta range for data collection 2.63 to 27.45 deg. 
Index ranges -7<h<8, -15<k<14, -12<1<13 
Reflections collected 5381 
Independent reflections 1735 [R(int) = 0.0238] 
Observed reflections, 1>2sigma(l) 1595 
Absorption correction Multi-scan 
Max. and min. transmission 0.843 and 0.726 
Refinement method Full-matrix least-squares on F''2 
Data I restraints I parameters 1718 I 0 I 114 
Goodness-of-fit on FA2 1.056 
Final R indices [1>2sigma(I)] R1 = 0.0253, wR2 = 0.0661 
R indices (all data) R1 = 0.0284, wR2 = 0.0726 
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> 
Extinction coefficient 0.006(2) 
Largest diff. peak and hole 
Largest shift/e.s.d. 
0.382 and -0.266 e.A-3 
0.001 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x 103) for (85). U(eq) is defined 
as one third of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
p 1969(1) 1740(1) 8712(1) 17(1) 
s 981(1) 1785(1) 10459(1) 25(1) 
N(l) 508(2) 802(1) 7764(1) 24(1) 
N(2) 957(2) 692(1) 6474(1) 19(1) 
C(l) -291(2) 54(1) . 5679(1) 16(1) 
C(2) -2217(2) -548(1) 6066(1) 22(1) 
C(3) 4789(2) 1389(1) 8730(2) 30(1) 
C(4) 1602(2) 2993(1) 7762(1) 22(1) 
Table 4. ~ond lengths [A] and angles [deg] for (85). 
P-N(l) 
P-C(4) 
P-C(3) 
P-S 
N(l)-N(2) 
N(l)-H(1) 
N(2)-C(1) 
C(l)-C(1)#1 
C(l)-C(2) 
C(2)-H(2A) 
C(2)-H(2B) 
C(2)-H(2C) 
C(3)-H(3A) 
C(3)-H(3B) 
C(3)-H(3C) 
C(4)-H(4A) 
C(4)-H(4B) 
C(4)-H(4C) 
N(l)-P-C(4) 
N(l)-P-C(3) 
C(4)-P-C(3) 
N(1)-P-S 
C(4)-P-S 
C(3)-P-S 
1.6757(11) 
1.7984(14) 
1.8026(14) 
1.9550(4) 
1.3817(14) 
0.83(2) 
1.296(2) 
1.478(2) 
1.500(2) 
0.97(2) 
0.92(2) 
0.94(2) 
0.99(2) 
0.97(2) 
0.93(2) 
0.99(2) 
0.93(2) 
0.94(2) 
104.47(6) 
107.15(7) 
104.90(7) 
109.01(4) 
115.40(5) 
115.11(5) 
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N(2)-N(l)-P 
N(2)-N(l)-H(l) 
P-N(l)-H(l) 
C(l)-N(2)-N(l) 
N(2)-C( 1)-C(1)#1 
N(2)-C(l)-C(2) 
C( 1 )#1-C( 1 )-C(2) 
C(l)-C(2)-H(2A) 
C(l)-C(2)-H(2B) 
H(2A)-C(2)-H(2B) 
C( 1 )-C(2)-H(2C) 
H(2A)-C(2)-H(2C) 
H(2B)-C(2)-H(2C) 
P-C(3)-H(3A) 
P-C(3)-H(3B) 
H(3A)-C(3 )-H(3B) 
P-C(3)-H(3C) 
H(3A)-C(3)-H(3C) 
H(3B )-C(3 )-H(3C) 
P-C(4)-H(4A) 
P-C(4)-H(4B) 
H(4A)-C(4)-H(4B) 
P-C(4)-H(4C) 
. H(4A)-C(4)-H(4C) 
H(4B)-C(4)-H(4C) 
116.36(9) 
121.1(13) 
122.1(13) 
117.63(10) 
115.41(13) 
124.07(10) 
120.52(13) 
109.5(12) 
111.2(12) 
108(2) 
112.4(11) 
109(2) 
107(2) 
108.2(11) 
108.0(12) 
108(2) 
109.9(11) 
110(2) 
113(2) 
109.9(10) 
106.4(12) 
110(2) 
109.5(11) 
109(2) 
112(2) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x,-y,-z+1 
Table 5. Anisotropic displacement parameters (A2 x 103) for (85). 
The anisotropic displacement factor exponent take.s the form: 
-2 n2 [ h2 a*2 U 11 + ... + 2 h k a* b* U 12] 
Ull U22 U33 U23 U13 U12 
p 17(1) 22(1) 12(1) -3(1) 2(1) -1(1) 
s 27(1) 38(1) 12(1) -5(1) 5(1) -5(1) 
N(l) 36(1) 26(1) 12(1) -5(1) 9(1) -12(1) 
N(2) 28(1) 18(1) 12(1) -1(1) 6(1) -2(1) 
C(l) 22(1) 15(1) 12(1) 1(1) 4(1) 2(1) 
C(2) 25(1) 26(1) 15(1) -2(1) 5(1) -6(1) 
C(3) 22(1) 43(1) 26(1) 6(1) 5(1) 8(1) 
C(4) 23(1) 21(1) 21(1) -2(1) 5(1) -2(1) 
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Table 6. Hydrogen coordinates ( x 104) and isotropic 
displacement parameters (A2 x 103) for (85). 
X y z U(eq) 
H(1) -339(31) 373(16) 8072(18) 40(5) 
H(2A) -3258(32) -21(17) 6316(18) 44(5) 
H(2B) -1817(30) -1004(16) 6782(19) 40(5) 
H(2C) -2903(29) -988(15) 5375(18) 36(5) 
H(3A) 5033(31) 647(17) 9133(19) 47(5) 
H(3B) 5653(33) 1910(16) 9304(20) 42(5) 
H(3C) 5133(30) 1388(16) 7866(19) 37(5) 
H(4A) 37(32) 3146(14) 7519(18) 33(5) 
H(4B) 2251(32) 3547(17) 8310(20) 44(5) 
H(4C) 2245(29) 2920(15) 6986(18) 34(4) 
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Appendix E X-ray crystal structure (86) 
Table 1. Crystal data and structure refinement for (86). 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
C8 H13 N2 P S 
200.23 
150(2) K 
0.71073 A 
Monoclinic 
P2(1)/c 
Appendices 
Unit cell dimensions a= 11.415(1) A 
b = 8.348(1) A 
c = 11.983(1) A 
alpha = 90 deg. 
beta= 114.54(1) deg. 
gamma = 90 deg. 
Volume 1038.7(2) A3 
z 4 
Density (calculated) 1.280 glcm3 
Absorption coefficient 0.416 mm-1 
F(OOO) 424 
Crystal size 0.4 x 0.3 x 0.2 mm 
Crystal colour colourless 
Theta range for data collection 1.96 to 30.43 deg. 
Index ranges -15<h<15, -11<k<11, -17<1<16 
Reflections collected 8012 
Independent reflections 2815 [R(int) = 0.0279] 
Observed reflections, 1>2sigma(l) 2425 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(I)] 
R indices (all data) 
Semiempirical 
0.9518 and 0.8574 
Full-matrix least-squares on f2 
2806 I 0 I 161 
1.163 
R1 = 0.0329, wRz = 0.0727 
R1 = 0.0432, wRz = 0.0824 
-203-
Largest shift/e.s.d. ratio -0.001 
Largest diff. peak and hole 0.353 and -0.255 e.A-3 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters (A2 x 103) for (86). U(eq) is defined 
as one third of the trace of the orthogonalized U ij tensor. 
X y z U(eq) 
s 5793(1) 6961(1) 1449(1) 27(1) 
p 3961(1) 7376(1) 1018(1) 19(1) 
N(l) 1063(1) 6969(2) -278(1) 19(1) 
N(2) 3079(1) 6056(2) -60(1) 22(1) 
C(2) 1735(1) 5985(2) -671(1) 18(1) 
C(3) 1161(2) 4909(2) -1643(2) 26(1) 
C(4) -169(2) 4867(2) -2214(2) 29(1) 
C(5) -884(1) 5879(2) -1815(2) 24(1) 
C(6) -239(1) 6910(2) -846(1) 20(1) 
C(7) -960(2) 8052(2) -387(2) 28(1) 
C(8) 3546(2) 7175(3) 2304(2) 31(1) 
C(9) 3467(2) 9355(2) 415(2) 27(1) 
Table 3. Bond lengths [A] and angles [deg] for (86) 
S-P 
P-N(2) 
P-C(9) 
P-C(8) 
N(l)-C(2) 
N(l)-C(6) 
N(2)-C(2) 
N(2)-H(2) 
C(2)-C(3) 
C(3)-C(4) 
C(3)-H(3) 
C(4)-C(5) 
C(4)-H(4) 
C(5)-C(6) 
C(5)-H(5) 
C(6)-C(7) 
C(7)-H(71) 
C(7)-H(72) 
C(7)-H(73) 
1.9655(5) 
1.6771(13) 
1.797(2) 
1.799(2) 
1.336(2) 
1.354(2) 
1.400(2) 
0.80(2) 
1.399(2) 
1.382(2) 
0.92(2) 
1.391(2) 
0.95(2) 
1.386(2) 
0.94(2) 
1.505(2) 
0.95(2) 
0.96(2) 
0.96(2) 
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C(8)-H(81) 
C(8)-H(82) 
C(8)-H(83) 
C(9)-H(91) 
C(9)-H(92) 
C(9)-H(93) 
N(2)-P-C(9) 
N(2)-P-C(8) 
C(9)-P-C(8) 
N(2)-P-S 
C(9)-P-S 
C(8)-P-S 
C(2)-N(l)-C(6) 
C(2)-N(2)-P 
C(2)-N(2)-H(2) 
P-N(2)-H(2) 
N ( 1 )-C(2 )-C(3) 
N(l)-C(2)-N(2) 
C(3)-C(2)-N(2) 
C( 4)-C(3)-C(2) 
C(4)-C(3)-H(3) 
C(2)-C(3 )-H(3) 
C(3)-C(4)-C(5) 
C(3)-C(4)-H(4) 
C(5)-C(4)-H(4) 
C(6)-C(5)-C(4) 
C(6)-C(5)-H(5) 
C(4)-C(5)-H(5) 
N ( 1 )-C( 6)-C( 5) 
N(l)-C(6)-C(7) 
C( 5)-C( 6)-C(7) 
C( 6)-C(7)-H(71) 
C(6)-C(7)-H(72) 
H(71 )-C(7)-H(72) 
C( 6)-C(7)-H(73) 
H(71 )-C(7)-H(73) 
H(72)-C(7)-H(73) 
. P-C(8)-H(81) 
P-C(8)-H(82) 
H(81 )-C(8)-H(82) 
P-C(8)-H(83) 
H(81)-C(8)-H(83) 
H(82)-C(8)-H(83) 
P-C(9)-H(91) 
P-C(9)-H(92) 
H(91)-C(9)-H(92) 
P-C(9)-H(93) 
H(91 )-C(9)-H(93) 
H(92)-C(9)-H(93) 
0.96(2) 
0.93(2) 
0.99(2) 
0.95(2) 
0.95(2) 
0.96(2) 
107.84(8) 
108.14(8) 
106.24(9) 
108.66(5) 
112.91(6) 
112.83(6) 
118.11(13) 
127.43(11) 
115(2) 
118(2) 
123.30(13) 
116.98(13) 
119.72(13) 
117.8(2) 
121.2(11) 
121.0(12) 
119.7(2) 
119.3(12) 
121.0(12) 
118.77(14) 
120.3(12) 
120.9(12) 
122.28(14) 
116.51(13) 
121.20(13) 
110.8(13) 
110.9(13) 
104(2) 
110.8(14) 
111(2) 
109(2) 
110.8(13) 
110.2(14) 
108(2) 
107.6(14) 
111 (2) 
110(2) 
108.6(13) 
105.2(14) 
109(2) 
109.1(14) 
112(2) 
113(2) 
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Table 4. Anisotropic displacement parameters cA2 X 103) for (86) 
The anisotropic displacement factor exponent takes the form: 
-2 A2 [ h2 a*2 U 11 + ... + 2 h k a* b* U 12] 
Ull U22 U33 U23 U13 U12 
s 13(1) 31(1) 33(1) -6(1) 5(1) 2(1) 
p 13(1) 22(1) 19(1) -3(1) 5(1) 0(1) 
N(l) 16(1) 20(1) 20(1) 0(1) 7(1) 0(1) 
N(2) 13(1) 24(1) 26(1) -7(1) 5(1) 2(1) 
C(2) 15(1) 20(1) 18(1) 1(1) 5(1) 1(1) 
C(3) 20(1) 28(1) 27(1) -9(1) 7(1) 3(1) 
C(4) 20(1) 30(1) 29(1) -10(1) 3(1) -1(1) 
C(5) 14(1) 25(1) 29(1) 0(1) 4(1) 0(1) 
C(6) 16(1) 19(1) 23(1) 4(1) 8(1) 1(1) 
C(7) 20(1) 28(1) 36(1) -3(1) 13(1) 3(1) 
C(8) 25(1) 47(1) 22(1) -4(1) 10(1) -4(1) 
C(9) 21(1) 23(1) 35(1) -2(1) 10(1) 1(1) 
Table 5. Hydrogen coordinates ( x 104) and isotropic 
displacement parameters (A2 x 103) for (86) 
X y z U(eq) 
H(2) 3457(20) 5423(26) -290(18) . 
H(3) 1653(18) 4242(23) -1886(16) 
H(4) -579(19) 4140(26) -2869(18) 
H(5) -1793(18) 5846(23) -2178(17) 
H(71) -928(20) 9117(28) -664(19) 
H(72) -554(21) 8133(26) 495(22) 
H(73) -1830(23) 7704(27) -626(21) 
H(81) 2648(21) 7392(25) 2066(19) 
H(82) 4013(21) 7899(26) 2914(21) 
H(83) 3759(22) 6068(30) 2618(21) 
H(91) 2556(20) 9422(25) 110(18) 
H(92) 3837(21) 10047(28) 1097(20) 
H(93) 3759(22) 9559(29) -218(21) 
Table 6. Torsion angles (degrees) for (86) 
S-P-N(2)-C(2) 
P-N(2)-C(2)-N(1) 
-176.19(12) 
-7.2(2) 
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33(5) 
26(5) 
36(5) 
29(5) 
39(6) 
43(6) 
44(6) 
37(6) 
39(6) 
49(7) 
35(5) 
44(6) 
51(7) 
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Appendices 
AppendixF Publications 
M.A.M. Easson and D. Parker, Synthesis of New Aza-thiophosphinate Ligands, 
Tetrahedron Letters, 1997, 38, 6091 
M.A.M. Easson and D. Parker, Aza-thiophosphinate Acids and Metal Complexes 
Thereof, British Patent Application no. 9616995.8; 1996; priority 130896 
M.A.M. Easson, Drug Suspects and Electronic Tagging, Chemistry and Industry, 1996, 
461 
.Appendix G 
Seminars 
Conferences, Lectures, Research Colloquia and 
The author attended the following meetings: 
Stereochemistry at Sheffield, University of Sheffield, 20th December 1994 
RSC UK Macrocycles Group Meeting, University of Newcastle, 4-5th January 
1995 
Stereochemistry at Sheffield, University of Sheffield, 19th December 1995 
RSC UK Macrocycles Group Meeting, University of Sheffield, 4-5th January 
1996 
31st International Conference of Coordination Chemistry,* Vancouver, BC, 
Canada, 18-23rd August 1996 
ICI Poster Presentation, University of Durham,* 18th December, 1996 (prize 
winner) 
Graduate Symposium,t University of Newcastle, 7th April1997 
21st Century Heterocyclic Chemistry, University of Sunderland, 7th May 1997 
* indicates a poster presentation by the author 
t indicates an oral presentation by the author 
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The author attended the following lecture courses: 
NMR Spectroscopy, by Dr A.M. Kenwright 
Organometallic Chemistry,-by Prof. V. Gibson and Prof. Parker 
Polymers, by Prof. W. Feast 
Appendices 
The author attended the following colloquia between October 1994 and September 
1997 
1994 
October 5 Prof. N. L. Owen, Brigham Young University, Utah, USA 
Determining Molecular Structure- the INADEQUATE NMR way 
October 19 Prof. N. Bartlett, University of California 
Some Aspects of Ag(II) and Ag(III) Chemistry 
November 2 Dr P. G. Edwards, University of Wales, Cardiff 
The Manipulation of Electronic and Structural Diversity in Metal 
Complexes - New Ligands 
November 3 Prof. B. F. G. Johnson, Edinburgh University 
Arene-metal Clusters 
November 9 Dr G. Hogarth, University College, London 
New Vistas in Metal-imido Chemistry 
November 10 Dr M. Block, Zeneca Pharmaceuticals, Macclesfield 
Large-scale Manufacture of ZD 1542, a Thromboxane Antagonist 
Synthase Inhibitor 
November 16 Prof. M. Page, University ofHuddersfield 
Four-membered Rings and ~-Lactamase 
November 23 Dr J. M. J. Williams, University of Loughborough 
New Approaches to Asymmetric Catalysis 
December 7 Prof. D. Briggs, ICI and University of Durham 
Surface Mass Spectrometry 
-208-
Appendices 
1995 
January 11 Prof. P. Parsons, University of Reading 
Applications of Tandem Reactions in Organic Synthesis 
January 25 Dr D. A. Roberts, Zeneca Pharmaceuticals 
The Design and Synthesis of Inhibitors of the Renin-angiotensin System 
February 22 Prof. E. Schaumann, University of Clausthal 
April26 
May4 
1995 
Silicon- and Sulphur-mediated Ring-opening Reactions of Epoxide 
Dr M. Schroder, University of Edinburgh 
Redox-active Macrocyclic Complexes : Rings, Stacks and Liquid 
Crystals 
Prof. A. J. Kresge, University of Toronto 
The Ingold Lecture Reactive Intermediates : Carboxylic-acid Enols and 
Other Unstable Species 
October 13 Prof. R. Schmutzler, Univ Braunschweig, FRO. 
Calixarene-Phosphorus Chemistry: A New Dimension in Phosphorus 
Chemistry 
October 18 Prof. A. Alexakis, Univ. Pierre et Marie Curie, Paris, 
Synthetic and Analytical Uses of Chiral Diamines 
October 25 Dr.D.Martin Davies, University of Northumbria 
Chemical reactions in organised systems. 
November 1 Prof. W. Motherwell, UCL London 
New Reactions for Organic Synthesis 
December 8 Professor M. T. Reetz, Max Planck Institut, Mulheim 
Perkin Regional Meeting 
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1996 
January 10 
January 11 
January 24 
Dr Bill Henderson, Waikato University, NZ 
Electrospray Mass Spectrometry - a new sporting technique 
Dr Terry 0' Brien, Rayne Institute, St. Thomas' Hospital 
Medical Sensors: The Changing Face of Critical Care 
Dr Alan Armstrong, Nottingham Univesity 
Alkene Oxidation and Natural Product Synthesis 
February 12 Dr Paul Pringle, University of Bristol 
Catalytic Self-Replication of Phosphines on Platinum( G) 
March 7 Dr D.S. Wright, University of Cambridge 
March 12 
Synthetic Applications of Me2N-p-Block Metal Reagents 
RSC Endowed Lecture- Prof. V. Balzani, Univ of Bologna 
Supramolecular Photochemistry 
Appendices 
April30 Dr L.D.Pettit, Chairman, IUPAC Commission of Equilibrium Data 
pH-metric studies using very small quantities of uncertain purity 
1996 
October 22 Professor Lutz Gade, Univ. Wurzburg, Germany 
Organic transformations with Early-Late Heterobimetallics: Synergism 
and Selectivity 
October 22 Professor B. J. Tighe, Department of Molecular Sciences and Chemistry, 
University of Aston 
Making Polymers for Biomedical Application- can we meet Nature's 
Challenge? 
October 23 Professor H. Ringsdorf (Perkin Centenary Lecture), Johannes 
Gutenberg- Universitat, Mainz, Germany 
Function Based on Organisation 
November 18 Professor G. A. Olah, University of Southern California, USA 
Crossing Conventional Lines in my Chemistry of the Elements 
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November 19 Professor R. E. Grigg, University of Leeds 
Assembly of Complex Molecules by Palladium-Catalysed Queueing 
Processes 
December 11 Dr Chris Richards, Cardiff University 
Stereochemical Games with Metallocenes 
1997 
January 15 
January 16 
March 3 
March 5 
March 11 
March 19 
May29 
Dr V. K. Aggarwal, University of Sheffield 
Sulfur Mediated Asymmetric Synthesis 
Dr Sally Brooker, University of Otago, NZ 
Macrocycles: Exciting yet Controlled Thiolate Coordination Chemistry 
Prof. Jim Riehl, Michigan, 
The Enantioselective Quenching of Lanthanide complexes 
Dr J. Staunton FRS, Cambridge University 
Tinkering with biosynthesis: towards a new generation of antibiotics 
Dr A. D. Taylor, ISIS Facility, Rutherford Appleton Laboratory 
Expanding the Frontiers of Neutron Scattering 
Dr Katharine Reid, University of Nottingham 
Probing Dynamical Processes with Photoelectrons 
Prof. R. Grubbs, California Institute of Technology, 
Olefin Metathesis Catalysts 
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